A61K   6/00  \	0	0	4C089	A61K   6/00	220	ޡΣ	Preparations for dentistry
A61K   6/15  \	1	1	4C089	A61K   6/15	1442	ʪŪħΤʪΣ	Compositions characterised by their physical properties
A61K   6/16  \	2	2	4C089	A61K   6/16	178	ΨΣ	Refractive index
A61K   6/17  \	2	2	4C089	A61K   6/17	1097	γҷ¡Σ	Particle size
A61K   6/18  \	2	2	4C089	A61K   6/18	11	̤Ρ㡥ѲޤȴΤλ³ĥѤʪΣ	causing dental retraction e.g. compositions for widening the sulcus for making dental impressions or removing teeth
A61K   6/19  \	2	2	4C089	A61K   6/19	19	ĥ㡥νŶΤΡΣ	Self-expanding e.g. for filling teeth
A61K   6/20  \	1	1	4C089	A61K   6/20	852	ޤϿ͹Τݸʤ㡥̩ʤޤϥ˥Σ	Protective coatings for natural or artificial teeth e.g. sealings dye coatings or varnish
A61K   6/25  \	1	1	4C089	A61K   6/25	70	Фޤ¬Τʪ㡥ޤϿ͹ΰ۾Σ	Compositions for detecting or measuring e.g. of irregularities on natural or artificial teeth
A61K   6/30  \	1	1	4C089	A61K   6/30	1600	ŪˤޤϱʵŪ˻ޤϸꤹ뤿ʪ㡥ѥץ饤ޡΣ	Compositions for temporarily or permanently fixing teeth or palates e.g. primers for dental adhesives
A61K   6/35  \	2	2	4C089	A61K   6/35	236	εꤵ뤿ޡΣ	Preparations for stabilising dentures in the mouth
A61K   6/40  \	1	1	4C089	A61K   6/40	357	ץ饤ޡʻѤΤΣˣˡΣ	Primers (for dental adhesives A61K6/30)
A61K   6/50  \	1	1	4C089	A61K   6/50	73	äŬ礷ޡΣ	Preparations specially adapted for dental root treatment
A61K   6/52  \	2	2	4C089	A61K   6/52	35	ݡΣ	Cleaning; Disinfecting
A61K   6/54  \	2	2	4C089	A61K   6/54	429	Ŷ̩Σ	Filling; Sealing
A61K   6/56  \	2	2	4C089	A61K   6/56	27	šΣ	Apical treatment
A61K   6/58  \	2	2	4C089	A61K   6/58	123	ʥץȤäŬ礷ΡΣ	specially adapted for dental implants
A61K   6/60  \	1	1	4C089	A61K   6/60	3726	ͭޤͭ°źʪޤΡΣ	comprising organic or organo-metallic additives
A61K   6/61  \	2	2	4C089	A61K   6/61	528	ۥޤϻԸϺޡΣ	Cationic anionic or redox initiators
A61K   6/62  \	2	2	4C089	A61K   6/62	1043	إ饸볫ϺޡΣ	Photochemical radical initiators
A61K   6/64  \	2	2	4C089	A61K   6/64	276	Ǯ饸볫ϺޡΣ	Thermal radical initiators
A61K   6/65  \	2	2	4C089	A61K   6/65	142	Σ	Dyes
A61K   6/66  \	3	3	4C089	A61K   6/66	20	եȥߥåΣ	Photochromic dyes
A61K   6/68  \	3	3	4C089	A61K   6/68	12	⥯ߥåΣ	Thermochromic dyes
A61K   6/69  \	2	2	4C089	A61K   6/69	375	ʡΣ	Medicaments
A61K   6/70  \	1	1	4C089	A61K   6/70	1482	̵źʪޤΡΣ	comprising inorganic additives
A61K   6/71  \	2	2	4C089	A61K   6/71	884	ŶޡΣ	Fillers
A61K   6/72  \	3	3	4C089	A61K   6/72	38	ǴͭʪޤΡΣ	comprising nitrogen-containing compounds
A61K   6/73  \	3	3	4C089	A61K   6/73	180	βͭʪޤΡΣ	comprising sulfur-containing compounds
A61K   6/74  \	3	3	4C089	A61K   6/74	351	ͭʪޤΡΣ	comprising phosphorus-containing compounds
A61K   6/75  \	4	4	4C089	A61K   6/75	328	ѥȡΣ	Apatite
A61K   6/76  \	3	3	4C089	A61K   6/76	963	ǴͭʪޤΡΣ	comprising silicon-containing compounds
A61K   6/77  \	3	3	4C089	A61K   6/77	519	饹Σ	Glass
A61K   6/78  \	2	2	4C089	A61K   6/78	156	Σ	Pigments
A61K   6/79  \	2	2	4C089	A61K   6/79	127	ϺޡΣ	Initiators
A61K   6/80  \	1	1	4C089	A61K   6/80	102	͹ŶޤʤΤޡΣ	Preparations for artificial teeth for filling teeth or for capping teeth
A61K   6/802  \	2	2	4C089	A61K   6/802	756	ߥåޤΡΣ	comprising ceramics
A61K   6/804  \	3	3	4C089	A61K   6/804	57	ޥ󥬥ޤΡΣ	comprising manganese oxide
A61K   6/807  \	3	3	4C089	A61K   6/807	154	ޥͥޤΡΣ	comprising magnesium oxide
A61K   6/809  \	3	3	4C089	A61K   6/809	2	٥ꥦޤΡΣ	comprising beryllium oxide
A61K   6/811  \	3	3	4C089	A61K   6/811	25	ޤΡΣ	comprising chromium oxide
A61K   6/813  \	3	3	4C089	A61K   6/813	108	ŴޤΡΣ	comprising iron oxide
A61K   6/816  \	3	3	4C089	A61K   6/816	286	ޤΡΣ	comprising titanium oxide
A61K   6/818  \	3	3	4C089	A61K   6/818	589	륳˥ޤΡΣ	comprising zirconium oxide
A61K   6/82  \	3	3	4C089	A61K   6/82	49	ϥե˥ޤΡΣ	comprising hafnium oxide
A61K   6/822  \	3	3	4C089	A61K   6/822	247	°ʪޤΡΣ	comprising rare earth metal oxides
A61K   6/824  \	3	3	4C089	A61K   6/824	155	ܶ°ʪޤΡΣ	comprising transition metal oxides
A61K   6/827  \	3	3	4C089	A61K   6/827	28	СΣ	Leucite
A61K   6/829  \	2	2	4C089	A61K   6/829	4	åȡʣʪޤΡΣ	comprising cermet composites
A61K   6/831  \	2	2	4C089	A61K   6/831	1828	°ǤޤϤβʪޤΡ㡥úǡΣ	comprising non-metallic elements or compounds thereof e.g. carbon
A61K   6/833  \	3	3	4C089	A61K   6/833	287	饹ݥߥåʣʪΣ	Glass-ceramic composites
A61K   6/836  \	3	3	4C089	A61K   6/836	807	饹Σ	Glass
A61K   6/838  \	3	3	4C089	A61K   6/838	732	ղʪ㡥ѥȡΣ	Phosphorus compounds e.g. apatite
A61K   6/84  \	2	2	4C089	A61K   6/84	746	°ޤϹޤΡΣ	comprising metals or alloys
A61K   6/842  \	3	3	4C089	A61K   6/842	103	°Σ	Rare earth metals
A61K   6/844  \	3	3	4C089	A61K   6/844	368	°Σ	Noble metals
A61K   6/847  \	3	3	4C089	A61K   6/847	56	ޥ륬Σ	Amalgams
A61K   6/849  \	2	2	4C089	A61K   6/849	156	̵ȤޤΡΣ	comprising inorganic cements
A61K   6/851  \	3	3	4C089	A61K   6/851	36	ݥȥɥȡΣ	Portland cements
A61K   6/853  \	3	3	4C089	A61K   6/853	180	Σ	Silicates
A61K   6/856  \	3	3	4C089	A61K   6/856	6	ݥΣ	Pozzolans
A61K   6/858  \	3	3	4C089	A61K   6/858	33	β륷ࡤ㡥ФΣ	Calcium sulfates e.g gypsum
A61K   6/86  \	3	3	4C089	A61K   6/86	90	ݥȡΣ	Al-cements
A61K   6/862  \	3	3	4C089	A61K   6/862	1	ãݣβݥȡΣ	Ca-Al-sulfate-cements
A61K   6/864  \	3	3	4C089	A61K   6/864	155	ջȡʥѥȣˣˡΣ	Phosphate cements (apatite A61K6/838)
A61K   6/867  \	3	3	4C089	A61K   6/867	1	˥ॻȡΣ	Ammonium cements
A61K   6/869  \	3	3	4C089	A61K   6/869	9	饤ȡΣ	Zeolites
A61K   6/871  \	3	3	4C089	A61K   6/871	146	бѡӣϣΣ	Quartz; SiO2
A61K   6/873  \	3	3	4C089	A61K   6/873	29	úΣ	Carbonates
A61K   6/876  \	3	3	4C089	A61K   6/876	31	륷Σ	Calcium oxide
A61K   6/878  \	3	3	4C089	A61K   6/878	67	륳˥Σ	Zirconium oxide
A61K   6/88  \	3	3	4C089	A61K   6/88	4	Σ	Chromium oxide
A61K   6/882  \	3	3	4C089	A61K   6/882	10	úʪΣ	Carbides
A61K   6/884  \	2	2	4C089	A61K   6/884	456	ŷޤϹޤΡΣ	comprising natural or synthetic resins
A61K   6/887  \	3	3	4C089	A61K   6/887	1935	úǡú˰·ΤߤͿȿˤä벽ʪΣ	Compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
A61K   6/889  \	4	4	4C089	A61K   6/889	384	ݥꥫܥȡ饹ΥޡȡΣ	Polycarboxylate cements; Glass ionomer cements
A61K   6/891  \	3	3	4C089	A61K   6/891	357	úǡú˰·ΤߤͿȿʳȿˤä벽ʪΣ	Compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
A61K   6/893  \	4	4	4C089	A61K   6/893	125	ݥꥦ쥿Σ	Polyurethanes
A61K   6/896  \	4	4	4C089	A61K   6/896	159	ݥꥪ륬Υꥳ󲽹ʪΣ	Polyorganosilicon compounds
A61K   6/898  \	3	3	4C089	A61K   6/898	145	¿Σ	Polysaccharides
A61K   6/90  \	1	1	4C089	A61K   6/90	474	ѲμΤʪΣ	Compositions for taking dental impressions
A61K   8/00  \	0	0	4C083	A61K   8/00	46742	ʤ뤤ޡΣ	Cosmetics or similar toiletry preparations [2006.01]
A61K   8/02  \	1	1	4C083	A61K   8/02	13811	̤ʪŪ֤ħΡΣ	characterised by special physical form
A61K   8/03  \	2	2	4C083	A61K   8/03	550	ޤϤʾΰۤʤؤͭվʪΣ	Liquid compositions with two or more distinct layers [8]
A61K   8/04  \	2	2	4C083	A61K   8/04	2879	ʬΣ	Dispersions; Emulsions [8]
A61K   8/06  \	3	3	4C083	A61K   8/06	10572	Σ	Emulsions [8]
A61K   8/11  \	2	2	4C083	A61K   8/11	1828	ץ벽줿ʪΣ	Encapsulated compositions [8]
A61K   8/14  \	2	2	4C083	A61K   8/14	891	ݥΣ	Liposomes [8]
A61K   8/18  \	1	1	4C083	A61K   8/18	3339	ħΡΣ	characterised by the composition
A61K   8/19  \	2	2	4C083	A61K   8/19	10341	̵۹ʬޤΡΣ	containing inorganic ingredients [8]
A61K   8/20  \	3	3	4C083	A61K   8/20	2514	ϥ󡨤βʪΣ	Halogens; Compounds thereof [8]
A61K   8/21  \	4	4	4C083	A61K   8/21	1245	դòʪͶƳΡΣ	Fluorides; Derivatives thereof [8]
A61K   8/22  \	3	3	4C083	A61K   8/22	2115	ʪǡΣ	Peroxides; Oxygen; Ozone [8]
A61K   8/23  \	3	3	4C083	A61K   8/23	2243	β󡨥ƥ롨βʪΣ	Sulfur; Selenium; Tellurium; Compounds thereof [8]
A61K   8/24  \	3	3	4C083	A61K   8/24	2440	󡨤βʪΣ	Phosphorus; Compounds thereof [8]
A61K   8/25  \	3	3	4C083	A61K   8/25	8082	ꥳ󡨤βʪΣ	Silicon; Compounds thereof [8]
A61K   8/26  \	3	3	4C083	A61K   8/26	3061	ߥ˥ࡨβʪΣ	Aluminium; Compounds thereof [8]
A61K   8/27  \	3	3	4C083	A61K   8/27	2629	βʪΣ	Zinc; Compounds thereof [8]
A61K   8/28  \	3	3	4C083	A61K   8/28	436	륳˥ࡨβʪΣ	Zirconium; Compounds thereof [8]
A61K   8/29  \	3	3	4C083	A61K   8/29	4485	󡨤βʪΣ	Titanium; Compounds thereof [8]
A61K   8/30  \	2	2	4C083	A61K   8/30	9620	ͭʪޤΡΣ	containing organic compounds [8]
A61K   8/31  \	3	3	4C083	A61K   8/31	7362	úǡΣ	Hydrocarbons [8]
A61K   8/33  \	3	3	4C083	A61K   8/33	5332	ǤޤΡΣ	containing oxygen [8]
A61K   8/34  \	4	4	4C083	A61K   8/34	21520	륳Σ	Alcohols [8]
A61K   8/35  \	4	4	4C083	A61K   8/35	4820	ȥ㡥Υ󡤥٥󥾥եΥΣ	Ketones, e.g. quinones, benzophenone [8]
A61K   8/36  \	4	4	4C083	A61K   8/36	12010	ܥαޤ̵ʪΣ	Carboxylic acids; Salts or anhydrides thereof [8]
A61K   8/362  \	5	5	4C083	A61K   8/362	1482	ݥꥫܥΣ	Polycarboxylic acids [8]
A61K   8/365  \	5	5	4C083	A61K   8/365	4911	ҥɥܥȥܥΣ	Hydroxycarboxylic acids; Ketocarboxylic acids [8]
A61K   8/368  \	5	5	4C083	A61K   8/368	1527	˧²ĤúǸҤľܷ礷ܥͭΡΣ	with carboxyl groups directly bound to carbon atoms of aromatic rings [8]
A61K   8/37  \	4	4	4C083	A61K   8/37	15717	ܥƥΣ	Esters of carboxylic acids [8]
A61K   8/38  \	4	4	4C083	A61K   8/38	399	ʪ㡥Σ	Percompounds, e.g. peracids [8]
A61K   8/39  \	4	4	4C083	A61K   8/39	5667	飱Υ륭ޤͶƳΡΣ	Derivatives containing from 2 to 10 oxyalkylene groups [8]
A61K   8/40  \	3	3	4C083	A61K   8/40	7120	ǤޤΡǤޤ७ΥˣˡΣ	containing nitrogen (quinones containing nitrogen A61K 8/35) [8]
A61K   8/41  \	4	4	4C083	A61K   8/41	8205	ߥΣ	Amines [8]
A61K   8/42  \	4	4	4C083	A61K   8/42	5953	ߥɡΣ	Amides [8]
A61K   8/43  \	4	4	4C083	A61K   8/43	673	˥Σ	Guanidines [8]
A61K   8/44  \	4	4	4C083	A61K   8/44	9794	ߥΥܥޤϤͶƳΡ㡥βޤॢߥΥܥƥޤϤΣΥ벽ͶƳΡΣ	Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts, esters or N-acylated derivatives thereof [8]
A61K   8/45  \	4	4	4C083	A61K   8/45	328	飱Υ륭ޤͶƳΡΣ	Derivatives containing from 2 to 10 oxyalkylene groups [8]
A61K   8/46  \	3	3	4C083	A61K   8/46	8201	βޤΡʣˣͥˡΣ	containing sulfur (A61K 8/44 takes precedence) [8]
A61K   8/49  \	3	3	4C083	A61K   8/49	15364	ʣǴļʪޤΡΣ	containing heterocyclic compounds [8]
A61K   8/55  \	3	3	4C083	A61K   8/55	2668	ޤΡΣ	containing phosphorus [8]
A61K   8/58  \	3	3	4C083	A61K   8/58	3140	úǡǡϥ󡤻ǡǡβޤϤʳθҤޤΡΣ	containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus [8]
A61K   8/60  \	3	3	4C083	A61K   8/60	7773	ࡨͶƳΡΣ	Sugars; Derivatives thereof [8]
A61K   8/63  \	3	3	4C083	A61K   8/63	2566	ƥɡͶƳΡΣ	Steroids; Derivatives thereof
A61K   8/64  \	3	3	4C083	A61K   8/64	7152	ڥץɡͶƳΤޤʬʪΣ	Proteins; Peptides; Derivatives or degradation products thereof [8]
A61K   8/65  \	4	4	4C083	A61K   8/65	2164	顼󡨥󡨥󡨤ͶƳΤޤʬʪΣ	Collagen; Gelatin; Keratin; Derivatives or degradation products thereof [8]
A61K   8/66  \	4	4	4C083	A61K   8/66	1985	ǡΣ	Enzymes [8]
A61K   8/67  \	3	3	4C083	A61K   8/67	4603	ӥߥΣ	Vitamins [8]
A61K   8/68  \	3	3	4C083	A61K   8/68	1112	ե󥴥ԥɡ㡥ߥɡ֥ɡ󥰥ꥪɡΣ	Sphingolipids, e.g. ceramides, cerebrosides, gangliosides [8]
A61K   8/69  \	3	3	4C083	A61K   8/69	137	եǤޤΡΣ	containing fluorine [8]
A61K   8/70  \	4	4	4C083	A61K   8/70	93	ѡե륪ޤΡ㡥ѡե륪ƥΣ	containing perfluoro groups, e.g. perfluoroethers [8]
A61K   8/72  \	2	2	4C083	A61K   8/72	7875	ͭʬҲʪޤΡΣ	containing organic macromolecular compounds [8]
A61K   8/73  \	3	3	4C083	A61K   8/73	16839	¿Σ	Polysaccharides [8]
A61K   8/81  \	3	3	4C083	A61K   8/81	10257	úǡú˰·ΤߤͿȿˤäΡΣ	obtained by reactions involving only carbon-to-carbon unsaturated bonds [8]
A61K   8/84  \	3	3	4C083	A61K   8/84	1019	úǡú˰·ΤߤͿȿʳȿˤäΡΣ	obtained by reactions other than those involving only carbon-to-carbon unsaturated bonds [8]
A61K   8/85  \	4	4	4C083	A61K   8/85	1270	ݥꥨƥΣ	Polyesters [8]
A61K   8/86  \	4	4	4C083	A61K   8/86	7786	ݥꥨƥΣ	Polyethers [8]
A61K   8/87  \	4	4	4C083	A61K   8/87	1324	ݥꥦ쥿Σ	Polyurethanes [8]
A61K   8/88  \	4	4	4C083	A61K   8/88	1309	ݥꥢߥɡΣ	Polyamides [8]
A61K   8/89  \	4	4	4C083	A61K   8/89	8810	ݥꥷΣ	Polysiloxanes [8]
A61K   8/891  \	5	5	4C083	A61K   8/891	8370	˰¾֤ˤΡ㡥󡤥ե˥ȥ󡤣ãݣãϥƥ롦Σ	saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone [8]
A61K   8/892  \	6	6	4C083	A61K   8/892	512	ҥɥˤ꽤ƤΡ㡥ΡΣ	modified by a hydroxy group, e.g. dimethiconol [8]
A61K   8/893  \	6	6	4C083	A61K   8/893	318	륳ϥ륪ˤ꽤ƤΡ㡥٥إΥϥƥΣ	modified by an alkoxy or aryloxy group, e.g. behenoxy dimethicone or stearoxy dimethicone [8]
A61K   8/894  \	6	6	4C083	A61K   8/894	1441	ݥꥪ륭ˤ꽤ƤΡ㡥른󥳥ݥꥪΣ	modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol [8]
A61K   8/895  \	5	5	4C083	A61K   8/895	558	˰¤λ²˷礷ꥳޤΡ㡥ӥ˥른Σ	containing silicon bound to unsaturated aliphatic groups, e.g. vinyl dimethicone [8]
A61K   8/896  \	5	5	4C083	A61K   8/896	73	ꥳúǡǤӿǰʳθҤޤΡ㡥󥳥ݥꥪΣ	containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate [8]
A61K   8/897  \	6	6	4C083	A61K   8/897	185	ϥޤΡ㡥ե륪ꥳΣ	containing halogen, e.g. fluorosilicones [8]
A61K   8/898  \	6	6	4C083	A61K   8/898	1405	ǤޤΡ㡥⥸󡤥ȥ륷륢⥸ϥץԥУǥ٥Σ	containing nitrogen, e.g. amodimethicone, trimethyl silyl amodimethicone or dimethicone propyl PG-betaine [8]
A61K   8/899  \	6	6	4C083	A61K   8/899	71	βޤΡ㡥Уǥץԥ른βΣᥳݥꥪΣ	containing sulfur, e.g. sodium PG-propyldimethicone thiosulfate copolyol [8]
A61K   8/90  \	3	3	4C083	A61K   8/90	816	֥åŹΡʣˣͥˡΣ	Block copolymers (A61K 8/89 takes precedence) [8]
A61K   8/91  \	3	3	4C083	A61K   8/91	418	եȶŹΡʣˣͥˡΣ	Graft copolymers (A61K 8/89 takes precedence) [8]
A61K   8/92  \	2	2	4C083	A61K   8/92	8861	äޤϤͶƳΡ㡥ǲʪΣ	Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products [8]
A61K   8/96  \	2	2	4C083	A61K   8/96	2538	¤ʪޤϤͶƳΤޤΡΣ	containing materials, or derivatives thereof, of undetermined constitution [8]
A61K   8/97  \	3	3	4C083	A61K   8/97	16544	ࡤࡤϰޤϿʪͳΤΡʪͳΤΡΣ	from algae, fungi, lichens or plants; from derivatives thereof [2017.01]
A61K   8/9706  \	4	4	4C083	A61K   8/9706	550	Σ	Algae [2017.01]
A61K   8/9711  \	5	5	4C083	A61K   8/9711	655	ʪγϡ㡥ҥХޥΣ	Phaeophycota or Phaeophyta [brown algae], e.g. Fucus [2017.01]
A61K   8/9717  \	5	5	4C083	A61K   8/9717	473	ʪιϡ㡥ΥΣ	Rhodophycota or Rhodophyta [red algae], e.g. Porphyra [2017.01]
A61K   8/9722  \	5	5	4C083	A61K   8/9722	369	ʪϡ㡥Σ	Chlorophycota or Chlorophyta [green algae], e.g. Chlorella [2017.01]
A61K   8/9728  \	4	4	4C083	A61K   8/9728	2099	ࡤ㡥Σ	Fungi, e.g. yeasts [2017.01]
A61K   8/9733  \	4	4	4C083	A61K   8/9733	50	ϰΣ	Lichens [2017.01]
A61K   8/9739  \	4	4	4C083	A61K   8/9739	51	ʪΥϡΣ	Bryophyta [mosses] [2017.01]
A61K   8/9741  \	4	4	4C083	A61K   8/9741	260	ʪΥϡΣ	Pteridophyta [ferns] [2017.01]
A61K   8/9749  \	5	5	4C083	A61K   8/9749	97	ˡΣ	Filicopsida or Pteridopsida [2017.01]
A61K   8/9755  \	4	4	4C083	A61K   8/9755	139	ҿʪε̿ʪϡΣ	Gymnosperms [Coniferophyta] [2017.01]
A61K   8/9761  \	5	5	4C083	A61K   8/9761	451	ҥΥʡΥȥʡϡ㡥ӥ㥯ޤϥȥΣ	Cupressaceae [Cypress family], e.g. juniper or cypress [2017.01]
A61K   8/9767  \	5	5	4C083	A61K   8/9767	554	ޥĲʡ㡥ޥĤޤϥҥޥ䥹Σ	Pinaceae [Pine family], e.g. pine or cedar [2017.01]
A61K   8/9771  \	4	4	4C083	A61K   8/9771	387	祦硤㡥祦ʡΣ	Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family] [2017.01]
A61K   8/9778  \	4	4	4C083	A61K   8/9778	50	ޥ硤㡥ޥʡΥƥʡϡΣ	Gnetophyta, e.g. Ephedraceae [Mormon-tea family] [2017.01]
A61K   8/9783  \	4	4	4C083	A61K   8/9783	179	ҿʪΣ	Angiosperms [Magnoliophyta] [2017.01]
A61K   8/9789  \	5	5	4C083	A61K   8/9789	15305	⥯ˡлտʪϡΣ	Magnoliopsida [dicotyledons] [2017.01]
A61K   8/9794  \	5	5	4C083	A61K   8/9794	5572	ˡñտʪϡΣ	Liliopsida [monocotyledons] [2017.01]
A61K   8/98  \	3	3	4C083	A61K   8/98	4437	ưʪͳΤΡΣ	of animal origin [8]
A61K   8/99  \	3	3	4C083	A61K   8/99	2537	ޤ϶ʳʪͳΤΡ㡥ưʪޤϥХƥꥢΣ	from microorganisms other than algae or fungi, e.g. protozoa or bacteria [2017.01]
A61K   9/00  \	0	0	4C076	A61K   9/00	4230	̤ʪŪ֤ˤäħŤ줿ʤ	Medicinal preparations characterised by special physical form
A61K   9/02  \	1	1	4C076	A61K   9/02	1739	ºޡ֥ºޤޤϥ֥Ѵޡ¤֣ʣƳ뤿δͣ	Suppositories; Bougies; Bases for suppositories or bougies (apparatus for making A61J 3/08; devices for introducing into the body A61M 31/00)
A61K   9/06  \	1	1	4C076	A61K   9/06	10315	ѡѴޡ¤֣ʣ	Ointments; Bases therefor (apparatus for making A61J 3/04)
A61K   9/08  \	1	1	4C076	A61K   9/08	23456	ϱպޡΣ	Solutions [2,3]
A61K   9/10  \	1	1	4C076	A61K   9/10	8842	ʬޡޡΣ	Dispersions; Emulsions [2,3]
A61K   9/107  \	2	2	4C076	A61K   9/107	7591	ޥ른Σ	Emulsions [5]
A61K   9/113  \	3	3	4C076	A61K   9/113	286	ʣ票ޥ른㡥塿Σ	Multiple emulsions, e.g. oil-in-water-in-oil [5]
A61K   9/12  \	2	2	4C076	A61K   9/12	5438	롨ˢޡΣ	Aerosols; Foams [2,3]
A61K   9/127  \	2	2	4C076	A61K   9/127	7142	إӥҥ롤㡥ݥޤͣۥե볦̳ޤȤƥ쥹ƥޤݥΣ	Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant[2025.01]
A61K   9/1271  \	3	3	4C076	A61K   9/1271	68	Ūʥݥࡤ㡥Уţǲݥࡤޤϥݥޡʤ줿ޤϥեȲ줿ݥʷΤȤƤΥݥˣˡΣ	Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers (liposomes as conjugates A61K47/69) [2025.01]
A61K   9/1272  \	4	4	4C076	A61K   9/1272	29	طʪȤƤۥե볦̳ޤޤΡ㡥ޤϥݥޡʤ줿ޤϥեȲ줿ۥեݥʽޤȤƤλˣˡΣ	comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers (lipids as modifying agents A61K47/54)[2025.01]
A61K   9/1273  \	4	4	4C076	A61K   9/1273	15	ݥޡࡨŹǽʤޤϽŹ礷طʪޤݥࡡΣ	Polymersomes; Liposomes with polymerisable or polymerised bilayer-forming substances [2025.01]
A61K   9/1274  \	3	3	4C076	A61K   9/1274	1	٥ع¤㡥վٴɡ塼ӥåޤϥꥨȡݥΣ	Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases[2025.01]
A61K   9/1275  \	3	3	4C076	A61K   9/1275	1	ޤϤʬ㡥ߥ󡨿͹̩٥Σȣģ̡ϡ̩٥Σ̣ģ̡ϤޤĶ̩٥Σ֣̣ģ̡ϡΡΣ	Lipoproteins or protein-free species thereof, e.g. chylomicrons; Artificial high-density lipoproteins [HDL], low-density lipoproteins [LDL] or very-low-density lipoproteins [VLDL]; Precursors thereof[2025.01]
A61K   9/1276  \	3	3	4C076	A61K   9/1276	5	õ塨ιʬΣ	Globules of milk; Constituents thereof[2025.01]
A61K   9/1277  \	3	3	4C076	A61K   9/1277	1126	ĴץץݥΣ	Preparation processes; Proliposomes[2025.01]
A61K   9/1278  \	4	4	4C076	A61K   9/1278	1	ݥȥǥ󥰡㡥ۤޤϣȸۤˤΡΣ	Post-loading, e.g. by ion or pH gradient[2025.01]
A61K   9/14  \	1	1	4C076	A61K   9/14	12638	γޡ㡥ޡʥޥץˣˡΣ	Particulate form, e.g. powders (microcapsules A61K 9/50) [2]
A61K   9/16  \	2	2	4C076	A61K   9/16	7027	ޡγޡޥӡåȡΣ	Agglomerates; Granulates; Microbeadlets [2]
A61K   9/18  \	2	2	4C076	A61K   9/18	208	ޡΣ	Adsorbates [2]
A61K   9/19  \	2	2	4C076	A61K   9/19	3788	봥ˤΡΣ	lyophilised [6]
A61K   9/20  \	1	1	4C076	A61K   9/20	14984	ݺޡҤޤޤϾޡΣ	Pills, lozenges or tablets [2]
A61K   9/22  \	2	2	4C076	A61K   9/22	1673	³ޤϽΤΡΣ	Sustained or differential release type [2]
A61K   9/24  \	3	3	4C076	A61K   9/24	826	ؾޤҾñͿΡΣ	Layered or laminated unitary dosage forms [2]
A61K   9/26  \	3	3	4C076	A61K   9/26	777	ٻ̸ĤγҤͭΡΣ	Discrete particles in supporting matrix [2]
A61K   9/28  \	2	2	4C076	A61K   9/28	2049	ʤ줿ݺޤޤϾޡΣ	Dragees; Coated pills or tablets [2]
A61K   9/30  \	3	3	4C076	A61K   9/30	1070	ͭʤޡΣ	Organic coatings [2]
A61K   9/32  \	4	4	4C076	A61K   9/32	911	ιݥޡͭΡΣ	containing solid synthetic polymers [2]
A61K   9/34  \	4	4	4C076	A61K   9/34	123	ŷޤϼͭΡΣ	containing natural gums or resins [2]
A61K   9/36  \	4	4	4C076	A61K   9/36	1013	ú岽ʪޤϤͶƳΤͭΡʣˣͥˡΣ	containing carbohydrates or derivatives thereof (A61K 9/34 takes precedence) [2]
A61K   9/38  \	4	4	4C076	A61K   9/38	85	ޤϤͶƳΤͭΡΣ	containing proteins or derivatives thereof [2]
A61K   9/40  \	5	5	4C076	A61K   9/40	89	ͭΤΡΣ	Gelatin containing [2]
A61K   9/42  \	4	4	4C076	A61K   9/42	115	ûå륳ޤϤͶƳΡ㡥祳졼ȡͭΡΣ	containing waxes, higher fatty acids, higher fatty alcohols, or derivatives thereof, e.g. chocolate [2]
A61K   9/44  \	2	2	4C076	A61K   9/44	366	줿ĦΤ롤ߤդΤޤϷΤΡΣ	printed, embossed, grooved, or perforated [2]
A61K   9/46  \	2	2	4C076	A61K   9/46	289	ˢΤΡΣ	effervescent [2]
A61K   9/48  \	1	1	4C076	A61K   9/48	11160	ץޡ㡥ΤΡ祳졼ΤΡΣ	Preparations in capsules, e.g. of gelatin, of chocolate [2]
A61K   9/50  \	2	2	4C076	A61K   9/50	3310	ޥץʣˣͥˡΣ	Microcapsules (A61K 9/52 takes precedence) [2]
A61K   9/51  \	3	3	4C076	A61K   9/51	2761	ʥΥץΣ	Nanocapsules [5]
A61K   9/52  \	2	2	4C076	A61K   9/52	1400	³ޤϽΤΡΣ	Sustained or differential release type [2]
A61K   9/54  \	3	3	4C076	A61K   9/54	184	ۤʤޤϰۤʤʪʤ줿γҤͭΡΣ	containing discrete particles with coatings of different thicknesses or different materials [2]
A61K   9/56  \	4	4	4C076	A61K   9/56	370	ͭʤޡΣ	Organic coatings [2]
A61K   9/58  \	5	5	4C076	A61K   9/58	502	ιݥޡͭΡΣ	containing solid synthetic polymers [2]
A61K   9/60  \	5	5	4C076	A61K   9/60	61	ŷޤϼͭΡΣ	containing natural gums or resins [2]
A61K   9/62  \	5	5	4C076	A61K   9/62	466	ú岽ʪޤϤͶƳΤͭΡʣˣͥˡΣ	containing carbohydrates or derivatives thereof (A61K 9/60 takes precedence) [2]
A61K   9/64  \	5	5	4C076	A61K   9/64	216	ޤϤͶƳΤͭΡΣ	containing proteins or derivatives thereof [2]
A61K   9/66  \	3	3	4C076	A61K   9/66	230	ޡʬޤޤϱպޤͭΡΣ	containing emulsions, dispersions or solutions [2]
A61K   9/68  \	1	1	4C076	A61K   9/68	647	奦󥰥෿Σ	chewing gum type [2]
A61K   9/70  \	1	1	4C076	A61K   9/70	4213	ۡȤޤΣ	Web, sheet or filament bases [2]
A61K   9/70 401 \	2	2	4C076	A61K   9/70	7557	Žպ	Sticking plasters for the skin
A61K   9/70 405 \	3	3	4C076	A61K   9/70	1329	ब޿ϤǤΡѥå׺	Hydrous bases, e.g. plaster layer or adhesive layer ;Cataplasms
A61K   9/72  \	1	1	4C076	A61K   9/72	2779	ʱѤޤϵѰޡΣ	for smoking or inhaling [2]
A61K  31/00  \	0	0	4C206	A61K  31/00	506	ͭʬͭޡΣ	Medicinal preparations containing organic active ingredients [2]
A61K  31/01  \	1	1	4C206	A61K  31/01	596	úǡΣ	Hydrocarbons [2]
A61K  31/015  \	2	2	4C206	A61K  31/015	1078	úǴļΤΡΣ	carbocyclic [2]
A61K  31/02  \	1	1	4C206	A61K  31/02	232	ϥúǡΣ	Halogenated hydrocarbons [2]
A61K  31/025  \	2	2	4C206	A61K  31/025	85	úǴļΤΡΣ	carbocyclic [2]
A61K  31/03  \	3	3	4C206	A61K  31/03	123	˧²ΤΡΣ	aromatic [2]
A61K  31/035  \	2	2	4C206	A61K  31/035	50	²˰·ͭΡΣ	having aliphatic unsaturation [2]
A61K  31/04  \	1	1	4C206	A61K  31/04	150	˥ȥʪΣ	Nitro compounds [2]
A61K  31/045  \	1	1	4C206	A61K  31/045	3083	ҥɥʪ㡥륳롨α㡥륳顼ȡʥҥɥѡɣˣˡΣ	Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates (hydroperoxides A61K 31/327) [2,7]
A61K  31/047  \	2	2	4C206	A61K  31/047	2121	ޤϤʾΥҥɥĤΡ㡥ӥȡΣ	having two or more hydroxy groups, e.g. sorbitol [7]
A61K  31/05  \	2	2	4C206	A61K  31/05	3263	եΡΣ	Phenols [2]
A61K  31/055  \	3	3	4C206	A61K  31/055	203	˧²ĤϥִƤΡΣ	the aromatic ring being substituted by halogen [2]
A61K  31/06  \	3	3	4C206	A61K  31/06	96	˧²Ĥ˥ȥִƤΡΣ	the aromatic ring being substituted by nitro groups [2]
A61K  31/065  \	2	2	4C206	A61K  31/065	46	ե˥ִļ륳Σ	Diphenyl-substituted acyclic alcohols [2]
A61K  31/07  \	2	2	4C206	A61K  31/07	1456	Ρ벽ʪ㡥ӥߥʥΥˣˡΣ	Retinol compounds, e.g. vitamin A (retinoic acids A61K 31/203) [2,7]
A61K  31/075  \	1	1	4C206	A61K  31/075	373	ƥޤϥΣ	Ethers or acetals [2]
A61K  31/08  \	2	2	4C206	A61K  31/08	370	ļΤΡ㡥ѥۥॢǥҥɡΣ	acyclic, e.g. paraformaldehyde [2]
A61K  31/085  \	2	2	4C206	A61K  31/085	1279	˧²ĤγúǤ˥ƥͭΡΣ	having an ether linkage to aromatic ring nuclear carbon [2]
A61K  31/09  \	3	3	4C206	A61K  31/09	710	η礬İʾΤΡΣ	having two or more such linkages [2]
A61K  31/095  \	1	1	4C206	A61K  31/095	345	βޤϥƥ벽ʪ㡥Σ	Sulfur, selenium or tellurium compounds, e.g. thiols [2]
A61K  31/10  \	2	2	4C206	A61K  31/10	905	եɡեɡեΣ	Sulfides; Sulfoxides; Sulfones [2]
A61K  31/105  \	2	2	4C206	A61K  31/105	71	βʪʥॸեɣˣۥˣˡΣ	Persulfides (thiuram disulfides A61K 31/145; thiosulfonic acids A61K 31/185) [2]
A61K  31/11  \	1	1	4C206	A61K  31/11	941	ǥҥɡΣ	Aldehydes [2]
A61K  31/115  \	2	2	4C206	A61K  31/115	36	ۥॢǥҥɡΣ	Formaldehyde [2]
A61K  31/12  \	1	1	4C206	A61K  31/12	3438	ȥΣ	Ketones [2]
A61K  31/121  \	2	2	4C206	A61K  31/121	813	ļΤΡΣ	acyclic [7]
A61K  31/122  \	2	2	4C206	A61K  31/122	3300	Ĥľܷ礷ǤĤΡ㡥Υ󡤥ӥߥˢȥΣ	having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K<sub>1</sub>, anthralin [7]
A61K  31/125  \	3	3	4C206	A61K  31/125	248	ǾγִͶƳΡΣ	Camphor; Nuclear substituted derivatives thereof [2]
A61K  31/13  \	1	1	4C206	A61K  31/13	2884	ߥ㡥ޥ󥿥ʣˣͥˡΣ	Amines, e.g. amantadine (A61K 31/04 takes precedence) [2]
A61K  31/131  \	2	2	4C206	A61K  31/131	284	ļΤΡΣ	acyclic [7]
A61K  31/132  \	2	2	4C206	A61K  31/132	340	ʾΥߥδͭΡ㡥ڥߥ󡤥ץȥ쥷Σ	having two or more amino groups, e.g. spermidine, putrescine [7]
A61K  31/133  \	2	2	4C206	A61K  31/133	555	ͭΡ㡥ե󥴥Σ	having hydroxy groups, e.g. sphingosine [7]
A61K  31/135  \	2	2	4C206	A61K  31/135	6849	˧²ĤĤΡ㡥᥿ɥΣ	having aromatic rings, e.g. methadone [2,7]
A61K  31/136  \	3	3	4C206	A61K  31/136	1075	˧²Ĥľܷ礷ߥδĤΡ㡥٥󥼥󥢥ߥΣ	having the amino group directly attached to the aromatic ring, e.g. benzeneamine [7]
A61K  31/137  \	3	3	4C206	A61K  31/137	3836	꡼륢륭륢ߥ㡥եߥ󡤥ԥͥե󡤥֥⡼롤եɥΣ	Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine [7]
A61K  31/138  \	3	3	4C206	A61K  31/138	1691	꡼륪륭륢ߥ㡥ץץΥ롤⥭ե󡤥եΥ٥󥺥ߥʥƥΥˣԥɥˣˣˡΣ	Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine (atenolol A61K 31/165; pindolol A61K 31/404; timolol A61K 31/5377) [7]
A61K  31/14  \	2	2	4C206	A61K  31/14	1098	裴饢˥ಽʪ㡥ɥե˥ࡤʤ٥ˣˡΣ	Quaternary ammonium compounds, e.g. edrophonium, choline (betaines A61K 31/205) [2]
A61K  31/145  \	2	2	4C206	A61K  31/145	383	βҤĤΡ㡥ʡΡݣáʡӡˡݣӡݣáʡӡˡݣΡޤϡΡݣáʡӡˡݣӡݣӡݣáʡӡˡݣΡˡե˥륢ߥʡݣΡӣϡˡե˥륢ߥʡݣΡӣϣˡʥǢǡˣˡΣ	having sulfur atoms, e.g. thiurams (&lt;N&mdash;C(S)&mdash;S&mdash;C(S)&mdash;N&lt; or &lt;N&mdash;C(S)&mdash;S&mdash;S&mdash;C(S)&mdash;N&lt;); Sulfinylamines (&mdash;N=SO); Sulfonylamines (&mdash;N=SO<sub>2</sub>) (isothioureas A61K 31/155) [2,7]
A61K  31/15  \	2	2	4C206	A61K  31/15	679	ʡáΡݣϡݡˡҥɥ饸ʡΡݣΡˡҥɥ饾ʡΡݣΡˡΣ	Oximes (&lt;C=N&mdash;O&mdash;); Hydrazines (&lt;N&mdash;N&lt;); Hydrazones (&lt;N&mdash;N=) [2]
A61K  31/155  \	2	2	4C206	A61K  31/155	2715	ߥֿޡס㡥˥ʣȢΡáʡΣȡˡΣȢˡǢǡʣΡáʣϣȡˡݣΣȢˡǢǡʡݣΡáʣӣȡˡݣΣȢˡΣ	Amidines ([figure]), e.g. guanidine (H<sub>2</sub>N&mdash;C(=NH)&mdash;NH<sub>2</sub>), isourea (HN=C(OH)NH<sub>2</sub>), isothiourea (HN=C(SH)&mdash;NH<sub>2</sub>) [2]
A61K  31/16  \	1	1	4C206	A61K  31/16	3685	ߥɡ㡥ҥɥΣ	Amides, e.g. hydroxamic acids [2]
A61K  31/164  \	2	2	4C206	A61K  31/164	805	ߥΥ륳ȥܥȤΥߥɡ㡥ߥɡΣ	of a carboxylic acid with an aminoalcohol, e.g. ceramides [7]
A61K  31/165  \	2	2	4C206	A61K  31/165	6733	˧²ĤĤΡ㡥ҥ󡤥ƥΥ롤ץХɡΣ	having aromatic rings, e.g. colchicine, atenolol, progabide [2]
A61K  31/166  \	3	3	4C206	A61K  31/166	1687	ܥߥɴúǤ˧²Ĥľܷ礷Ρ㡥ץ󥢥ߥɡץХ󡤥ȥץߥɡ٥Σ	having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol [7]
A61K  31/167  \	3	3	4C206	A61K  31/167	3860	ܥߥɴǤ˧²Ĥľܷ礷Ρ㡥ɥ󡤥ѥ饻⡼Σ	having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol [7]
A61K  31/17  \	2	2	4C206	A61K  31/17	2266	ΡݣáʣϡˡݣΡޤϡΡݣáʣӡˡݣΡĤΡ㡥ǢǡǢǡॹʥǢǡǢǣˣե˥ǢǣˣˡΣ	having the group &lt;N&mdash;C(O)&mdash;N&lt; or &lt;N&mdash;C(S)&mdash;N&lt;, e.g. urea, thiourea, carmustine (isoureas, isothioureas A61K 31/155; sulfonylureas A61K 31/64) [2,7]
A61K  31/175  \	3	3	4C206	A61K  31/175	265	ֿޡסӣΡݣáʣϡˡݣΡΡݡޤϡֿޡסĤΡ㡥ХɡʤܥΥҥɥ饸ɡХ󡤥ߥХɡߥХ󡨤ΥΡΣ	having the group [figure], &lt;N&mdash;C(O)&mdash;N=N&mdash; or [figure], e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof [2,7]
A61K  31/18  \	2	2	4C206	A61K  31/18	3241	ե󥢥ߥɡʥѥݣΡݥ٥󥼥ݥե˥ݣΡݴͭ벽ʪˣˡΣ	Sulfonamides (compounds containing a para-N-benzene-sulfonyl-N-group A61K 31/63) [2]
A61K  31/185  \	1	1	4C206	A61K  31/185	1649	̵ʪϥʪޤϱ㡥βλߥɻҥɥ饾ҥɥʥҥɥˣǻˣˡΣ	Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids (hydroxamic acids A61K 31/16; peroxy acids A61K 31/327) [2,7]
A61K  31/19  \	2	2	4C206	A61K  31/19	8621	ܥ㡥ХץʥˣˡΣ	Carboxylic acids, e.g. valproic acid (salicylic acid A61K 31/60) [2,7]
A61K  31/191  \	3	3	4C206	A61K  31/191	398	İʾΥҥɥļ㡥륳Σ	Acyclic acids having two or more hydroxy groups, e.g. gluconic acid [7]
A61K  31/192  \	3	3	4C206	A61K  31/192	5704	˧²ĤΡ㡥ݥ꡼ݥץԥΣ	having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid[2006.01]
A61K  31/194  \	3	3	4C206	A61K  31/194	1373	İʾΥܥĤΡ㡥ϥޥ쥤եΣ	having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid [7]
A61K  31/195  \	3	3	4C206	A61K  31/195	6121	ߥδĤΡΣ	having an amino group
A61K  31/196  \	4	4	4C206	A61K  31/196	2219	ߥδ𤬴Ĥľܷ礷ƤΡ㡥ȥ˥եʥեʥĥ֥Σ	the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil [7]
A61K  31/197  \	4	4	4C206	A61K  31/197	2195	ߥδȥܥȤƱļúǺ˷礷ƤΡ㡥áݥߥΣǣ£ϡ¡ݥ˥󡤦šݥߥΥץޤϥѥȥƥʥ˥ˣˡΣ	the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid (carnitine A61K 31/205) [2006.01]
A61K  31/198  \	5	5	4C206	A61K  31/198	6751	ݥߥλ㡥˥ޤϥǥȻΣţģԣϡʥ٥ˣץˣȥץȥեˣҥˣġΥߥλޤʬ򤵤ƤʤڥץɣˣˡΣ	Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K 31/205; proline A61K 31/401; tryptophan A61K 31/405; histidine A61K 31/4172; peptides not degraded to individual amino acids A61K 38/00) [2006.01]
A61K  31/20  \	3	3	4C206	A61K  31/20	1917	İʾúǸҺ˷礷ܥĤΡ㡥ƥѥߥ饭ɥΣ	having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid [2]
A61K  31/201  \	4	4	4C206	A61K  31/201	1025	ϣĤŷĤΡ㡥쥤ΡΣ	having one or two double bonds, e.g. oleic or linoleic acid [7]
A61K  31/202  \	4	4	4C206	A61K  31/202	2122	İʾŷĤΡ㡥ΥʥΥɡ㡥ȥꥨ󡡣ˣˡΣ	having three or more double bonds, e.g. linolenic acid (eicosanoids, e.g. leukotrienes, A61K 31/557) [7]
A61K  31/203  \	4	4	4C206	A61K  31/203	591	ΥΣ	Retinoic acids [7]
A61K  31/205  \	2	2	4C206	A61K  31/205	889	ͭΥߥղñʬ裴饢˥㡥٥󡤥˥Σ	Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine [2]
A61K  31/21  \	1	1	4C206	A61K  31/21	659	ƥ롤㡥˥ȥꥻ󡤥Υ͡ȡΣ	Esters, e.g. nitroglycerine, selenocyanates [2]
A61K  31/215  \	2	2	4C206	A61K  31/215	4803	ܥΥƥΣ	of carboxylic acids [2]
A61K  31/216  \	3	3	4C206	A61K  31/216	2568	˧²ĤĻΥƥ롤㡥٥ʥ󡤥ե֥졼ȡΣ	of acids having aromatic rings, e.g. benactizyne, clofibrate [7]
A61K  31/22  \	3	3	4C206	A61K  31/22	4068	ļΥƥ롤㡥ץХΣ	of acyclic acids, e.g. pravastatin [2]
A61K  31/221  \	4	4	4C206	A61K  31/221	402	ߥδĲʪȤΤΡ㡥륳󡤥륫˥Σ	with compounds having an amino group, e.g. acetylcholine, acetylcarnitine [7]
A61K  31/222  \	4	4	4C206	A61K  31/222	770	˧²ĲʪȤΤΡ㡥ԥ٥ե󡤥ܥѥߥΣ	with compounds having aromatic groups, e.g. dipivefrine, ibopamine [7]
A61K  31/223  \	4	4	4C206	A61K  31/223	558	ݥߥλΥƥΣ	of alpha-amino acids [7]
A61K  31/225  \	4	4	4C206	A61K  31/225	620	ݥꥫܥΣ	Polycarboxylic acids [2]
A61K  31/23  \	4	4	4C206	A61K  31/23	1811	İʾúǸҺ˷礷ܥĻΥƥΣ	of acids having a carboxyl group bound to a chain of seven or more carbon atoms [2]
A61K  31/231  \	5	5	4C206	A61K  31/231	555	ϣĤŷĤΡΣ	having one or two double bonds [7]
A61K  31/232  \	5	5	4C206	A61K  31/232	958	İʾŷĤΡ㡥ȥʡȡΣ	having three or more double bonds, e.g. etretinate [7]
A61K  31/235  \	3	3	4C206	A61K  31/235	1690	ܥ˷礹˧ĤĤΡΣ	having an aromatic ring attached to a carboxyl group [2]
A61K  31/24  \	4	4	4C206	A61K  31/24	536	ߥΤޤϥ˥ȥĤΡΣ	having an amino or nitro group [2]
A61K  31/245  \	5	5	4C206	A61K  31/245	1001	ߥΰ©ΤΡ㡥ץ󡤥ΥܥʥƥͭޣˣˡΣ	Amino benzoic acid types, e.g. procaine, novocaine (salicylic acid esters A61K 31/60) [2]
A61K  31/25  \	3	3	4C206	A61K  31/25	90	ݥꥪ륭벽륳ȤΤΡʥݥꥨ󥰥ꥳΥƥˡΣ	with polyoxyalkylated alcohols, e.g. esters of polyethylene glycol [2]
A61K  31/255  \	2	2	4C206	A61K  31/255	974	βλǻޤϤβΤΥƥΣ	of sulfoxy acids or sulfur analogues thereof [2]
A61K  31/26  \	2	2	4C206	A61K  31/26	317	ʡȤޤϥʡȥƥ롨ʡȤޤϥʡȥƥΣ	Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters [2,7]
A61K  31/265  \	2	2	4C206	A61K  31/265	456	úúޤϥܥΥƥ롤㡥ݻȥȥúΣ	of carbonic, thiocarbonic or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid [2]
A61K  31/27  \	2	2	4C206	A61K  31/27	2554	ХߥޤϥХߥΥƥ롤㡥ץХ᡼ȡХ롤ͥߥΣ	of carbamic or thiocarbamic acids, e.g. meprobamate, carbachol, neostigmine [2]
A61K  31/275  \	1	1	4C206	A61K  31/275	2003	˥ȥ롨˥ȥΣ	Nitriles; Isonitriles [2]
A61K  31/277  \	2	2	4C206	A61K  31/277	1558	ļĤΡ㡥٥ѥߥΣ	having a ring, e.g. verapamil [7]
A61K  31/28  \	1	1	4C206	A61K  31/28	1019	Ŷ°ͭ벽ʪΣ	Compounds containing heavy metals [2]
A61K  31/282  \	2	2	4C206	A61K  31/282	2109	ⲽʪΣ	Platinum compounds [7]
A61K  31/285  \	2	2	4C206	A61K  31/285	66	ǲʪΣ	Arsenic compounds [2]
A61K  31/29  \	2	2	4C206	A61K  31/29	73	ޤϥӥޥʪΣ	Antimony or bismuth compounds [2]
A61K  31/295  \	2	2	4C206	A61K  31/295	263	Ŵ²°ʪΣ	Iron group metal compounds [2]
A61K  31/30  \	2	2	4C206	A61K  31/30	126	ƼʪΣ	Copper compounds [2]
A61K  31/305  \	2	2	4C206	A61K  31/305	44	䲽ʪΣ	Mercury compounds [2]
A61K  31/31  \	3	3	4C206	A61K  31/31	14	ǤͭΡΣ	containing nitrogen [2]
A61K  31/315  \	2	2	4C206	A61K  31/315	234	ʪΣ	Zinc compounds [2]
A61K  31/32  \	2	2	4C206	A61K  31/32	47	ⲽʪΣ	Tin compounds [2]
A61K  31/325  \	1	1	4C206	A61K  31/325	280	ХߥХߥ̵ʪޤϱʥˣˡΣ	Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof (thiurams A61K 31/145) [2]
A61K  31/327  \	1	1	4C206	A61K  31/327	231	ѡʪ㡥ҥɥѡɡѡɡΣ	Peroxy compounds, e.g. hydroperoxides, peroxides, peroxy acids [7]
A61K  31/33  \	1	1	4C086	A61K  31/33	269	ʣǴļʪΣ	Heterocyclic compounds [2]
A61K  31/335  \	2	2	4C086	A61K  31/335	1868	İۼ︶ҤȤƻǤΤߤĤΡ㡥ե󥮥ߥΣ	having oxygen as the only ring hetero atom, e.g. fungichromin [2]
A61K  31/336  \	3	3	4C086	A61K  31/336	833	ĤĤΡ㡥󡤥եޥΣ	having three-membered rings, e.g. oxirane, fumagillin [7]
A61K  31/337  \	3	3	4C086	A61K  31/337	4171	ĤĤΡ㡥Σ	having four-membered rings, e.g. taxol [7]
A61K  31/34  \	3	3	4C086	A61K  31/34	2783	İۼ︶ҤȤƣĤλǤΤߤͭ룵ĤĤΡ㡥ӥɡΣ	having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide [2]
A61K  31/341  \	4	4	4C086	A61K  31/341	3341	¾δĤȽ̹礷ƤʤΡ㡥˥󡤥եߥɡ֥եȥ롤ॹΣ	not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine [7]
A61K  31/343  \	4	4	4C086	A61K  31/343	3589	úǴĤȽ̹礷Ρ㡥ޥ󡤥ץե롤ڥեΥ롤٥ե롤ߥΣ	condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone [7]
A61K  31/345  \	4	4	4C086	A61K  31/345	62	˥ȥեʥ˥ȥե˥ȥˣˡΣ	Nitrofurans (nitrofurantoin A61K 31/4178) [2,7]
A61K  31/35  \	3	3	4C086	A61K  31/35	3442	ۼ︶ҤȤƣĤλǤΤߤͭ룶ĤĤΡΣ	having six-membered rings with one oxygen as the only ring hetero atom [2]
A61K  31/351  \	4	4	4C086	A61K  31/351	2279	¾δĤȽ̹礷ƤʤΡΣ	not condensed with another ring [7]
A61K  31/352  \	4	4	4C086	A61K  31/352	5795	úǴĤȽ̹礷Ρ㡥ʥӥΡ롤᥿ƥΣ	condensed with carbocyclic rings, e.g. cannabinols, methantheline [7]
A61K  31/353  \	5	5	4C086	A61K  31/353	3401	ݥҥɥ٥󥾥ԥ㡥ޥ󡤥ƥʥȥեˣˡΣ	3,4-Dihydrobenzopyrans, e.g. chroman, catechin [7]
A61K  31/355  \	6	6	4C086	A61K  31/355	2528	ȥե롤㡥ӥߥšΣ	Tocopherols, e.g. vitamin E [2]
A61K  31/357  \	3	3	4C086	A61K  31/357	2659	İʾλǸҤƱͭΡ㡥饦󥨡ƥ롤ʥɥΣ	having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel [7]
A61K  31/36  \	4	4	4C086	A61K  31/36	1878	󥸥ե˥ͭ벽ʪ㡥ߥΣ	Compounds containing methylenedioxyphenyl groups, e.g. sesamin [2]
A61K  31/365  \	3	3	4C086	A61K  31/365	2815	饯ȥΣ	Lactones [2]
A61K  31/366  \	4	4	4C086	A61K  31/366	1479	ĤĤΡ㡥ġݥ饯ȥΣ	having six-membered rings, e.g. delta-lactones [7]
A61K  31/37  \	5	5	4C086	A61K  31/37	767	ޥ㡥ץΣ	Coumarins, e.g. psoralen [2]
A61K  31/375  \	4	4	4C086	A61K  31/375	2738	ӥʤӥߥáαΣ	Ascorbic acid, i.e. vitamin C; Salts thereof [2]
A61K  31/38  \	2	2	4C086	A61K  31/38	2032	İۼ︶ҤȤβĤΡΣ	having sulfur as a ring hetero atom [2]
A61K  31/381  \	3	3	4C086	A61K  31/381	5523	ĤĤΡΣ	having five-membered rings [7]
A61K  31/382  \	3	3	4C086	A61K  31/382	858	ĤĤΡ㡥ƥʥˣˡΣ	having six-membered rings, e.g. thioxanthenes (thiothixene A61K 31/496) [7]
A61K  31/385  \	3	3	4C086	A61K  31/385	720	ƱˣİʾβҤĤΡΣ	having two or more sulfur atoms in the same ring [2]
A61K  31/39  \	3	3	4C086	A61K  31/39	213	Ʊ˻ǤĤΡΣ	having oxygen atoms in the same ring [2]
A61K  31/395  \	2	2	4C086	A61K  31/395	2027	İۼ︶ҤȤǤĤΡ㡥ͥޤϥեޥΣ	having nitrogen as a ring hetero atom e.g. guanethidine or rifamycins
A61K  31/396  \	3	3	4C086	A61K  31/396	145	ĤĤΡ㡥ꥸΣ	having three-membered rings, e.g. aziridine [7]
A61K  31/397  \	3	3	4C086	A61K  31/397	2440	ĤĤΡ㡥Σ	having four-membered rings, e.g. azetidine [7]
A61K  31/40  \	3	3	4C086	A61K  31/40	11294	İۼ︶ҤȤƣĤǤģĤͭΡ㡥ԥɡ󥤥ߥɡȥ󡤥ץե᥷Σ	having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil [2]
A61K  31/401  \	4	4	4C086	A61K  31/401	1471	ץ󡨤ͶƳΡ㡥ץȥץΣ	Proline; Derivatives thereof, e.g. captopril [7]
A61K  31/4015  \	4	4	4C086	A61K  31/4015	1663	ʣǴĤľܷ礷ĤΡ㡥ԥ饻ࡤȥߥɡΣ	having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide [7]
A61K  31/402  \	4	4	4C086	A61K  31/402	462	ݥ꡼ִ줿Ρ㡥ԥ쥿˥ɡΣ	1-aryl-substituted, e.g. piretanide [7]
A61K  31/4025  \	4	4	4C086	A61K  31/4025	2416	̹礹뤳ȤʤʣǴĤͭ벽ʪ㡥ޥΣ	not condensed and containing further heterocyclic rings, e.g. cromakalim [7]
A61K  31/403  \	4	4	4C086	A61K  31/403	3974	úǴĤȽ̹礷Ρ㡥ХΣ	condensed with carbocyclic rings, e.g. carbazole [7]
A61K  31/4035  \	5	5	4C086	A61K  31/4035	1534	ɡ롤㡥ե륤ߥɡΣ	Isoindoles, e.g. phthalimide [7]
A61K  31/404  \	5	5	4C086	A61K  31/404	5654	ɡ롤㡥ԥɥΣ	Indoles, e.g. pindolol [7]
A61K  31/4045  \	6	6	4C086	A61K  31/4045	1814	ɡݥ륭륢ߥڤӤΥߥɡ㡥ȥ˥󡤥ȥ˥Σ	Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin [7]
A61K  31/405  \	6	6	4C086	A61K  31/405	2710	ɡ륢륫󥫥ܥͶƳΡ㡥ȥץȥե󡤥ɥ᥿Σ	Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin [2]
A61K  31/407  \	4	4	4C086	A61K  31/407	2949	¾ʣǴķϤȽ̹礷Ρ㡥ȥåեߥΣ	condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine [7]
A61K  31/409  \	4	4	4C086	A61K  31/409	671	ĤĤĤΡ㡥ݥեͶƳΡӥӥ󡤥ӥ٥ǥʤإߥ󡤤إޥˣˡΣ	having four such rings, e.g. porphine derivatives, bilirubin, biliverdine (hemin, hematin A61K 31/555) [7]
A61K  31/41  \	3	3	4C086	A61K  31/41	3801	İʾδİۼ︶ҤͭΤʤȤ⣱ĤǤǤ룵ĤĤΡ㡥ƥȥ饾Σ	having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole [2]
A61K  31/415  \	4	4	4C086	A61K  31/415	7916	ݥΣ	1,2-Diazoles [2,7]
A61K  31/4152  \	5	5	4C086	A61K  31/4152	575	ʣǴĤľܷ礷ĤΡ㡥ԥ󡤥ե˥֥󡤥եԥ饾Σ	having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone [7]
A61K  31/4155  \	5	5	4C086	A61K  31/4155	2425	̹礹뤳ȤʤʣǴĤޤΡΣ	not condensed and containing further heterocyclic rings [7]
A61K  31/416  \	5	5	4C086	A61K  31/416	1744	úǴĤȽ̹礷Ρ㡥Σ	condensed with carbocyclic ring systems, e.g. indazole [7]
A61K  31/4162  \	5	5	4C086	A61K  31/4162	494	¾ʣǴķϤȽ̹礷ΡΣ	condensed with heterocyclic ring systems [7]
A61K  31/4164  \	4	4	4C086	A61K  31/4164	2763	쥸롤㡥ߥΣ	1,3-Diazoles [7]
A61K  31/4166  \	5	5	4C086	A61K  31/4166	1357	ľܷ礷ĤΡ㡥ե˥ȥΣ	having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin [7]
A61K  31/4168  \	5	5	4C086	A61K  31/4168	505	̤˷礷ǤĤΡ㡧˥Σ	having a nitrogen atom attached in position 2, e.g. clonidine [7]
A61K  31/417  \	5	5	4C086	A61K  31/417	535	ߥݥ륭륢ߥ㡥ҥߥ󡤥եȥߥΣ	Imidazole-alkylamines, e.g. histamine, phentolamine [7]
A61K  31/4172  \	5	5	4C086	A61K  31/4172	681	ߥݥ륫󥫥ܥ㡥ҥΣ	Imidazole-alkanecarboxylic acids, e.g. histidine [7]
A61K  31/4174  \	5	5	4C086	A61K  31/4174	971	꡼륢륭륤ߥ롤㡥᥿󡤥ʥե󡤥ߥʥΣ	Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole [7]
A61K  31/4178  \	5	5	4C086	A61K  31/4178	3698	̹礹뤳ȤʤʣǴĤͭΡ㡥ԥԥ󡤥˥ȥեȥΣ	not condensed and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin [7]
A61K  31/4184  \	5	5	4C086	A61K  31/4184	4912	úǴĤȽ̹礷Ρ㡥٥󥺥ߥΣ	condensed with carbocyclic rings, e.g. benzimidazoles [7]
A61K  31/4188  \	5	5	4C086	A61K  31/4188	1550	¾ʣǴķϤȽ̹礷Ρ㡥ӥ󡤥ӥ˥Σ	condensed with heterocyclic ring systems, e.g. biotin, sorbinil [7]
A61K  31/4192  \	4	4	4C086	A61K  31/4192	1457	ݥȥꥢΣ	1,2,3-Triazoles [7]
A61K  31/4196  \	4	4	4C086	A61K  31/4196	2643	ݥȥꥢΣ	1,2,4-Triazoles [7]
A61K  31/42  \	4	4	4C086	A61K  31/42	3956	Σ	Oxazoles [2,7]
A61K  31/421  \	5	5	4C086	A61K  31/421	2116	ݥ롤㡥ڥ󡤥ȥ᥿Σ	1,3-Oxazoles, e.g. pemoline, trimethadione [7]
A61K  31/422  \	5	5	4C086	A61K  31/422	3226	̹礹뤳ȤʤʣǴĤޤΡΣ	not condensed and containing further heterocyclic rings [7]
A61K  31/423  \	5	5	4C086	A61K  31/423	2209	úǴĤȽ̹礷ΡΣ	condensed with carbocyclic rings [7]
A61K  31/424  \	5	5	4C086	A61K  31/424	453	¾ʣǴķϤȽ̹礷Ρ㡥֥Σ	condensed with heterocyclic ring systems, e.g. clavulanic acid [7]
A61K  31/4245  \	4	4	4C086	A61K  31/4245	2914	Σ	Oxadiazoles [7]
A61K  31/425  \	4	4	4C086	A61K  31/425	3403	Σ	Thiazoles [2,7]
A61K  31/426  \	5	5	4C086	A61K  31/426	4863	ݥΣ	1,3-Thiazoles [7]
A61K  31/427  \	5	5	4C086	A61K  31/427	5325	̹ʣǴĤޤΡΣ	not condensed and containing further heterocyclic rings [7]
A61K  31/428  \	5	5	4C086	A61K  31/428	3080	úǴĤȽ̹礷ΡΣ	condensed with carbocyclic rings [7]
A61K  31/429  \	5	5	4C086	A61K  31/429	672	¾ʣǴķϤȽ̹礷ΡΣ	condensed with heterocyclic ring systems [7]
A61K  31/43  \	6	6	4C086	A61K  31/43	1418	ݥݣݥӥ̣ͥإץķϤͭ벽ʪʤֿޡפδķϤͭ벽ʪ㡥ڥ˥ͶƳΡڥͥͶƳΡΣ	Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula [figure], e.g. penicillins, penems [2,6]
A61K  31/431  \	7	7	4C086	A61K  31/431	222	ʣǴķϤͭΡ㡥륷󡤥󡤡Σ	containing further heterocyclic ring systems, e.g. ticarcillin, azlocillin, oxacillin [7]
A61K  31/433  \	4	4	4C086	A61K  31/433	2266	Σ	Thiadiazoles [7]
A61K  31/435  \	3	3	4C086	A61K  31/435	5219	İۼ︶ҤȤƣĤǤΤߤͭ룶ĤĤΡ㡥úǴķϤȽ̹礷ΡʥΥˣˡΣ	having six-membered rings with one nitrogen as the only ring hetero atom [2]
A61K  31/4353  \	4	4	4C086	A61K  31/4353	330	ʣǴĤȥȤޤϥڥ̹礷ΡΣ	ortho- or peri-condensed with heterocyclic ring systems [7]
A61K  31/4355  \	5	5	4C086	A61K  31/4355	654	İۼ︶ҤȤƻǤģĤޤʣǴķϤȽ̹礷ΡΣ	the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom [7]
A61K  31/436  \	5	5	4C086	A61K  31/436	2305	İۼ︶ҤȤƻǤģĤޤʣǴķϤȽ̹礷Ρ㡥ѥޥΣ	the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin [7]
A61K  31/4365  \	5	5	4C086	A61K  31/4365	1201	İۼ︶ҤȤβʣǴķϤȽ̹礷Ρ㡥ԥΣ	the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine [7]
A61K  31/437  \	5	5	4C086	A61K  31/437	7438	İۼ︶ҤȤǤģĤޤʣǴķϤȽ̹礷Ρ㡥ɥꥸ󡤦¡ݥܥΣ	the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline [7]
A61K  31/4375  \	5	5	4C086	A61K  31/4375	2566	İۼ︶ҤȤǤģĤޤʣǴķϤȽ̹礷Ρ㡥Υꥸ󡤥ʥեꥸ󡤥ӥ󥫥ߥΣ	the heterocyclic ring system containing a six-membered ring having nitrogen as a ring hetero atom, e.g. quinolizines, naphthyridines, berberine, vincamine [7]
A61K  31/438  \	4	4	4C086	A61K  31/438	1704	ĤúǴķʣǴķϤȥԥ̹礷ƤΡΣ	the ring being spiro-condensed with carbocyclic or heterocyclic ring systems [7]
A61K  31/439  \	4	4	4C086	A61K  31/439	2332	ĤͶķϤʬƤΡ㡥̥ꥸʣݥݥӥΣϥˣˡΣ	the ring forming part of a bridged ring system, e.g. quinuclidine (8-azabicyclo [3.2.1] octanes A61K 31/46) [7]
A61K  31/44  \	4	4	4C086	A61K  31/44	10028	̹ԥꥸ󡨤οźͶƳΡΣ	Non-condensed pyridines; Hydrogenated derivatives thereof [2,7]
A61K  31/4402  \	5	5	4C086	A61K  31/4402	3230	̤Τִ줿Ρ㡥ե˥ߥ󡤥ӥΣ	only substituted in position 2, e.g. pheniramine, bisacodyl [7]
A61K  31/4406  \	5	5	4C086	A61K  31/4406	2584	̤Τִ줿Ρ㡥륷ʥ˥ˣˡΣ	only substituted in position 3, e.g. zimeldine (nicotinic acid A61K 31/455) [7]
A61K  31/4409  \	5	5	4C086	A61K  31/4409	2416	̤Τִ줿Ρ㡥˥ɡץ˥ɡΣ	only substituted in position 4, e.g. isoniazid, iproniazid [7]
A61K  31/4412  \	5	5	4C086	A61K  31/4412	964	ʣǴĤľܷ礷ĤΡΣ	having oxo groups directly attached to the heterocyclic ring [7]
A61K  31/4415  \	5	5	4C086	A61K  31/4415	929	ԥɥ󡤤ʤӥߥ¢ʥԥɥˣˡΣ	Pyridoxine, i.e.vitamin B<sub>6</sub> (pyridoxal phosphate A61K 31/675) [7]
A61K  31/4418  \	5	5	4C086	A61K  31/4418	3324	ʣǴĤľܷ礷úǴĤĤΡ㡥ץإץΣ	having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine [7]
A61K  31/4422  \	5	5	4C086	A61K  31/4422	812	ݥҥɥԥꥸ㡥˥եԥ󡤥˥른ԥΣ	1,4-Dihydropyridines, e.g. nifedipine, nicardipine [7]
A61K  31/4425  \	5	5	4C086	A61K  31/4425	747	ԥꥸ˥ͶƳΡ㡥ץɥࡤԥɥߥΣ	Pyridinium derivatives, e.g. pralidoxime, pyridostigmine [7]
A61K  31/4427  \	5	5	4C086	A61K  31/4427	4369	ʣǴķϤͭΡΣ	containing further heterocyclic ring systems [7]
A61K  31/443  \	6	6	4C086	A61K  31/443	3538	İۼ︶ҤȤƻǤͭ룵ĤޤΡΣ	containing a five-membered ring with oxygen as a ring hetero atom [7]
A61K  31/4433  \	6	6	4C086	A61K  31/4433	2575	İۼ︶ҤȤƻǤͭ룶ĤޤΡΣ	containing a six-membered ring with oxygen as a ring hetero atom [7]
A61K  31/4436  \	6	6	4C086	A61K  31/4436	1363	İۼ︶ҤȤβͭʣǴĤޤΡΣ	containing a heterocyclic ring having sulfur as a ring hetero atom [7]
A61K  31/4439  \	6	6	4C086	A61K  31/4439	13349	İۼ︶ҤȤǤͭ룵ĤޤΡ㡥ץ饾ʥ˥ˣˡΣ	containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole (nicotine A61K0031465000)[2006.01]
A61K  31/444  \	6	6	4C086	A61K  31/444	6687	İۼ︶ҤȤǤͭ룶ĤޤΡ㡥ΥΣ	containing a six-membered ring with nitrogen as a ring hetero atom, e.g. amrinone [7]
A61K  31/445  \	5	5	4C086	A61K  31/445	9092	̹ԥڥꥸ㡥ԥڥΣ	Non-condensed piperidines, e.g. piperocaine [2,7]
A61K  31/4453  \	6	6	4C086	A61K  31/4453	1309	̤Τִ줿Ρ㡥ץԥݥ󡤥ڥɥΣ	only substituted in position 1, e.g. propipocaine, diperodon [7]
A61K  31/4458  \	6	6	4C086	A61K  31/4458	350	̤Τִ줿Ρ㡥ե˥ǡȡΣ	only substituted in position 2, e.g. methylphenidate [7]
A61K  31/4462  \	6	6	4C086	A61K  31/4462	167	̤Τִ줿ΡΣ	only substituted in position 3 [7]
A61K  31/4465  \	6	6	4C086	A61K  31/4465	934	̤Τִ줿ΡΣ	only substituted in position 4 [7]
A61K  31/4468  \	6	6	4C086	A61K  31/4468	1196	̤ľܷ礷ǤĤΡ㡥ܥץɡե󥿥˥Σ	having a nitrogen atom directly attached in position 4, e.g. clebopride, fentanyl [7]
A61K  31/45  \	6	6	4C086	A61K  31/45	406	ʣǴĤľܷ礷ĤΡ㡥إߥɡʥƥߥɣˣˡΣ	having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide [2,7]
A61K  31/451  \	6	6	4C086	A61K  31/451	1885	ʣǴĤľܷ礷úǴĴĤΡ㡥ƥߥɡڥꥸ󡤥ڥߥɡե󥷥ꥸ󡤥ԥߥΥΣ	having a carbocyclic ring directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine [7]
A61K  31/4515  \	6	6	4C086	A61K  31/4515	133	̤˥֥եΥĤΡ㡥ϥڥɡʥԥѥڥˣˡΣ	having a butyrophenone group in position 1, e.g. haloperidol (pipamperone A61K 31/4545) [7]
A61K  31/452  \	6	6	4C086	A61K  31/452	121	ԥڥꥸ˥ͶƳΡʥѥ󥯥˥ˣˡΣ	Piperidinium derivatives (pancuronium A61K 31/58) [7]
A61K  31/4523  \	6	6	4C086	A61K  31/4523	825	ʣǴķϤͭΡΣ	containing further heterocyclic ring systems [7]
A61K  31/4525  \	7	7	4C086	A61K  31/4525	1203	İۼ︶ҤȤƻǤͭ룵ĤޤΡΣ	containing a five-membered ring with oxygen as a ring hetero atom [7]
A61K  31/453  \	7	7	4C086	A61K  31/453	755	İۼ︶ҤȤƻǤͭ룶ĤޤΡΣ	containing a six-membered ring with oxygen as a ring hetero atom [7]
A61K  31/4535  \	7	7	4C086	A61K  31/4535	1508	İۼ︶ҤȤβͭʣǴĤޤΡ㡥ԥեΣ	containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen [7]
A61K  31/454  \	7	7	4C086	A61K  31/454	8332	İۼ︶ҤȤǤͭ룵ĤޤΡ㡥ԥ⥸ɡɥڥɥΣ	containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone [7]
A61K  31/4545  \	7	7	4C086	A61K  31/4545	7491	İۼ︶ҤȤǤͭ룶ĤޤΡ㡥ԥѥڥ󡤥ʥХΣ	containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine [7]
A61K  31/455  \	5	5	4C086	A61K  31/455	3254	˥㡥ʥ󡨤ͶƳΡ㡥ƥ롤ߥɡΣ	Nicotinic acid, i.e. niacin; Derivatives thereof, e.g. esters, amides [2]
A61K  31/46  \	4	4	4C086	A61K  31/46	1556	ݥӥΣϥ󡨤ͶƳΡ㡥ȥԥ󡤥Σ	8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine [2]
A61K  31/465  \	4	4	4C086	A61K  31/465	510	˥󡨤ͶƳΡΣ	Nicotine; Derivatives thereof [2]
A61K  31/47  \	4	4	4C086	A61K  31/47	8891	Υ󡨥ΥΣ	Quinolines; Isoquinolines [2]
A61K  31/4704  \	5	5	4C086	A61K  31/4704	880	ݥΥΥ㡥ܥΣ	2-Quinolinones, e.g. carbostyril [7]
A61K  31/4706  \	5	5	4C086	A61K  31/4706	638	ݥߥΥΥ󡨣ݥߥΥΥ㡥󡤥ץޥΣ	4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine [7]
A61K  31/4709  \	5	5	4C086	A61K  31/4709	6865	̹礹뤳ȤʤʣǴĤޤ७ΥΣ	Non-condensed quinolines containing further heterocyclic rings [7]
A61K  31/472  \	5	5	4C086	A61K  31/472	2588	̹祤Υ㡥ѥѥ٥Σ	Non-condensed isoquinolines, e.g. papaverine [7]
A61K  31/4725  \	6	6	4C086	A61K  31/4725	3874	ʣǴĤޤΡΣ	containing further heterocyclic rings [7]
A61K  31/473  \	5	5	4C086	A61K  31/473	1368	úǴķϤȥ륽ϥڥ̹礷Ρ㡥ꥸ󡤥եʥȥꥸΣ	ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines [7]
A61K  31/4738  \	5	5	4C086	A61K  31/4738	263	ʣǴķϤȥ륽ϥڥ̹礷ΡΣ	ortho- or peri-condensed with heterocyclic ring systems [7]
A61K  31/4741  \	6	6	4C086	A61K  31/4741	496	İۼ︶ҤȤƻǤĴķϤǽ̹礷Ρ㡥ĥܥͶƳΡΥԥ󡤥ӥΣ	condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline [7]
A61K  31/4743  \	6	6	4C086	A61K  31/4743	85	İۼ︶ҤȤβĴķϤǽ̹礷ΡΣ	condensed with ring systems having sulfur as a ring hetero atom [7]
A61K  31/4745  \	6	6	4C086	A61K  31/4745	3624	İۼ︶ҤȤǤĴķϤǽ̹礷Ρ㡥եʥȥʥҥӥͶƳΡӥ֥饹ˣ르ͶƳΣˣˡΣ	condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenanthrolines (yohimbine derivatives, vinblastine A61K0031475000;ergoline derivatives A61K0031480000)[2006.01]
A61K  31/4747  \	5	5	4C086	A61K  31/4747	133	ԥ̹礷ΡΣ	spiro-condensed [7]
A61K  31/4748  \	5	5	4C086	A61K  31/4748	149	ͶķϤʬΡʥȥꥭ˥ˣեʥͶƳΣˣˡΣ	forming part of bridged ring systems (strychnine A61K0031475000;morphinan derivatives A61K0031485000)[2006.01]
A61K  31/475  \	5	5	4C086	A61K  31/475	1442	ɡĤĤΡ㡥ҥӥ󡤥쥻ԥ󡤥ȥꥭ˥󡤥ӥץ饹ʥӥ󥫥ߥˣˡΣ	having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine (vincamine A61K 31/4375) [2,7]
A61K  31/48  \	5	5	4C086	A61K  31/48	603	르ͶƳΡ㡥ꥻ륰르ߥΣ	Ergoline derivatives, e.g. lysergic acid, ergotamine [2,7]
A61K  31/485  \	5	5	4C086	A61K  31/485	2472	եʥͶƳΡ㡥ե󡤥ǥΣ	Morphinan derivatives, e.g. morphine, codeine [2,7]
A61K  31/49  \	5	5	4C086	A61K  31/49	169	󥳥ʥͶƳΡ㡥˥Σ	Cinchonan derivatives, e.g. quinine [2,7]
A61K  31/495  \	3	3	4C086	A61K  31/495	8432	İۼ︶ҤȤƣĤǤΤߤͭ룶ĤĤΡ㡥ԥڥ饸ʣˣͥˡΣ	having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine (A61K 31/48 takes precedence) [2]
A61K  31/496  \	4	4	4C086	A61K  31/496	13796	̹ԥڥ饸ʣǴĤޤಽʪ㡥եԥ󡢥󡢥ѥեΣ	Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin [2006.01]
A61K  31/4965  \	4	4	4C086	A61K  31/4965	1412	̹ԥ饸Σ	Non-condensed pyrazines [7]
A61K  31/497  \	5	5	4C086	A61K  31/497	5513	ʣǴĤޤ̹ԥ饸Σ	containing further heterocyclic rings [7]
A61K  31/498  \	4	4	4C086	A61K  31/498	2319	úǴķϤȥϥڥ̹礷ԥ饸ϥԥڥ饸㡥Υ󡤥եʥΣ	Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine [7]
A61K  31/4985  \	4	4	4C086	A61K  31/4985	3991	ʣǴķϤȥϥڥ̹礷ԥ饸ϥԥڥ饸Σ	Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems [7]
A61K  31/499  \	4	4	4C086	A61K  31/499	258	ԥ̹礷ԥ饸ޤϥԥڥ饸Σ	Spiro-condensed pyrazines or piperazines [7]
A61K  31/4995  \	4	4	4C086	A61K  31/4995	764	ͶķϤʬԥ饸ޤϥԥڥ饸Σ	Pyrazines or piperazines forming part of bridged ring systems [7]
A61K  31/50  \	4	4	4C086	A61K  31/50	2078	ԥ󡨿źåԥΣ	Pyridazines; Hydrogenated pyridazines [2,7]
A61K  31/501  \	5	5	4C086	A61K  31/501	3630	̹礹뤳ȤʤʣǴĤޤΡΣ	not condensed and containing further heterocyclic rings [7]
A61K  31/502  \	5	5	4C086	A61K  31/502	1275	úǴķϤȥ륽ϥڥ̹礷Ρ㡥Υ󡤥ե饸Σ	ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine [7]
A61K  31/5025  \	5	5	4C086	A61K  31/5025	1807	ʣǴķϤȥ륽ϥڥ̹礷ΡΣ	ortho- or peri-condensed with heterocyclic ring systems [7]
A61K  31/503  \	5	5	4C086	A61K  31/503	11	ԥ̹礷ΡΣ	spiro-condensed [7]
A61K  31/504  \	5	5	4C086	A61K  31/504	73	ͶķϤʬΡΣ	forming part of bridged ring systems [7]
A61K  31/505  \	4	4	4C086	A61K  31/505	9264	ԥߥ󡨿źåԥߥ㡥ȥȥץΣ	Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim [2,7]
A61K  31/506  \	5	5	4C086	A61K  31/506	14688	̹礹뤳ȤʤʣǴĤͭΡΣ	not condensed and containing further heterocyclic rings [7]
A61K  31/51  \	6	6	4C086	A61K  31/51	951	ߥ㡥ӥߥ¢Σ	Thiamines, e.g. vitamin B<sub>1</sub> [2]
A61K  31/513  \	5	5	4C086	A61K  31/513	3142	ʣǴĤľܷ礷ĤΡ㡥ȥΣ	having oxo groups directly attached to the heterocyclic ring, e.g. cytosine [7]
A61K  31/515  \	6	6	4C086	A61K  31/515	225	ХӥġͶƳΡ㡥ڥȥХӥʥȥꥦΣ	Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital [2]
A61K  31/517  \	5	5	4C086	A61K  31/517	5383	úǴķϤȥ륽ϥڥ̹礷Ρ㡥ʥ󡤥ڥߥΣ	ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine [7]
A61K  31/519  \	5	5	4C086	A61K  31/519	12849	ʣǴķϤȥ륽ޤϥڥ̹礷ΡΣ	ortho- or peri-condensed with heterocyclic rings [7]
A61K  31/52  \	6	6	4C086	A61K  31/52	3450	ץ㡥ǥ˥Σ	Purines, e.g. adenine [2,7]
A61K  31/522  \	7	7	4C086	A61K  31/522	3237	ʣǴĤľܷ礷ĤΡ㡥ҥݥ󡤥˥󡤥ӥΣ	having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir [7, 2006.01]
A61K  31/525  \	6	6	4C086	A61K  31/525	1062	㡥ܥեӥ󡤥ӥߥ¢Σ	Isoalloxazines, e.g. riboflavins, vitamin B<sub>2</sub> [2]
A61K  31/527  \	5	5	4C086	A61K  31/527	173	ԥ̹礷ΡΣ	spiro-condensed [7]
A61K  31/529  \	5	5	4C086	A61K  31/529	330	ͶķϤʬΡΣ	forming part of bridged ring systems [7]
A61K  31/53  \	3	3	4C086	A61K  31/53	3359	İۼ︶ҤȤƣĤǤΤߤͭ룶ĤĤΡ㡥饶˥롤ߥʥ륽֥ˣˡΣ	having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine (melarsoprol A61K 31/555) [2]
A61K  31/535  \	3	3	4C086	A61K  31/535	3293	İۼ︶ҤȤƾʤȤ⣱ĤǵڤӣĤλǤͭ룶ĤĤΡ㡥ݥΣ	having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines [2]
A61K  31/5355  \	4	4	4C086	A61K  31/5355	878	̹礹뤳ȤʤʣǴĤͭ륪Σ	Non-condensed oxazines containing further heterocyclic rings [7]
A61K  31/536  \	4	4	4C086	A61K  31/536	577	úǴķϤȥ륽ϥڥ̹礷ΡΣ	ortho- or peri-condensed with carbocyclic ring systems [7]
A61K  31/5365  \	4	4	4C086	A61K  31/5365	701	ʣǴķϤȥ륽ϥڥ̹礷ΡΣ	ortho- or peri-condensed with heterocyclic ring systems [7]
A61K  31/537  \	4	4	4C086	A61K  31/537	866	ԥ̹ޤϲͶķϤʬΡΣ	spiro-condensed or forming part of bridged ring systems [7]
A61K  31/5375  \	4	4	4C086	A61K  31/5375	3235	ݥ㡥ۥΣ	1,4-Oxazines, e.g. morpholine [7]
A61K  31/5377  \	5	5	4C086	A61K  31/5377	18740	̹礹뤳ȤʤʣǴĤͭΡ㡥Σ	not condensed and containing further heterocyclic rings, e.g. timolol [7]
A61K  31/538  \	5	5	4C086	A61K  31/538	1865	úǴķϤȥ륽ϥڥ̹礷ΡΣ	ortho- or peri-condensed with carbocyclic ring systems [7]
A61K  31/5383  \	5	5	4C086	A61K  31/5383	1872	ʣǴķϤȥ륽ϥڥ̹礷ΡΣ	ortho- or peri-condensed with heterocyclic ring systems [7]
A61K  31/5386  \	5	5	4C086	A61K  31/5386	1134	ԥ̹ϲͶķϤʬΡΣ	spiro-condensed or forming part of bridged ring systems [7]
A61K  31/539  \	4	4	4C086	A61K  31/539	58	ƱĤˣİʾλǸҤĤΡ㡥Σ	having two or more oxygen atoms in the same ring, e.g dioxazines [7]
A61K  31/5395  \	4	4	4C086	A61K  31/5395	199	ƱĤˣİʾǸҤĤΡΣ	having two or more nitrogen atoms in the same ring, e.g. oxadiazines [7]
A61K  31/54  \	3	3	4C086	A61K  31/54	2300	İۼ︶ҤȤƾʤȤ⣱ĤǵڤӣĤβͭ룶ĤĤΡ㡥Σ	having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame [2]
A61K  31/541  \	4	4	4C086	A61K  31/541	3205	̹ʣǴĤͭ벽ʪΣ	Non-condensed thiazines containing further heterocyclic rings [7]
A61K  31/5415  \	4	4	4C086	A61K  31/5415	1753	úǴķϤȥ륽ϥڥ̹礷Ρ㡥եΥ󡤥ץޥ󡤥ԥΣ	ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam[2006.01]
A61K  31/542  \	4	4	4C086	A61K  31/542	612	ʣǴķϤȥ륽ϥڥ̹礷ΡΣ	ortho- or peri-condensed with heterocyclic ring systems [7]
A61K  31/545  \	5	5	4C086	A61K  31/545	2026	ݥݣݥӥΣϥķϤͭ벽ʪֿޡס㡥եݥ󡤥ե롤ե쥭Σ	Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula [figure], e.g. cephalosporins, cefaclor, cephalexine [2,6]
A61K  31/546  \	6	6	4C086	A61K  31/546	2435	ʣǴĤޤΡ㡥եΣ	containing further heterocyclic rings, e.g. cephalothin [7]
A61K  31/547  \	4	4	4C086	A61K  31/547	83	ԥ̹ޤϲͶķϤʬΡΣ	spiro-condensed or forming part of bridged ring systems [7]
A61K  31/548  \	4	4	4C086	A61K  31/548	28	ƱĤˣİʾβҤĤΡΣ	having two or more sulfur atoms in the same ring [7]
A61K  31/549  \	4	4	4C086	A61K  31/549	472	ƱĤˣİʾǸҤĤΡΣ	having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide [7]
A61K  31/55  \	3	3	4C086	A61K  31/55	10786	ĤĤΡ㡥饹󡤥ڥƥȥ饾Σ	having seven-membered rings, e.g. azelastine, pentylenetetrazole [2]
A61K  31/551  \	4	4	4C086	A61K  31/551	4576	İۼ︶ҤȤƣĤǸҤĤΡ㡥ԥ󡤥饼סΣ	having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep [7]
A61K  31/5513  \	5	5	4C086	A61K  31/5513	1506	ݥ٥󥾥ԥ㡥ѥΣ	1,4-Benzodiazepines, e.g. diazepam [7]
A61K  31/5517  \	6	6	4C086	A61K  31/5517	895	İۼ︶ҤȤǤģĤȽ̹礷Ρ㡥ߥ٥󥾥ҥ󡤥ȥꥢΣ	condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam [7]
A61K  31/553  \	4	4	4C086	A61K  31/553	2268	İۼ︶ҤȤƾʤȤ⣱ĤǵڤӣĤλǤĤΡ㡥ӥ󡤥ݥΣ	having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine [7]
A61K  31/554  \	4	4	4C086	A61K  31/554	1212	İۼ︶ҤȤƾʤȤ⣱ĤǵڤӣĤβĤΡ㡥ӥ󡤥Σ	having at least one nitrogen and at least one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem[2006.01]
A61K  31/555  \	2	2	4C086	A61K  31/555	1153	Ŷ°ͭΡ㡥إߥ󡤤إޥ󡤥륽ץΣ	containing heavy metals, e.g. hemin, hematin, melarsoprol [2]
A61K  31/557  \	1	1	4C086	A61K  31/557	1544	Υɡ㡥ȥꥨΣ	Eicosanoids, e.g. leukotrienes [3,7]
A61K  31/5575  \	2	2	4C086	A61K  31/5575	1698	ڥ󥿥ĤĤΡ㡥ץ󥸥ţץ󥸥ƣΣ	having a cyclopentane ring, e.g. prostaglandin E<sub>2</sub>, prostaglandin F<sub>2-alpha</sub> [7]
A61K  31/5578  \	2	2	4C086	A61K  31/5578	117	ڥ󥿥ĤĤΡ㡥Х󡤥ץȡΣ	having a pentalene ring system, e.g. carbacyclin, iloprost [7]
A61K  31/558  \	2	2	4C086	A61K  31/558	48	İۼ︶ҤȤƻǤΤߤޤʣǴĤĤΡ㡥ȥܥΣ	having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes [7]
A61K  31/5585  \	3	3	4C086	A61K  31/5585	190	İۼ︶ҤȤƻǤΤߤޤࣵĤĤΡ㡥ץΣ	having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin [7]
A61K  31/559  \	2	2	4C086	A61K  31/559	60	ǰʳδİۼ︶ҤޤʣǴĤĤΡΣ	having heterocyclic rings containing hetero atoms other than oxygen [7]
A61K  31/56  \	1	1	4C086	A61K  31/56	2510	ڥ󥿡ΣϥҥɥեʥȥķϤޤಽʪݡƥɤޤϤ줫ͶƳ벽ʪΣ	Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids[2006.01]
A61K  31/565  \	2	2	4C086	A61K  31/565	2269	°̤úǸҤˤäִƤʤΡ㡥ȥ󡤥ȥ饸Σ	not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol [2]
A61K  31/566  \	3	3	4C086	A61K  31/566	315	°̤˥ĤΡ㡥ȥΣ	having an oxo group in position 17, e.g. oestrone [7]
A61K  31/567  \	3	3	4C086	A61K  31/567	344	ִ̤줿Ρ㡥᥹ȥΡ롤Υ륨ɥΣ	substituted in position 17 alpha, e.g. mestranol, norethandrolone [7]
A61K  31/568  \	3	3	4C086	A61K  31/568	624	̤ʤȤ⣱ĤúǸҤͭúǺˤäִ줿Ρ㡥ɥ㡥ƥȥƥΣ	substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstane, testosterone [7]
A61K  31/5685  \	4	4	4C086	A61K  31/5685	260	°̤˥ĤΡ㡥ɥƥΣ	having an oxo group in position 17, e.g. androsterone [7]
A61K  31/569  \	4	4	4C086	A61K  31/569	294	ִ̤줿Ρ㡥ƥΣ	substituted in position 17 alpha, e.g. ethisterone [7]
A61K  31/57  \	2	2	4C086	A61K  31/57	2287	°̤ĤúǸҤͭúǺˤäִ줿Ρ㡥ץ쥰ʥ󡤥ץƥΣ	substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone [2006.01]
A61K  31/573  \	3	3	4C086	A61K  31/573	3806	ִ̤줿Ρ㡥󡤥ǥ᥿󡤥ץɥ˥󡤥ɥƥΣ	substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone [2006.01]
A61K  31/575  \	2	2	4C086	A61K  31/575	2601	°̤ʤȤ⣳ĤúǸҤͭúǺˤäִ줿Ρ㡥󡤥쥹󡤥르ƥ롤ȥƥΣ	substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol [2]
A61K  31/58  \	2	2	4C086	A61K  31/58	2642	ʣǴĤͭΡ㡥ʥ롤Υ롤ѥ󥯥˥ࡤȥ˥ʥȥˣˡΣ	containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin (digitoxin A61K 31/704) [2006.01]
A61K  31/585  \	3	3	4C086	A61K  31/585	495	饯ȥĤͭΡ㡥ɥ󡤥֥եΣ	containing lactone rings, e.g. oxandrolone, bufalin [2]
A61K  31/59  \	1	1	4C086	A61K  31/59	1947	ݥݥڥ󥿡ΣϥҥɥݥեʥȥķϤͭ벽ʪΣ	Compounds containing 9,10-seco-cyclopenta[a]hydro- phenanthrene ring systems [2]
A61K  31/592  \	2	2	4C086	A61K  31/592	394	ݥ르ͶƳΡ㡥르륷ե롤ӥߥĢΣ	9,10-Secoergostane derivatives, e.g. ergocalciferol, vitamin D<sub>2</sub> [7]
A61K  31/593  \	2	2	4C086	A61K  31/593	820	ݥ쥹ͶƳΡ㡥쥫륷ե롤ʤӥߥĢΣ	9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3[2006.01]
A61K  31/60  \	1	1	4C086	A61K  31/60	1678	ͶƳΡΣ	Salicylic acid; Derivatives thereof [2]
A61K  31/603  \	2	2	4C086	A61K  31/603	80	˧²ĤĤΡ㡥ե˥Σ	having further aromatic rings, e.g. diflunisal [7]
A61K  31/606  \	2	2	4C086	A61K  31/606	270	ߥδĤΡΣ	having amino groups [7]
A61K  31/609  \	2	2	4C086	A61K  31/609	112	ߥɡ㡥륢ߥɡΣ	Amides, e.g. salicylamide [7]
A61K  31/612  \	2	2	4C086	A61K  31/612	17	̤˥ƥ벽줿ĤΡ㡥βʥեեˣˡΣ	having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid (fosfosal A61K 31/661) [7]
A61K  31/616  \	3	3	4C086	A61K  31/616	925	ܥˤΡ㡥륵Σ	by carboxylic acids, e.g. acetylsalicylic acid [7]
A61K  31/618  \	2	2	4C086	A61K  31/618	193	̤˥ƥ벽줿ܥĤΡ㡥륵顼ȡΣ	having the carboxyl group in position 1 esterified, e.g. salsalate [7]
A61K  31/621  \	3	3	4C086	A61K  31/621	43	̤ˤ⥨ƥ벽줿ĤΡ㡥٥Υ顼ȡΣ	having the hydroxy group in position 2 esterified, e.g. benorylate [7]
A61K  31/625  \	2	2	4C086	A61K  31/625	62	ʣǴļִĤΡ㡥ݥ륪եʥե饸ˣˡΣ	having heterocyclic substituents, e.g. 4-salicyloylmorpholine (sulfasalazine A61K 31/635) [2,7]
A61K  31/63  \	1	1	4C086	A61K  31/63	627	ѥݣΡݥ٥󥼥󥹥ۥ˥ݣΡݴͭ벽ʪ㡥ե˥륢ߥɡСݥ˥ȥ٥󥼥󥹥եΥҥɥ饸ɡΣ	Compounds containing para-N-benzene- sulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonohydrazide [2]
A61K  31/635  \	2	2	4C086	A61K  31/635	660	ʣǴĤͭΡ㡥եΣ	having a heterocyclic ring, e.g. sulfadiazine [2]
A61K  31/64  \	1	1	4C086	A61K  31/64	838	ۥ˥Ǣǡ㡥٥󥯥ߥɡȥ֥ߥɡץѥߥɡΣ	Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide [2]
A61K  31/65  \	1	1	4C086	A61K  31/65	1194	ƥȥ饵Σ	Tetracyclines [2]
A61K  31/655  \	1	1	4C086	A61K  31/655	421	ʡݣΡΡݡˡʡ΢ˡʡӣΡʣϡˡݣΡҤޤϣΡʡϡˡΡҡˡɡʡݣ΢ˡޤϥߥΡʡݣΡΡݣΡ˲ʪΣ	Azo (&mdash;N=N&mdash;), diazo (=N<sub>2</sub>), azoxy (&lt;N&mdash;O&mdash;N&lt; or N(=O)&mdash;N&lt;), azido (&mdash;N<sub>3</sub>) or diazoamino (&mdash;N=N&mdash;N&lt;) compounds [2]
A61K  31/66  \	1	1	4C086	A61K  31/66	1736	󲽹ʪΣ	Phosphorus compounds [2]
A61K  31/661  \	2	2	4C086	A61K  31/661	1583	Сݣ÷ʤޤϤΥƥ롤㡥ۥե롤ܥޥΣ	Phosphorus acids or esters thereof not having P&mdash;C bonds, e.g. fosfosal, dichlorvos, malathion [7]
A61K  31/6615  \	3	3	4C086	A61K  31/6615	344	ޤϤʾΥƥ벽줿Ĳʪ㡥ΥȡȥۥեȡեΣ	Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid[2006.01]
A61K  31/662  \	2	2	4C086	A61K  31/662	917	Сݣ÷ĥϤΥƥ롤㡥ۥͥåȡȥꥯۥΣ	Phosphorus acids or esters thereof having P&mdash;C bonds, e.g. foscarnet, trichlorfon [7]
A61K  31/663  \	3	3	4C086	A61K  31/663	780	ϤʾΥϤΥƥĲʪ㡥ɥѥߥɥΣ	Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid [7]
A61K  31/664  \	2	2	4C086	A61K  31/664	358	ΥߥɡΣ	Amides of phosphorus acids [7]
A61K  31/665  \	2	2	4C086	A61K  31/665	625	Ĺۼ︶ҤȤƻǤĤΡ㡥ۥۥޥΣ	having oxygen as a ring hetero atom, e.g. fosfomycin [2]
A61K  31/67  \	2	2	4C086	A61K  31/67	123	Ĺۼ︶ҤȤβĤΡΣ	having sulfur as a ring hetero atom [2]
A61K  31/675  \	2	2	4C086	A61K  31/675	4070	Ĺۼ︶ҤȤǤĤΡ㡥ԥɥ롡Σ	having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate [2]
A61K  31/683  \	2	2	4C086	A61K  31/683	385	ĤΥҥɥʪȥȤΥƥ롤㡥ۥե륤ΥȡΣ	Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols [7]
A61K  31/685  \	3	3	4C086	A61K  31/685	1305	ΥҥɥʪǸҤĤΡ㡥ۥե륻󡤥쥷Σ	one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin [2,7]
A61K  31/688  \	3	3	4C086	A61K  31/688	198	ΥҥɥʪǸҤĤΡ㡥ե󥴥ߥΣ	both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins [7]
A61K  31/69  \	1	1	4C086	A61K  31/69	1214	ۤǲʪΣ	Boron compounds [2]
A61K  31/695  \	1	1	4C086	A61K  31/695	1279	ǲʪΣ	Silicon compounds [2]
A61K  31/70  \	1	1	4C086	A61K  31/70	9569	ú岽ʪͶƳΡʥӥȡˣˡΣ	Carbohydrates; Sugars; Derivatives thereof (sorbitol A61K 31/047)
A61K  31/7004  \	2	2	4C086	A61K  31/7004	1339	úǡǡǸҤΤߤñΣ	Monosaccharides having only carbon, hydrogen and oxygen atoms [7]
A61K  31/7008  \	2	2	4C086	A61K  31/7008	844	ľܷ礹룱ĤΥߥδĲʪ㡥ġݥ饯ȥߥ󡤥˥ॹΣ	Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine [7]
A61K  31/7012  \	2	2	4C086	A61K  31/7012	357	ľܤޤúǺ𤷤Ʒ礷ͷΥޤϥƥ벽줿ܥĲʪ㡥륯Υߥʥ륳ˣӥˣˡΣ	Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid (gluconic acid A61K 31/191; ascorbic acid A61K 31/375) [7]
A61K  31/7016  \	2	2	4C086	A61K  31/7016	1102	ࡤ㡥饯ȡ饯ʥ饯ȥӥˣˡΣ	Disaccharides, e.g. lactose, lactulose (lactobionic acid A61K 31/7032) [7]
A61K  31/702  \	2	2	4C086	A61K  31/702	1608	ࡤʤꥳɷˤߤ˷礷ĤĤΡΣ	Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages [7]
A61K  31/7024  \	2	2	4C086	A61K  31/7024	1129	ΥƥΣ	Esters of saccharides [7]
A61K  31/7028  \	2	2	4C086	A61K  31/7028	3039	ꥳɷˤꡤǤʤʪȷ礷ĲʪΣ	Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages [7]
A61K  31/7032  \	3	3	4C086	A61K  31/7032	591	ݥꥪ롤ʤİʾͷΥޤϥƥ벽줿ʥꥳɷ˴ޤޤޤˤĲʪ˷礷Ρ㡥Υ륳롾륰ꥻɡ饯ȥӥ󥰥ꥪɡΣ	attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyl-diacylglycerides, lactobionic acid, gangliosides [7]
A61K  31/7034  \	3	3	4C086	A61K  31/7034	2229	úǴĤȷ礷Ρ㡥եꥸΣ	attached to a carbocyclic compound, e.g. phloridzin [7]
A61K  31/7036  \	4	4	4C086	A61K  31/7036	1094	úǴĤľܷ礷ʤȤ⣱ĤΥߥδĤΡ㡥ȥץȥޥ󡤥󥿥ޥ󡤥ߥ󡤥Хޥ󡤥եޥΣ	having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins [7]
A61K  31/704  \	4	4	4C086	A61K  31/704	4867	̹úǴķϤ˷礷Ρ㡥Υɡɡ󡤥Υӥ󡤥ȥΣ	attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin, digitoxin [7]
A61K  31/7042  \	2	2	4C086	A61K  31/7042	3138	ʣǴĤȤĲʪΣ	Compounds having saccharide radicals and heterocyclic rings [7]
A61K  31/7048  \	3	3	4C086	A61K  31/7048	5677	Ĺۼ︶ҤȤƻǸҤĤΡ㡥륳󡤤إڥꥸ󡤥ꥹޥ󡤥ʥΣ	having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin [7]
A61K  31/7052  \	3	3	4C086	A61K  31/7052	2579	Ĺۼ︶ҤȤǤĤΡ㡥̥쥪ɡ̥쥪ɡΣ	having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides [7]
A61K  31/7056  \	4	4	4C086	A61K  31/7056	1432	Ĺۼ︶ҤȤǤޤࣵĤޤΡΣ	containing five-membered rings with nitrogen as a ring hetero atom [7]
A61K  31/706  \	4	4	4C086	A61K  31/706	1862	Ĺۼ︶ҤȤǤޤࣶĤޤΡΣ	containing six-membered rings with nitrogen as a ring hetero atom [7]
A61K  31/7064  \	5	5	4C086	A61K  31/7064	1131	̹ޤ̹ΥԥߥޤΡΣ	containing condensed or non-condensed pyrimidines [7]
A61K  31/7068  \	6	6	4C086	A61K  31/7068	2927	ԥߥĤľܷ礷ޤΡ㡥󡤥Σ	having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid [7]
A61K  31/7072  \	7	7	4C086	A61K  31/7072	1614	ԥߥĤľܷ礷ĤΥĤΡ㡥ꥸ󡤥ꥸߥ󡤥ɥ֥Σ	having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine [7]
A61K  31/7076  \	6	6	4C086	A61K  31/7076	2604	ץޤΡ㡥ǥΥ󡤥ǥ˥Σ	containing purines, e.g. adenosine, adenylic acid [7]
A61K  31/708  \	7	7	4C086	A61K  31/708	695	ץĤľܷ礷ĤΡ㡥Υ󡤥˥Σ	having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid [7]
A61K  31/7084  \	2	2	4C086	A61K  31/7084	521	ĤΥ̥쥪ɤޤϥ̥쥪ɤĲʪ㡥˥󥢥ߥɡǥ˥󥸥̥쥪ɡեӥ󡾥ǥ˥󥸥̥쥪ɡΣ	Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide [7]
A61K  31/7088  \	2	2	4C086	A61K  31/7088	13419	İʾΥ̥쥪ɤޤϥ̥쥪ɤĲʪΣ	Compounds having three or more nucleosides or nucleotides [7]
A61K  31/7105  \	3	3	4C086	A61K  31/7105	6088	ŷΥܳ˻ʤǥ˥󡤥˥󡤥ȥޤϥ饷˷礷ܡΤߤޤߡǡݣǥۥۥƥĤΡΣ	Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links [7]
A61K  31/711  \	3	3	4C086	A61K  31/711	3291	ŷΥǥܳ˻ʤǥ˥󡤥˥󡤥ȥϥߥ˷礷ǡݥǥܡΤߤޤߡǡݣǥۥۥƥĤΡΣ	Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links [7]
A61K  31/7115  \	3	3	4C086	A61K  31/7115	1050	𡤤ʤǥ˥󡤥˥󡤥ȥ󡤥饷ϥߥʳĳ˻ϥꥴ̥쥪ɡΣ	Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine [7]
A61K  31/712  \	3	3	4C086	A61K  31/712	1481	줿ʤܡޤϣǡǥܡʳĳ˻ϥꥴ̥쥪ɡΣ	Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose [7]
A61K  31/7125  \	3	3	4C086	A61K  31/7125	1781	줿̥쥪ɴ֤η硤ʤǡݣǥۥܥƥʳηĳ˻ϥꥴ̥쥪ɡΣ	Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters [7]
A61K  31/713  \	3	3	4C086	A61K  31/713	5314	ܺγ˻ޤϥꥴ̥쥪ɡΣ	Double-stranded nucleic acids or oligonucleotides [7]
A61K  31/7135  \	2	2	4C086	A61K  31/7135	238	Ŷ°ޤಽʪΣ	Compounds containing heavy metals [7]
A61K  31/714  \	3	3	4C086	A61K  31/714	930	Хߥ㡥ΥХߥ󡤥ӥߥ¢Σ	Cobalamins, e.g. cyanocobalamin, vitamin B<sub>12</sub> [7]
A61K  31/715  \	2	2	4C086	A61K  31/715	3790	¿ࡤʤꥳɷˤߤ˷礵줿İʾĤΡڤӤͶƳΡ㡥ƥ롤ƥΣ	Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters[2006.01]
A61K  31/716  \	3	3	4C086	A61K  31/716	751	륫Σ	Glucans [7]
A61K  31/717  \	4	4	4C086	A61K  31/717	493	Σ	Celluloses [7]
A61K  31/718  \	4	4	4C086	A61K  31/718	514	ʴڤʴÿʬʪ㡥ߥߥڥΣ	Starch or degraded starch, e.g. amylose, amylopectin [7]
A61K  31/719  \	4	4	4C086	A61K  31/719	51	ץΣ	Pullulans [7]
A61K  31/721  \	4	4	4C086	A61K  31/721	219	ǥȥΣ	Dextrans [7]
A61K  31/722  \	4	4	4C086	A61K  31/722	608	󡤥ȥΣ	Chitin; Chitosan [7]
A61K  31/723  \	4	4	4C086	A61K  31/723	87	󥿥Σ	Xanthans [7]
A61K  31/724  \	4	4	4C086	A61K  31/724	271	ǥȥΣ	Cyclodextrins [7]
A61K  31/726  \	3	3	4C086	A61K  31/726	638	ꥳߥΥꥫ󡤤ʤॳ¿ʥɥβǥޥβˣˡΣ	Glycosaminoglycans, i.e. mucopolysaccharides (chondroitin sulfate, dermatan sulfate A61K 31/737) [7]
A61K  31/727  \	4	4	4C086	A61K  31/727	830	إѥ󡨥إѥΣ	Heparin; Heparan[2006.01]
A61K  31/728  \	4	4	4C086	A61K  31/728	1436	ҥΣ	Hyaluronic acid [7]
A61K  31/729  \	3	3	4C086	A61K  31/729	83	ŷڥΣ	Agar; Agarose; Agaropectin [7]
A61K  31/731  \	3	3	4C086	A61K  31/731	112	饮ʥΣ	Carrageenans [7]
A61K  31/732  \	3	3	4C086	A61K  31/732	232	ڥΣ	Pectin [7]
A61K  31/733  \	3	3	4C086	A61K  31/733	200	ե륯ȥ㡥̥Σ	Fructosans, e.g. inulin [7]
A61K  31/734  \	3	3	4C086	A61K  31/734	382	륮Σ	Alginic acid [7]
A61K  31/736  \	3	3	4C086	A61K  31/736	277	륳ޥʥޤϥ饯ȥޥʥ㡥ȥӡ󥬥ࡤΣ	Glucomannans or galactomannans, e.g locust bean gum, guar gum [7]
A61K  31/737  \	3	3	4C086	A61K  31/737	954	β¿㡥ɥβǥޥβʣˣͥˡΣ	Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate (A61K 31/727 takes precedence) [7]
A61K  31/738  \	3	3	4C086	A61K  31/738	32	򺹷¿Σ	Cross-linked polysaccharides [7]
A61K  31/739  \	3	3	4C086	A61K  31/739	129	¿Σ	Lipopolysaccharides [7]
A61K  31/74  \	1	1	4C086	A61K  31/74	210	νŹΣ	Synthetic polymeric materials [2]
A61K  31/745  \	2	2	4C086	A61K  31/745	72	úǤνŹΡΣ	Polymers of hydrocarbons [2]
A61K  31/75  \	3	3	4C086	A61K  31/75	18	ƥνŹΡΣ	of ethene [2]
A61K  31/755  \	2	2	4C086	A61K  31/755	22	ϥͭŹΡΣ	Polymers containing halogen [2]
A61K  31/76  \	3	3	4C086	A61K  31/76	7	ӥ˥νŹΡΣ	of vinyl chloride [2]
A61K  31/765  \	2	2	4C086	A61K  31/765	681	ǤͭŹΡΣ	Polymers containing oxygen [2]
A61K  31/77  \	3	3	4C086	A61K  31/77	466	νŹΡΣ	of oxiranes [2]
A61K  31/775  \	3	3	4C086	A61K  31/775	34	եΡΣ	Phenolic resins [2]
A61K  31/78  \	3	3	4C086	A61K  31/78	412	ޤϤͶƳΤνŹΡΣ	of acrylic acid or derivatives thereof [2]
A61K  31/785  \	2	2	4C086	A61K  31/785	1165	ǤͭŹΡΣ	Polymers containing nitrogen [2]
A61K  31/787  \	3	3	4C086	A61K  31/787	264	Ĺۼ︶ҤȤǤʣǴĤޤΡΣ	containing heterocyclic rings having nitrogen as a ring hetero atom [7]
A61K  31/79  \	4	4	4C086	A61K  31/79	219	ӥ˥ԥɥνŹΡΣ	Polymers of vinyl pyrrolidone [2]
A61K  31/795  \	2	2	4C086	A61K  31/795	247	βͭŹΡΣ	Polymers containing sulfur [2]
A61K  31/80  \	2	2	4C086	A61K  31/80	361	롼ףˣˣ°ʤإƥҤͭŹΡΣ	Polymers containing hetero atoms not provided for in groups A61K 31/755-A61K 31/795 [2]
A61K  33/00  \	0	0	4C086	A61K  33/00	3239	̵ʬͭޡΣ	Medicinal preparations containing inorganic active ingredients [2]
A61K  33/02  \	1	1	4C086	A61K  33/02	66	˥βʪΣ	Ammonia; Compounds thereof [2]
A61K  33/04  \	1	1	4C086	A61K  33/04	708	βޤϥƥ롤βʪΣ	Sulfur, selenium or tellurium; Compounds thereof [2]
A61K  33/06  \	1	1	4C086	A61K  33/06	2280	ߥ˥ࡤ륷ޤϥޥͥࡨβʪΣ	Aluminium, calcium or magnesium; Compounds thereof [2]
A61K  33/08  \	2	2	4C086	A61K  33/08	601	ʪʪΣ	Oxides; Hydroxides [2]
A61K  33/10  \	2	2	4C086	A61K  33/10	730	úúΣ	Carbonates; Bicarbonates [2]
A61K  33/12  \	2	2	4C086	A61K  33/12	112	ޥͥΣ	Magnesium silicate [2]
A61K  33/14  \	1	1	4C086	A61K  33/14	841	륫°αʪ륫°αʪΣ	Alkali metal chlorides; Alkaline earth metal chlorides [2]
A61K  33/16  \	1	1	4C086	A61K  33/16	266	դǲʪΣ	Fluorine compounds [2]
A61K  33/18  \	1	1	4C086	A61K  33/18	689	ǡβʪΣ	Iodine; Compounds thereof [2]
A61K  33/20  \	1	1	4C086	A61K  33/20	370	ǡǤФ̵ʪΣ	Elemental chlorine; Inorganic compounds releasing chlorine [2]
A61K  33/22  \	1	1	4C086	A61K  33/22	281	ۤǲʪΣ	Boron compounds [2]
A61K  33/24  \	1	1	4C086	A61K  33/24	2164	Ŷ°βʪΣ	Heavy metals; Compounds thereof [2]
A61K  33/241  \	2	2	4C086	A61K  33/241	220	βʪΣ	Lead; Compounds thereof
A61K  33/242  \	2	2	4C086	A61K  33/242	534	⡨βʪΣ	Gold; Compounds thereof
A61K  33/243  \	2	2	4C086	A61K  33/243	2221	⡨βʪΣ	Platinum; Compounds thereof
A61K  33/244  \	2	2	4C086	A61K  33/244	523	󥿥˥ɡβʪǤμŤޤϸѤ󥿥˥ɤͭޣˣˡΣ	Lanthanides; Compounds thereof (medicinal preparations containing radioactive lanthanides for use in therapy or testing in vivo A61K51/00)
A61K  33/245  \	2	2	4C086	A61K  33/245	303	ӥޥβʪΣ	Bismuth; Compounds thereof
A61K  33/26  \	2	2	4C086	A61K  33/26	1928	ŴβʪΣ	Iron; Compounds thereof [2]
A61K  33/28  \	2	2	4C086	A61K  33/28	167	䡨βʪΣ	Mercury; Compounds thereof [2]
A61K  33/30  \	2	2	4C086	A61K  33/30	2124	βʪΣ	Zinc; Compounds thereof [2]
A61K  33/32  \	2	2	4C086	A61K  33/32	735	ޥ󥬥󡨤βʪΣ	Manganese; Compounds thereof [2]
A61K  33/34  \	2	2	4C086	A61K  33/34	1275	ƼβʪΣ	Copper; Compounds thereof [2]
A61K  33/36  \	2	2	4C086	A61K  33/36	271	ǡβʪΣ	Arsenic; Compounds thereof [2]
A61K  33/38  \	2	2	4C086	A61K  33/38	781	䡨βʪΣ	Silver; Compounds thereof [2]
A61K  33/40  \	1	1	4C086	A61K  33/40	394	ʪΣ	Peroxides [2]
A61K  33/42  \	1	1	4C086	A61K  33/42	756	󡨤βʪΣ	Phosphorus; Compounds thereof [2]
A61K  33/44  \	1	1	4C086	A61K  33/44	489	úǡ㡥úܥ֥åΣ	Elemental carbon, e.g. charcoal, carbon black [2]
A61K  35/00  \	0	0	4C087	A61K  35/00	228	¤̤ΤʪޤϤȿʪͭޡΣ	Medicinal preparations containing material or reaction products thereof with undetermined constitution [2]
A61K  35/02  \	1	1	4C087	A61K  35/02	844	̵ʪΤΤΡúǣˣˡΣ	from inanimate materials (carbon A61K33/44) [2, 2015.01]
A61K  35/04  \	2	2	4C087	A61K  35/04	65	롨ӥ塼󡨹ӥ塼ߥΥۥ˥Σ	Tars; Bitumens; Mineral oils; Ammonium bituminosulfonate [2]
A61K  35/06  \	3	3	4C087	A61K  35/06	21	㡥ѥեޤ˧²úǤ˴Ť˧²Σ	Mineral oils, e.g. aromatic oil based on  paraffin oil or Aromatic hydrocarbons [2]
A61K  35/08  \	2	2	4C087	A61K  35/08	179	Σ	Mineral waters; Sea waters [2, 2015.01]
A61K  35/10  \	2	2	4C087	A61K  35/10	109	ťúᡨťú忢ڡΣ	Peat; Amber Block of peat; Humus soil [2, 2015.01]
A61K  35/12  \	1	1	4C087	A61K  35/12	7815	ӮưʪʪꤵƤʤȿޤϺ˦ʤʪ˦ʤʪŪ˽줿˦ʥ說ޤϹޤϹΤͭޣˣˡΣ	Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells (vaccines or medicinal preparations containing antigens or antibodies A61K39/00)
A61K  35/13  \	2	2	4C087	A61K  35/13	484	ͳ褹ȿʤ˦ʼ說ˣˡΣ	Tumour cells, irrespective of tissue of origin(tumour vaccines A61K39/00)  [2015.01]
A61K  35/14  \	2	2	4C087	A61K  35/14	3438	ա͹աʥѡե륪ܥˣӷˣإ⥰ӥˣˡΣ	Blood; Artificial blood (perfluorocarbons A61K31/02; umbilical cord blood A61K35/51; haemoglobin A61K38/42) [2, 2015.01]
A61K  35/15  \	3	3	4C087	A61K  35/15	2164	˦㡥γ塤塤塤塤塤ñ塤ޥեޤϥޥȺ˦˦󼨺˦㡥˦ʼŤΤιΤޤϤΥե饰Ȥȷͳ˦Ȥ߹碌ˣ˦ȱˡˣˡΣ	Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells  (therapeutic combinations of antibodies, or fragments thereof, and blood-derived cells A61K 39/00;  cellular immunotherapy A61K 40/00)[2025.01]
A61K  35/16  \	3	3	4C087	A61K  35/16	1576	ӷˣˡΣ	Plasma; Serum (cord blood A61K35/51) [2, 2015.01]
A61K  35/17  \	3	3	4C087	A61K  35/17	6461	ѵ塨º˦Ժ˦ʥ륭顼˦󥿡եޤϥȥѵʺ˦ȱˡˣˡΣ	Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes (cellular immunotherapy A61K 40/00)[2025.01]
A61K  35/18  \	3	3	4C087	A61K  35/18	667	ַʥإ⥰ӥˣˡΣ	Erythrocytes (haemoglobin A61K38/42) [2, 2015.01]
A61K  35/19  \	3	3	4C087	A61K  35/19	568	쾮ġ˵Σ	Platelets; Megakaryocytes  [2015.01]
A61K  35/20  \	2	2	4C087	A61K  35/20	1244	ۥΣ	Milk; whey; Colostrum [2]
A61K  35/22  \	2	2	4C087	A61K  35/22	774	ǢǢϩ㡥¡ޤ᥵󥮥˦մպ˦աΣ	Urine; Urinary tract, e.g. kidney or urinary bladder; mesangium; Kidney mesenchymal cell; adrenal gland [2, 2015.01]
A61K  35/24  \	2	2	4C087	A61K  35/24	228	ǴաǴդΤաաʬʬԿաñգˣˡΣ	Mucus; Mucous glands; Synovial fluid; Bursa; Arthral fluid; Excreta; Spinal fluid (saliva A61K35/38) [2, 2015.01]
A61K  35/26  \	2	2	4C087	A61K  35/26	738	ѡᡨ¡¡˦˦Σ	Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes [2, 2015.01]
A61K  35/28  \	2	2	4C087	A61K  35/28	4035	¤촴˦ͳʤշϴ˦㡥ͳ贴˦Σ	Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells [2, 2015.01]
A61K  35/30  \	2	2	4C087	A61K  35/30	1719	СǾ㡨˦ǾԿաд˦˦ꥢ˦ꥴǥɥȺ˦˦籺˦˦̮֡ԿȿΣ	Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue [2, 2015.01]
A61K  35/32  \	2	2	4C087	A61K  35/32	1180	˦˦秡秺˦ݲ˦˦Σ	Bones; Bone cell; Osteoblast; Tendons; Tendon cell; Teeth; Odontoblast; Cartilage; Cartilage cell; Synovial membrane [2, 2015.01]
A61K  35/33  \	2	2	4C087	A61K  35/33	534	ݲ˦Σ	Fibroblasts  [2015.01]
A61K  35/34  \	2	2	4C087	A61K  35/34	1209	ʿں˦¡ڴ˦ڲ˦ں˦ں˦ʷʿڣˣˡΣ	Muscles; Smooth muscle cell; Heart;  Cardiac stem cell;  Myoblast;  Muscle cell; Myocardial cell (vascular smooth muscle A61K35/44) [2, 2015.01]
A61K  35/35  \	2	2	4C087	A61K  35/35	681	ȿú˦ּ˦ȿʻͳ贴˦ˣ顼ˣˡΣ	Fat tissue; Adipocytes; Stromal cells; Connective tissues (adipose-derived stem cells A61K35/28; collagen A61K38/39)  [2015.01]
A61K  35/36  \	2	2	4C087	A61K  35/36	1276	桨Ƭȱޡɽ顨˦Υȡ󥲥ϥ󥹺˦պ˦ʥ󥲥ϥˣˡΣ	Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells (islets of Langerhans A61K35/39) [4, 2015.01]
A61K  35/37  \	2	2	4C087	A61K  35/37	186	òﴱΣ	Digestive system [3,2015.01]
A61K  35/38  \	3	3	4C087	A61K  35/38	451	ߡĲվ˦Ǵ졨ñաΣ	Stomach; Intestine; Goblet cells; Oral mucosa; Saliva [3, 2015.01]
A61K  35/39  \	3	3	4C087	A61K  35/39	877	¡󥲥ϥʾΥ󥲥ϥ󥹺˦ˣˡΣ	Pancreas; Islets of Langerhans (Langerhans cells of epidermis A61K35/36) [3, 2015.01]
A61K  35/407  \	3	3	4C087	A61K  35/407	1010	¡κ˦Σ	Liver; Hepatocytes [3, 2015.01]
A61K  35/413  \	3	3	4C087	A61K  35/413	158	ǹΣ	Gall bladder; Bile [3, 2015.01]
A61K  35/42  \	2	2	4C087	A61K  35/42	347	Ƶ۴ﴱ㡥١ɻ٤ޤٺ˦Σ	expiratory system, e.g. lungs, bronchi or lung cells [2, 2015.01]
A61K  35/44  \	2	2	4C087	A61K  35/44	848	ɡʿں˦˦˦Σ	Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells [2, 2015.01]
A61K  35/48  \	2	2	4C087	A61K  35/48	324	Σ	Reproductive organs [2, 2015.01]
A61K  35/50  \	3	3	4C087	A61K  35/50	1126	ס״˦ӿ塨졨촴˦Σ	Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells [2, 2015.01]
A61K  35/51  \	3	3	4C087	A61K  35/51	967	ӡӷ졨Ӵ˦Σ	Umbilical cord; Umbilical cord blood; Umbilical stem cells  [2015.01]
A61K  35/52  \	3	3	4C087	A61K  35/52	224	ҡΩաΥ饤ǥåҺ˦Σ	Sperm; Prostate; Seminal fluid; Leydig cells of testes [2, 2015.01]
A61K  35/54  \	3	3	4C087	A61K  35/54	823	㡨ҡ̤ۻ˦˦Σ	Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells [2, 2015.01]
A61K  35/545  \	4	4	4C087	A61K  35/545	2180	˦¿ǽ˦͹¿ǽ˦ʤУӺ˦ħŤƤʤ˦Σ	Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells  [2015.01]
A61K  35/55  \	2	2	4C087	A61K  35/55	224	롼ףˣˣʬवʤ㡥þþޤϾΣ	Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands [3, 2015.01]
A61K  35/56  \	1	1	4C087	A61K  35/56	1304	ӮưʪʳưʪʪΣ	Materials from animals other than mammals [2, 2015.01]
A61K  35/57  \	2	2	4C087	A61K  35/57	684	ĻࡨĻफʪ㡥񡤱ӡ񲫤ޤϷΣ	Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium carenum gingerier gall  [2015.01]
A61K  35/58  \	2	2	4C087	A61K  35/58	174	ʼؤιˣˡΣ	insects (antigensfrom snakes A61K39/38) [2, 2015.01]
A61K  35/583  \	3	3	4C087	A61K  35/583	178	ءȥ㡥쥪ʼμŤؤλѣˣˡΣ	Snakes; Lizards, e.g. chameleons(therapeutic use of a snake venom protein A61K38/00)  [2015.01]
A61K  35/586  \	3	3	4C087	A61K  35/586	36	ߥᡨΦᡤ㡥Σ	Turtles; Tortoises, e.g. terrapins  [2015.01]
A61K  35/60  \	2	2	4C087	A61K  35/60	1560	ࡤ㡥ĥΥȥΣ	fishes, e.g. seahorses; fish egg [2]
A61K  35/612  \	2	2	4C087	A61K  35/612	217	óࡤ㡥ˡ֥ӡߤޤϥꥬˡեĥܡΣ	Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles  [2015.01]
A61K  35/614  \	2	2	4C087	A61K  35/614	126	˦ưʪ㡥㥯󥴡ޤϥ饲Σ	Cnidarian, e.g. sea anemones, corals, coral animals or jellyfish  [2015.01]
A61K  35/616  \	2	2	4C087	A61K  35/616	100	ưʪ㡥ҥȥǡʥޥޤϥˡΣ	Echinodermata, e.g. starfish, sea cucumbers or sea urchins  [2015.01]
A61K  35/618  \	2	2	4C087	A61K  35/618	656	ưʪ㡥øưʪ糭ޤϥʥ᥯Σ	Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs  [2015.01]
A61K  35/62  \	2	2	4C087	A61K  35/62	180	Ҥ롨㡥֡ʥॷߥߥࡤեꥢޤϾΣ	Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia [2]
A61K  35/63  \	2	2	4C087	A61K  35/63	23	­ưʪʿóˣˡΣ	Arthropods(aquatic crustaceans A61K35/612)  [2015.01]
A61K  35/64  \	3	3	4C087	A61K  35/64	1357	㡥˪ХޤϥΥߡΣ	Insects, e.g. bees, wasps or fleas [2, 2015.01]
A61K  35/644  \	4	4	4C087	A61K  35/644	829	ߤĤץݥꥹ를꡼ϤߤġΣ	Beeswax; Propolis; Royal jelly; Honey  [2015.01]
A61K  35/646  \	3	3	4C087	A61K  35/646	60	ưʪ㡥⡤ꡤ緿ˤޤϾˡΣ	Arachnids, e.g. spiders, scorpions, ticks or mites  [2015.01]
A61K  35/648  \	3	3	4C087	A61K  35/648	2	¿­ࡤ㡥५Ǥޤϥ䥹ǡΣ	Myriapods, e.g. centipedes or millipedes  [2015.01]
A61K  35/65  \	2	2	4C087	A61K  35/65	83	ξࡤ㡥ҥ롤롤󥷥祦ޤϥΣ	Amphibians, e.g. toads, frogs, salamanders or newts  [2015.01]
A61K  35/655  \	2	2	4C087	A61K  35/655	125	롼ףˣˣʬवʤʪΣ	Aquatic animals other than those covered by groups A61K35/57 to A61K35/65   [2015.01]
A61K  35/66  \	1	1	4C087	A61K  35/66	471	ʪޤʪʪʶࡤޤϥ󥸥ݣˣˡΣ	Microorganism or materials from microorganism (fungi, yeast or candida A61K36/06) [2, 2015.01]
A61K  35/68  \	2	2	4C087	A61K  35/68	220	ưʪ㡥᡼С˦ץ饺⥸ޤϥȥץ饺ޡΣ	Protozoa, e.g. flagella, amoebas, sporozoans, plasmodium or toxoplasma [2]
A61K  35/74  \	2	2	4C087	A61K  35/74	1437	ХƥꥢʥХƥꥢμŤؤλѣˣˡΣ	Bacteria(therapeutic use of a bacterial protein A61K38/00) [2, 2015.01]
A61K  35/74  A	2	0	4C087	A61K  35/74	3782		Cell body whole
A61K  35/74  B	2	0	4C087	A61K  35/74	527	ʬ	Cell body part
A61K  35/74  C	2	0	4C087	A61K  35/74	246	εڤӶʬ	Cell body whole and cell body part
A61K  35/74  D	2	0	4C087	A61K  35/74	1071	ʪ	Substances in bacteria
A61K  35/74  E	2	0	4C087	A61K  35/74	2462	ʪ	Antibiotics
A61K  35/74  F	2	1	4C087	A61K  35/74	936	Ӥꤵ줿ʪ	Antibiotics with specific medical purpose
A61K  35/74  G	2	0	4C087	A61K  35/74	1865	ˣˣƤʬवʤܱͳʪ	Substances of culture origin not provided got by A61K35/74@A-A61K35/74@F
A61K  35/74  Z	2	0	4C087	A61K  35/74	513	¾Τ	Others
A61K  35/741  \	3	3	4C087	A61K  35/741	823	Ĳͭ׶ݡĲ졤㡥åߥˣˡΣ	Probiotics(probiotic yeast, e.g. saccharomyces A61K36/06)  [2015.01]
A61K  35/742  \	4	4	4C087	A61K  35/742	976	˦ݡ㡥Х饹󥹡ݡȥꥸ°ޤͭ˦ݡΣ	Spore-forming bacteria, e.g. Bacillus coagulants, Bacillus subtilis, clostridium or Lactobacillus sporogenes  [2015.01]
A61K  35/744  \	4	4	4C087	A61K  35/744	2084	ݡ㡥ƥå°ڥǥå°饯ȥå°Ϣݤޤϥ塼Υȥå°Σ	Lactic acid bacteria, e.g. enterococci, pediococci,  lactococci, streptococci or leuconostocs  [2015.01]
A61K  35/745  \	5	5	4C087	A61K  35/745	1437	ӥեɥХƥꥦ°Σ	Bifidobacterium  [2015.01]
A61K  35/747  \	5	5	4C087	A61K  35/747	2255	饯ȥХ饹°㡥ɥե륹ݤޤϥ֥ӥݡΣ	Lactobacilli, e.g. L. acidophilus or L. brevis  [2015.01]
A61K  35/748  \	3	3	4C087	A61K  35/748	112	ΥХƥꥢʤٶݤޤࡤ㡥ԥʡࡤޤٿʪˣˡΣ	Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina(algae, microalgae or microphyte A61K36/02)  [2015.01]
A61K  35/76  \	2	2	4C087	A61K  35/76	11127	륹֥륹γҡХƥꥪեΣ	Viruses; Subviruses particles; bacteriophage [2, 2015.01]
A61K  35/761  \	3	3	4C087	A61K  35/761	3043	ǥΥ륹Σ	Adenovirus  [2015.01]
A61K  35/763  \	3	3	4C087	A61K  35/763	1123	إڥ륹Σ	Herpes virus  [2015.01]
A61K  35/765  \	3	3	4C087	A61K  35/765	175	쥪륹륹Σ	Reovirus; Rotavirus  [2015.01]
A61K  35/766  \	3	3	4C087	A61K  35/766	206	֥ɥ륹㡥ꥦ륹Σ	Rhabdovirus, e.g. vesicular stomatitis virus  [2015.01]
A61K  35/768  \	3	3	4C087	A61K  35/768	482	롼ףˣˣʬवʤϲ륹Σ	Oncolytic viruses not provided for in groups A61K35/761 to A61K35/766 [2015.01]
A61K  36/00  \	0	0	4C088	A61K  36/00	256	ࡤϰࡤ⤷ϿʪޤϤʪʪͭ빽¤̤Τΰޡ㡥ŪΣ	pharmaceutical preparation having unknown structure and including materials from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
A61K  36/02  \	1	1	4C088	A61K  36/02	643	Σ	Algae [8]
A61K  36/03  \	2	2	4C088	A61K  36/03	814	ʪ㡥ҥХޥΣ	Phaeophycota or phaeophyta (brown algae), e.g. Fucus [8]
A61K  36/04  \	2	2	4C088	A61K  36/04	443	ʪ㡥ΥΣ	Rhodophycota or rhodophyta (red algae), e.g. Porphyra [8]
A61K  36/05  \	2	2	4C088	A61K  36/05	599	ʪ㡥Σ	Chlorophycota or chlorophyta (green algae), e.g. Chlorella [8]
A61K  36/06  \	1	1	4C087	A61K  36/06	163	ࡤ㡥Σ	Fungi, e.g. yeasts [8]
A61K  36/06  A	1	0	4C088	A61K  36/06	520		Advanced fungi
A61K  36/06  Z	1	0	4C087	A61K  36/06	639	¾	Others
A61K  36/062  \	2	2	4C087	A61K  36/062	1088	ǹݡΣ	Ascomycota [8]
A61K  36/064  \	3	3	4C087	A61K  36/064	814	åߥʡ㡥ѥΣ	Saccharomycetaceae, e.g. baker's yeast [8]
A61K  36/066  \	3	3	4C087	A61K  36/066	7	ХåʡΣ	Clavicipitaceae [8]
A61K  36/068  \	4	4	4C087	A61K  36/068	143	°Σ	Cordyceps [8]
A61K  36/07  \	2	2	4C088	A61K  36/07	2048	ôҶݡ㡥ôҶݹΣ	Basidiomycota, e.g. Cryptococcus [8]
A61K  36/074  \	3	3	4C088	A61K  36/074	523	ǡΣ	Bracket fungus [8]
A61K  36/076  \	3	3	4C088	A61K  36/076	376	֥祦Σ	Hoelen [8]
A61K  36/09  \	1	1	4C088	A61K  36/09	55	ϰΣ	Lichens [8]
A61K  36/10  \	1	1	4C088	A61K  36/10	72	ʪΣ	Bryophyta [8]
A61K  36/11  \	1	1	4C088	A61K  36/11	182	ʪΣ	Pteridophyte [8]
A61K  36/12  \	2	2	4C088	A61K  36/12	231	֡Σ	Filicopsida or Pteridopsida [8]
A61K  36/126  \	3	3	4C088	A61K  36/126	1	ɥʥꥢʡΣ	Drynaria [8]
A61K  36/13  \	1	1	4C088	A61K  36/13	262	̿ʪΣ	Pinophyta [8]
A61K  36/14  \	2	2	4C088	A61K  36/14	459	ҥΥʡ㡥ӥ㥯ޤϥȥΣ	Cupressaceae, e.g. juniper or cypress [8]
A61K  36/15  \	2	2	4C088	A61K  36/15	766	ޥĲʡ㡥ޥĤޤϥҥޥ䥹Σ	Pinaceae (Pine family), e.g. pine or cedar [8]
A61K  36/16  \	1	1	4C088	A61K  36/16	611	祦硤㡥祦ʡΣ	Ginkgophyta, e.g. Ginkgoaceae [8]
A61K  36/17  \	1	1	4C088	A61K  36/17	198	ޥ硤㡥ޥʡΣ	Gnetophyta, e.g. Ephedraceae [8]
A61K  36/18  \	1	1	4C088	A61K  36/18	1009	ҿʪΣ	Magnoliophyta [8]
A61K  36/185  \	2	2	4C088	A61K  36/185	5919	⥯֡лտʪˡΣ	Magnoliatae (dicotyledons) [8]
A61K  36/19  \	3	3	4C088	A61K  36/19	116	ĥͥΥޥʡΣ	Acanthaceae [8]
A61K  36/195  \	4	4	4C088	A61K  36/195	17	ϥʥ°Σ	Strobilanthes [8]
A61K  36/20  \	3	3	4C088	A61K  36/20	110	ǲʡΣ	Aceraceae [8]
A61K  36/21  \	3	3	4C088	A61K  36/21	241	ҥʡ㡥ȥåȤޤϥ˥Σ	Amaranthaceae, e.g. Amaranthus retroflexus, Saponaria ocymoides  or Gomphrena globosa [8]
A61K  36/22  \	3	3	4C088	A61K  36/22	387	륷ʡ㡥ϥޥΥ륷ޤϥݥ󥪡Σ	Anacardiaceae, e.g. smoke trees, Rhus verniciflua or poison oak [8]
A61K  36/23  \	3	3	4C088	A61K  36/23	1246	ʡ㡥ǥ롤㡼ӥ롤ꥢޤϥߥΣ	Umbelliferae, e.g. dill, chervil, coriander or cumin [8]
A61K  36/232  \	4	4	4C088	A61K  36/232	757	°Σ	Angelica [8]
A61K  36/233  \	4	4	4C088	A61K  36/233	241	ߥޥ°Σ	Bupleurum [8]
A61K  36/234  \	4	4	4C088	A61K  36/234	305	ϥޥ°Σ	Cnidium [8]
A61K  36/235  \	4	4	4C088	A61K  36/235	253	祦°Σ	Foeniculum [8]
A61K  36/236  \	4	4	4C088	A61K  36/236	44	ޥХȥ°Σ	Ligusticum (licorice-root) [8]
A61K  36/237  \	4	4	4C088	A61K  36/237	24	祦ġΣ	Notopterygium [8]
A61K  36/238  \	4	4	4C088	A61K  36/238	156	ܥեΣ	Saposhnikovia [8]
A61K  36/24  \	3	3	4C088	A61K  36/24	327	祦ȥʡ㡥ץꥢޤϥĥ˥	Apocynaceae, e.g. frangipanni or Vinca major
A61K  36/25  \	3	3	4C088	A61K  36/25	301	ʡ㡥ΥեޤϥߥĥǡΣ	Araliaceae, e.g. ivy, Aralia elata, Dwarf schefflera or  Tetrapanax paypriferum [8]
A61K  36/254  \	4	4	4C088	A61K  36/254	292	°Σ	Eleutherococcus [8]
A61K  36/258  \	4	4	4C088	A61K  36/258	1391	ͥ˥󥸥°Σ	Panax [8]
A61K  36/26  \	3	3	4C088	A61K  36/26	49	ޥΥʡ㡥󥢥Σ	Aristolochiaceae, e.g. heartleaf [8]
A61K  36/264  \	4	4	4C088	A61K  36/264	18	ޥΥ°Σ	Aristolochia [8]
A61K  36/268  \	4	4	4C088	A61K  36/268	88	եХ°Σ	Asarum [8]
A61K  36/27  \	3	3	4C088	A61K  36/27	189	ʡ㡥Σ	Asclepiadaceae, e.g. wax plant [8]
A61K  36/28  \	3	3	4C088	A61K  36/28	2542	ʡ㡥ߡ롤ʥĥΥ꥽ޤϥʥΣ	Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea [8]
A61K  36/282  \	4	4	4C088	A61K  36/282	768	⥮°㡥⥮ޤϥޥ⥮Σ	Artemisia, e.g. wormwood or sagebrush [8]
A61K  36/284  \	4	4	4C088	A61K  36/284	378	°Σ	Atractylodes [8]
A61K  36/285  \	4	4	4C088	A61K  36/285	4	ڹΣ	Aucklandia [8]
A61K  36/286  \	4	4	4C088	A61K  36/286	352	٥˥Х°Σ	Carthamus [8]
A61K  36/287  \	4	4	4C088	A61K  36/287	163	°㡥ҥʥΣ	Chrysanthemum, e.g. daisy [8]
A61K  36/288  \	4	4	4C088	A61K  36/288	145	ݥ°Σ	Taraxacum [8]
A61K  36/289  \	4	4	4C088	A61K  36/289	2	ڹΣ	Vladimiria [8]
A61K  36/29  \	3	3	4C088	A61K  36/29	141	᥮ʡ㡥᥮祦ޤޤϥꥫߥ䥪Σ	Berberidaceae, e.g. barberry, cohosh or mayapple [8]
A61K  36/296  \	4	4	4C088	A61K  36/296	110	꥽°Σ	Epimedium [8]
A61K  36/30  \	3	3	4C088	A61K  36/30	363	饵ʡ㡥ե꡼󥰥Ȥޤϥ凉ʥΣ	Boraginaceae, e.g. comfrey, lungwort or forget-me-not [8]
A61K  36/31  \	3	3	4C088	A61K  36/31	1101	֥ʲʡ㡥֥å꡼٥ĤޤϥӡΣ	Brassicaceae or Cruciferae, e.g. broccoli, cabbage or kohlrabi [8]
A61K  36/315  \	4	4	4C088	A61K  36/315	51	°㡥ۥХΣ	Isatis, e.g. Dyer's wood [8]
A61K  36/32  \	3	3	4C088	A61K  36/32	103	ʡΣ	Burseraceae (Frankincense family) [8]
A61K  36/324  \	4	4	4C088	A61K  36/324	300	ܥꥢ㡥Σ	Boswellia, e.g. frankincense [8]
A61K  36/328  \	4	4	4C088	A61K  36/328	21	ߥե°㡥ޤϥꥢɥХ륵Σ	Commiphora, e.g. mecca myrrh or balm of Gilead [8]
A61K  36/33  \	3	3	4C088	A61K  36/33	71	ܥƥʡ㡥掠ܥƥޤϥϥ饵ܥƥ	Cactaceae, e.g. pricklypear or Cereus [8]
A61K  36/34  \	3	3	4C088	A61K  36/34	46	祦ʡΣ	Campanulaceae [8]
A61K  36/342  \	4	4	4C088	A61K  36/342	36	ĥꥬͥ˥󥸥°Σ	Adenophora [8]
A61K  36/344  \	4	4	4C088	A61K  36/344	64	ĥ˥󥸥°Σ	Codonopsis [8]
A61K  36/346  \	4	4	4C088	A61K  36/346	246	祦°Σ	Platycodon [8]
A61K  36/35  \	3	3	4C088	A61K  36/35	222	ʡΣ	Caprifoliaceae (Honeysuckle family) [8]
A61K  36/355  \	4	4	4C088	A61K  36/355	242	°Σ	Lonicera [8]
A61K  36/36  \	3	3	4C088	A61K  36/36	152	ʥǥʡ㡥ߥޤϥܥ󥽥Σ	Caryophyllaceae (Pink family), e.g. babysbreath or soapwort [8]
A61K  36/37  \	3	3	4C088	A61K  36/37	140	˥ʡ㡥ޤϥ奦˥Σ	Celastraceae, e.g. tripterygium or spindletree [8]
A61K  36/38  \	3	3	4C088	A61K  36/38	512	ȥ꥽ʡʥҥڥꥫޤϥޥ󥴥ʡˡ㡥󡦥ȥ衼󥺥ȡΣ	Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort [8]
A61K  36/39  \	3	3	4C088	A61K  36/39	346	ҥ륬ʡ㡥ҥ륬Σ	Convolvulaceae (Morning-glory family), e.g. bindweed [8]
A61K  36/40  \	3	3	4C088	A61K  36/40	155	ߥʡΣ	Cornaceae (Dogwood family) [8]
A61K  36/41  \	3	3	4C088	A61K  36/41	140	٥󥱥ʡΣ	Crassulaceae (Stonecrop family) [8]
A61K  36/42  \	3	3	4C088	A61K  36/42	698	ʡΣ	Cucurbitaceae (Cucumber family) [8]
A61K  36/424  \	4	4	4C088	A61K  36/424	131	ޥ㥺°Σ	Gynostemma [8]
A61K  36/428  \	4	4	4C088	A61K  36/428	61	饹°Σ	Trichosanthes [8]
A61K  36/43  \	3	3	4C088	A61K  36/43	25	ͥʥʡ㡥ͥʥޤϥͥʥΣ	Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder [8]
A61K  36/44  \	3	3	4C088	A61K  36/44	269	Υʡ㡥Σ	Ebenaceae (Ebony family), e.g. persimmon [8]
A61K  36/45  \	3	3	4C088	A61K  36/45	629	ĥĥʤޤϥʡ㡥֥롼٥꡼٥꡼ޤϥӥ٥꡼Σ	Ericaceae or Vacciniaceae, e.g. blueberry, cranberry or bilberry [8]
A61K  36/46  \	3	3	4C088	A61K  36/46	212	ȥ奦ʡ㡥ȥ奦Σ	Eucommiaceae (Eucommia family), e.g. hardy rubber tree [8]
A61K  36/47  \	3	3	4C088	A61K  36/47	616	ȥʡ㡥ҥޡʥȥޡˡΣ	Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean) [8]
A61K  36/48  \	3	3	4C088	A61K  36/48	3735	ޥʡ㥱ĥХʡͥΥʡĳְʡΣ	Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae [8]
A61K  36/481  \	4	4	4C088	A61K  36/481	377	°Σ	Astragalus [8]
A61K  36/482  \	4	4	4C088	A61K  36/482	155	饱ĥᥤ°㡥ʥХ󥵥Σ	Cassia, e.g. golden shower tree [8]
A61K  36/483  \	4	4	4C088	A61K  36/483	32	°Σ	Gleditsia [8]
A61K  36/484  \	4	4	4C088	A61K  36/484	1332	󥾥°Σ	Glycyrrhiza [8]
A61K  36/485  \	4	4	4C088	A61K  36/485	8	٥°Σ	Gueldenstaedtia [8]
A61K  36/486  \	4	4	4C088	A61K  36/486	16	ʥĥե°Σ	Millettia [8]
A61K  36/487  \	4	4	4C088	A61K  36/487	32	ӥ°Σ	Psoralea [8]
A61K  36/488  \	4	4	4C088	A61K  36/488	362	°Σ	Pueraria [8]
A61K  36/489  \	4	4	4C088	A61K  36/489	309	°㡥եޤϥޥޥ͡Σ	Sophora, e.g. necklacepod or mamani [8]
A61K  36/49  \	3	3	4C088	A61K  36/49	343	֥ʲʡ㡥ޤϥȥΣ	Fagaceae (Beech family), e.g. oak or chestnut [8]
A61K  36/50  \	3	3	4C088	A61K  36/50	5	ޥ󥽥ʡ㡥ޥΣ	Fumariaceae, e.g. dicentra [8]
A61K  36/505  \	4	4	4C088	A61K  36/505	60	ޥ°Σ	Corydalis [8]
A61K  36/51  \	3	3	4C088	A61K  36/51	261	ɥʡΣ	Gentianaceae (Gentian family) [8]
A61K  36/515  \	4	4	4C088	A61K  36/515	162	ɥ°Σ	Gentiana [8]
A61K  36/52  \	3	3	4C088	A61K  36/52	240	߲ʡΣ	Juglandaceae (Walnut family) [8]
A61K  36/53  \	3	3	4C088	A61K  36/53	1828	ʡ㡥ࡤޥ꡼ޤϥ٥Σ	Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender [8]
A61K  36/532  \	4	4	4C088	A61K  36/532	34	ߥɥ°㡥Σ	Agastache, e.g. giant hyssop [8]
A61K  36/533  \	4	4	4C088	A61K  36/533	53	ϥ°Σ	Leonurus [8]
A61K  36/534  \	4	4	4C088	A61K  36/534	658	ϥå°Σ	Mentha [8]
A61K  36/535  \	4	4	4C088	A61K  36/535	448	°Σ	Perilla [8]
A61K  36/536  \	4	4	4C088	A61K  36/536	57	ĥܥ°Σ	Prunella [8]
A61K  36/537  \	4	4	4C088	A61K  36/537	437	ӥ°Σ	Salvia [8]
A61K  36/538  \	4	4	4C088	A61K  36/538	84	°Σ	Schizonepeta [8]
A61K  36/539  \	4	4	4C088	A61K  36/539	574	ĥʥߥ°Σ	Scutellaria [8]
A61K  36/54  \	3	3	4C088	A61K  36/54	1126	Υʡ㡥ʥޤϥåե饹Σ	Lauraceae, e.g. cinnamon or sassafras [8]
A61K  36/55  \	3	3	4C088	A61K  36/55	169	޲ʡ㡥ޡΣ	Linaceae (Flax family), e.g. Linum [8]
A61K  36/56  \	3	3	4C088	A61K  36/56	66	ۥ饤ʡ㡥Υ󥫥ޤϥå󥽥Σ	Loganiaceae (Logania family), e.g. trumpetflower or pinkroot [8]
A61K  36/57  \	3	3	4C088	A61K  36/57	61	⥯ʡΣ	Magnoliaceae [8]
A61K  36/575  \	4	4	4C088	A61K  36/575	232	⥯°Σ	Magnolia [8]
A61K  36/58  \	3	3	4C088	A61K  36/58	207	ʡ㡥ɥʥˡˡΣ	Meliaceae, e.g. azadirrachta indica (neem) [8]
A61K  36/59  \	3	3	4C088	A61K  36/59	202	ĥťեʡ㡥ĥťեޤϥӡΣ	Menispermaceae, e.g. cocculus trilobus or coral beads [8]
A61K  36/60  \	3	3	4C088	A61K  36/60	319	ʡ㡥ѥΥޤϥΣ	Moraceae, e.g. breadfruit or fig [8]
A61K  36/605  \	4	4	4C088	A61K  36/605	530	°Σ	Morus [8]
A61K  36/61  \	3	3	4C088	A61K  36/61	1172	եȥʡ㡥ƥĥ꡼ޤϥ桼Σ	Myrtaceae, e.g. tea tree or eucalyptus [8]
A61K  36/62  \	3	3	4C088	A61K  36/62	159	ʡΣ	Nymphaeaceae (Water-lily family) [8]
A61K  36/63  \	3	3	4C088	A61K  36/63	588	⥯ʡ㡥㥹ߥ󡤥饤åޤϥͥꥳΥΣ	Oleaceae, e.g. jasmine, lilac or ash tree [8]
A61K  36/634  \	4	4	4C088	A61K  36/634	168	󥮥祦°Σ	Forsythia [8]
A61K  36/638  \	4	4	4C088	A61K  36/638	61	ܥΥ°㡥ȥͥߥΣ	Ligustrum, e.g. Chinese privet [8]
A61K  36/64  \	3	3	4C088	A61K  36/64	96	ϥޥĥܲʡΣ	Orobanchaceae (Broom-rape family) [8]
A61K  36/65  \	3	3	4C088	A61K  36/65	1197	ܥʡ㡥㥯䥯Σ	Paeoniaceae (Peony family), e.g. Chinese peony [8]
A61K  36/66  \	3	3	4C088	A61K  36/66	159	ʡ㡥ͥΣ	Papaveraceae (Poppy family), e.g. bloodroot [8]
A61K  36/67  \	3	3	4C088	A61K  36/67	392	祦ʡ㡥ޥڥåѡޤϥСΣ	Piperaceae (Pepper family), e.g. Jamaican pepper or kava [8]
A61K  36/68  \	3	3	4C088	A61K  36/68	295	ХʡΣ	Plantaginaceae (Plantain Family) [8]
A61K  36/69  \	3	3	4C088	A61K  36/69	164	ҥϥʡΣ	Polygalaceae (Milkwort family) [8]
A61K  36/70  \	3	3	4C088	A61K  36/70	518	ǲʡ㡥ԥեޤϥΣ	Polygoraceae, e.g. spin flower or sorrel [8]
A61K  36/704  \	4	4	4C088	A61K  36/704	168	°㡥ǡΣ	Polygonum, e.g. knotweed [8]
A61K  36/708  \	4	4	4C088	A61K  36/708	276	°Σ	Rheum [8]
A61K  36/71  \	3	3	4C088	A61K  36/71	253	ݥʡ㡥ҥ󥽥ϥޥҥɥ饹ޥޤϥǥ󥷡Σ	Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal [8]
A61K  36/714  \	4	4	4C088	A61K  36/714	99	ȥꥫ֥°Σ	Aconiyum [8]
A61K  36/716  \	4	4	4C088	A61K  36/716	43	˥󥽥°Σ	Clematis [8]
A61K  36/718  \	4	4	4C088	A61K  36/718	327	°Σ	Coptis [8]
A61K  36/72  \	3	3	4C088	A61K  36/72	121	ɥʡ㡥ɥϥ֥饷ΥޤϥΥΣ	Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree [8]
A61K  36/725  \	4	4	4C088	A61K  36/725	434	ʥĥ°㡥ʥĥΣ	Ziziphus, e.g. jujube [8]
A61K  36/73  \	3	3	4C088	A61K  36/73	1634	Хʡ㡥祳٥꡼ʥޤϥȥ掠󥶥Σ	Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn [8]
A61K  36/732  \	4	4	4C088	A61K  36/732	131	ܥ°㡥ܥΣ	Chaenomeles, e.g. flowering quince [8]
A61K  36/734  \	4	4	4C088	A61K  36/734	293	󥶥°Σ	Crataegus [8]
A61K  36/736  \	4	4	4C088	A61K  36/736	941	°㡥⡤ܡ⡤󥺤ޤϥɡΣ	Prunus, e.g. plum, cherry, peach, apricot or almond [8]
A61K  36/738  \	4	4	4C088	A61K  36/738	541	Х°Σ	Rosa [8]
A61K  36/739  \	4	4	4C088	A61K  36/739	122	⥳°Σ	Sanguisorba [8]
A61K  36/74  \	3	3	4C088	A61K  36/74	754	ͲʡΣ	Rubiaceae [8}
A61K  36/744  \	4	4	4C088	A61K  36/744	265	ʥ°Σ	Gardenia [8]
A61K  36/746  \	4	4	4C088	A61K  36/746	77	䥨ޥ°Σ	Morinda [8]
A61K  36/748  \	4	4	4C088	A61K  36/748	29	եХ॰°Σ	Oldenlandia or Hedyotis [8]
A61K  36/75  \	3	3	4C088	A61K  36/75	342	ߥʡΣ	Rutaceae (Rue family) [8]
A61K  36/752  \	4	4	4C088	A61K  36/752	1551	ߥ°㡥饤ࡤ󥸤ޤϥΣ	Citrus, e.g. lime, orange or lemon [8]
A61K  36/754  \	4	4	4C088	A61K  36/754	88	°Σ	Evodia [8]
A61K  36/756  \	4	4	4C088	A61K  36/756	414	ϥ°㡥ϥΣ	Phellodendron, e.g. corktree [8]
A61K  36/758  \	4	4	4C088	A61K  36/758	246	󥷥祦°㡥󥷥祦Σ	Zanthoxylum, e.g. pricklyash [8]
A61K  36/76  \	3	3	4C088	A61K  36/76	165	ʥʡ㡥ݥץΣ	Salicaceae (Willow family), e.g. poplar [8]
A61K  36/77  \	3	3	4C088	A61K  36/77	364	९ʡ㡥饤ޤϥ९Σ	Sapindaceae (Soapberry family), e.g. lychee or soapberry [8]
A61K  36/78  \	3	3	4C088	A61K  36/78	314	ɥ߲ʡΣ	Saururaceae (Lizard's-tail family) [8]
A61K  36/79  \	3	3	4C088	A61K  36/79	181	ޥĥ֥ʡΣ	Schisandraceae (Schisandra family) [8]
A61K  36/80  \	3	3	4C088	A61K  36/80	191	ޥΥϥʡΣ	Scrophulariaceae (Figwort family) [8]
A61K  36/804  \	4	4	4C088	A61K  36/804	289	°Σ	Rehmannia [8]
A61K  36/808  \	4	4	4C088	A61K  36/808	45	ޥΥϥ°Σ	Scrophulariaceae (Figwort family) [8]
A61K  36/81  \	3	3	4C088	A61K  36/81	1286	ʥʡ㡥Х̥ۥȥޥȡ٥ɥʡȥ饷ޤϥ祦󥢥Σ	Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed [8]
A61K  36/815  \	4	4	4C088	A61K  36/815	302	°Σ	Lycium [8]
A61K  36/82  \	3	3	4C088	A61K  36/82	1919	ĥХʡ㡥ĥХΣ	Theaceae (Tea family), e.g. camellia [8]
A61K  36/83  \	3	3	4C088	A61K  36/83	70	祦ʡ㡥Υޤϥե륹إΣ	Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo [8]
A61K  36/835  \	4	4	4C088	A61K  36/835	35	󥳥°Σ	Aquilaria [8]
A61K  36/84  \	3	3	4C088	A61K  36/84	164	ߥʥʡ㡥ΥΣ	Valerianaceae, e.g. valerian [8]
A61K  36/85  \	3	3	4C088	A61K  36/85	129	ޥĥťʡΣ	Verbenaceae (Verbena family) [8]
A61K  36/855  \	4	4	4C088	A61K  36/855	18	°㡥Σ	Clerodendrum, e.g. glorybower [8]
A61K  36/86  \	3	3	4C088	A61K  36/86	51	ߥʡΣ	Violaceae (Violet family) [8]
A61K  36/87  \	3	3	4C088	A61K  36/87	897	֥ɥʡ㡥衼åѥ֥ɥޥޤϥڥѡХΣ	Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine [8]
A61K  36/88  \	2	2	4C088	A61K  36/88	742	ˡñտʪˡΣ	Liliopsida (monocotyledons) [8]
A61K  36/882  \	3	3	4C088	A61K  36/882	113	祦ֲʡ㡥ȥեåޤϥ祦֡Σ	Acoraceae (Calamus family), e.g. sweetflag or Acorus calamus [8]
A61K  36/884  \	3	3	4C088	A61K  36/884	110	ʡΣ	Alismataceae (Water-plantain family) [8]
A61K  36/886  \	3	3	4C088	A61K  36/886	534	ʡ㡥٥Σ	Aloeaceae (Aloe family), e.g. aloe vera [8]
A61K  36/888  \	3	3	4C088	A61K  36/888	196	ȥʡ㡥饸ࡤޤϥߥХ祦Σ	Araceae, e.g. caladium, calla lily or skunk cabbage [8]
A61K  36/8884  \	4	4	4C088	A61K  36/8884	6	ƥʥ󥷥祦°㡥ޥॷΣ	Arisaema, e.g. Jack in the pulpit [8]
A61K  36/8888  \	4	4	4C088	A61K  36/8888	134	ϥ°Σ	Pinellia [8]
A61K  36/889  \	3	3	4C088	A61K  36/889	433	䥷ʡ㡥ʥĥ䥷㤷ϥ䥷ڤޤϥѥåȡΣ	Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto [8]
A61K  36/8895  \	4	4	4C088	A61K  36/8895	1	ȥ°㡥ȥΣ	Calamus, e.g. calamus [8]
A61K  36/89  \	3	3	4C088	A61K  36/89	54	ĥꥰʡΣ	Cyperaceae [8]
A61K  36/8905  \	4	4	4C088	A61K  36/8905	54	ڥ饹°Σ	Cyperus [8]
A61K  36/894  \	3	3	4C088	A61K  36/894	163	ޥΥʡΣ	Dioscoreacea [8]
A61K  36/8945  \	4	4	4C088	A61K  36/8945	137	।⡤㡥ࡤʥޤϥΣ	Dioscorea, e.g. yam, Chinese yam or water yam [8]
A61K  36/896  \	3	3	4C088	A61K  36/896	514	ʡ㡥ƥܥҥ䥷󥹤ޤϥΣ	Liliaceae, e.g. daylily, plantain lily, Hyacinth or narcissus [8]
A61K  36/8962  \	4	4	4C088	A61K  36/8962	912	ͥ°㡥ѥޥͥͥ˥˥ޤϥ㥤֡Σ	Allium, e.g. garden onion, leek, garlic or chives [8]
A61K  36/8964  \	4	4	4C088	A61K  36/8964	51	ϥʥΣ	Anemarrhena [8]
A61K  36/8965  \	4	4	4C088	A61K  36/8965	111	ѥ饬㡥ѥѥ饬ޤϥΥ֥ܥΣ	Asparagus, e.g. garden asparagus or asparagus fern [8]
A61K  36/8966  \	4	4	4C088	A61K  36/8966	24	Х°㡥襦饯ޤϥߥå٥Σ	Fritillaria, e.g. checker lily or mission bells [8]
A61K  36/8967  \	4	4	4C088	A61K  36/8967	84	°㡥˥ޤϥƥåݥΣ	Lilium, e.g. tiger lily or Easter lily [8]
A61K  36/8968  \	4	4	4C088	A61K  36/8968	121	Υҥ°Σ	Ophiopogon [8]
A61K  36/8969  \	4	4	4C088	A61K  36/8969	130	ޥɥ°Σ	Polygonatum [8]
A61K  36/898  \	3	3	4C088	A61K  36/898	158	ʡΣ	Orchidaceae (Orchid family) [8]
A61K  36/8984  \	4	4	4C088	A61K  36/8984	30	å°Σ	Dendrobium [8]
A61K  36/8988  \	4	4	4C088	A61K  36/8988	32	˥Υ䥬°Σ	Gastrodia [8]
A61K  36/899  \	3	3	4C088	A61K  36/899	3285	Ͳʡ㡥ȥޤϥȥӡΣ	Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane [8]
A61K  36/8994  \	4	4	4C088	A61K  36/8994	424	奺°Σ	Coix [8]
A61K  36/8998  \	4	4	4C088	A61K  36/8998	651	८°Σ	Hordeum [8]
A61K  36/90  \	3	3	4C088	A61K  36/90	51	ȥꥤХʡ㡥ȥꥤХޤϥ륵ѥΣ	Smilacaceae, e.g. smilax china or Sarsaparilla [8]
A61K  36/902  \	3	3	4C088	A61K  36/902	19	ߥʡΣ	Sparganiaceae (Bur-reed family) [8]
A61K  36/904  \	3	3	4C088	A61K  36/904	13	ӥ㥯ֲʡ㡥ʥ٥Σ	Stemonaceae (Stemona family), e.g. croomia [8]
A61K  36/906  \	3	3	4C088	A61K  36/906	426	祦ʡΣ	Zingiberaceae (Ginger family) [8]
A61K  36/9062  \	4	4	4C088	A61K  36/9062	256	ϥʥߥ祦°㡥åɥ󥸥㡼ޤϥ祦祦Σ	Alpinia formosana, e.g. red ginger or Alpiniae Officinari Rhizoma. [8]
A61K  36/9064  \	4	4	4C088	A61K  36/9064	48	ޥ°㡥饦ɥΣ	Amomum, e.g. round cardamom [8]
A61K  36/9066  \	4	4	4C088	A61K  36/9066	756	°㡥󡦥å쥤ɥ롼Ȥޤϥޥ󥴡󥸥㡼Σ	Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger [8]
A61K  36/9068  \	4	4	4C088	A61K  36/9068	996	祦°㡥ѥ祦Σ	Zingiber, e.g. garden ginger [8]
A61K  38/00  \	0	0	4C084	A61K  38/00	42990	ڥץɤͭޡʦ¡ݥ饯ĴͭڥץɣˣľڥץɤǤäơʬˤδĤڥץɷʳΥڥץɷͭʤΡ㡥ԥڥ饸ݣݥˣ르˴Ťڥץɣˣʬ׳ŪʬۤƤ륢ߥλñ̤ͭʬҲʪͭΣˣޤϹΤͭޣˣԳʬħΤޡ㡥ôΤȤƤΥڥץɡˣˡΣ	Medicinal preparations containing peptides(peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergoline-based peptides A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00) [6]
A61K  38/01  \	1	1	4C084	A61K  38/01	3265	ÿʬ򤷤ͶƳΡΣ	Hydrolyzed proteins; Derivatives thereof [6]
A61K  38/02  \	1	1	4C084	A61K  38/02	9436	ԳΥߥλΥڥץɡͶƳΡΣ	Peptides of undefined number of amino acids; Derivatives thereof [6]
A61K  38/03  \	1	1	4C084	A61K  38/03	1509	ԳޤʬŪˤΤ߳ꤷˤΣʲΥߥλĥڥץɡͶƳΡΣ	Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof [6]
A61K  38/04  \	1	1	4C084	A61K  38/04	227	˳ꤷˤΡʲΥߥλĥڥץɡͶƳΡʥȥˣޥȥˣΥȥԥˣˡΣ	Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof (gastrins A61K38/16, somatostatins A61K38/31, melanotropins A61K38/34) [6]
A61K  38/05  \	2	2	4C084	A61K  38/05	4308	ڥץɡΣ	Dipeptides [6]
A61K  38/06  \	2	2	4C084	A61K  38/06	3316	ȥڥץɡΣ	Tripeptides [6]
A61K  38/07  \	2	2	4C084	A61K  38/07	2837	ƥȥڥץɡΣ	Tetrapeptides [6]
A61K  38/08  \	2	2	4C084	A61K  38/08	6934	ΥߥλĥڥץɡΣ	Peptides having 5 to 11 amino acids [6]
A61K  38/09  \	3	3	4C084	A61K  38/09	544	ηۥХۥΣ̣ȣңȡϡϢڥץɡΣ	Luteinizing hormone-releasing hormone (LHRH); Related peptides [6]
A61K  38/095  \	3	3	4C084	A61K  38/095	374	ȥ󡨥Хץ쥷󡨴ϢڥץɡΣ	Oxytocins; Vasopressins; Related peptides
A61K  38/10  \	2	2	4C084	A61K  38/10	5134	ΥߥλĥڥץɡΣ	Peptides having 12 to 20 amino acids [6]
A61K  38/12  \	2	2	4C084	A61K  38/12	3468	ľڥץɡΣ	Cyclic peptides [6]
A61K  38/13  \	3	3	4C084	A61K  38/13	1157	ݥΣ	Cyclosporins [6]
A61K  38/14  \	2	2	4C084	A61K  38/14	1144	ͭڥץɡͶƳΡΣ	Peptides containing saccharide radicals; Derivatives thereof [6]
A61K  38/15  \	2	2	4C084	A61K  38/15	373	ǥץڥץɡͶƳΡΣ	Depsipeptides; Derivatives thereof [6]
A61K  38/16  \	1	1	4C084	A61K  38/16	18474	ʾΥߥλĥڥץɡȥ󡨥ޥȥ󡨥Υȥԥ󡨤ͶƳΡΣ	Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof [6]
A61K  38/16 100 \	2	2	4C084	A61K  38/16	309	Ž	agglutinin
A61K  38/16 200 \	2	2	4C084	A61K  38/16	1891	ץƥ˳ޤι˳	proteinous enzyme inhibitors excluding protease inhibitors
A61K  38/17  \	2	2	4C084	A61K  38/17	5678	ưʪͳ表ҥͳΣ	from animals; from humans [6]
A61K  38/17 100 \	3	3	4C084	A61K  38/17	1804	֥	Globulins
A61K  38/18  \	3	3	4C084	A61K  38/18	2936	ĹҡĹĴҡΣ	Growth factors; Growth regulators [6]
A61K  38/19  \	3	3	4C084	A61K  38/19	4072	ȥ󡨥ե󡨥󥿡եΣ	Cytokines; Lymphokines; Interferons [6]
A61K  38/20  \	4	4	4C084	A61K  38/20	3671	󥿡Σ	Interleukins [6]
A61K  38/21  \	4	4	4C084	A61K  38/21	3832	󥿡եΣ	Interferons [6]
A61K  38/22  \	3	3	4C084	A61K  38/22	6441	ۥʥץԥΥ󡤥ץ󥱥եޤϥץΥե󤫤ͶƳΣˣ㡥ȥԥˣˡΣ	Hormones(derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin A61K38/33, e.g. corticotropin A61K38/35) [6]
A61K  38/23  \	4	4	4C084	A61K  38/23	710	륷ȥ˥Σ	Calcitonins [6]
A61K  38/24  \	4	4	4C084	A61K  38/24	701	˦ɷۥΣƣӣȡϡɷۥ㡥ȣãǡηۥΣ̣ȡϡþɷۥΣԣӣȡϡΣ	Follicle-stimulating hormone (FSH); Chorionic gonadotropins, e.g. HCG; Luteinising hormone (LH); Thyroid-stimulating hormone (TSH) [6]
A61K  38/25  \	4	4	4C084	A61K  38/25	468	ĹۥаҡΣǣȣңơϡʤޥȥ٥Σ	Growth hormone-releasing factor [GH-RF], i.e. somatoliberin [2006.01]
A61K  38/26  \	4	4	4C084	A61K  38/26	1125	륫Σ	Glucagons [6]
A61K  38/27  \	4	4	4C084	A61K  38/27	1719	ĹۥΣǣȡϡʤޥȥȥԥΣ	Growth hormone [GH], i.e. somatotropin [2006.01]
A61K  38/28  \	4	4	4C084	A61K  38/28	2593	󥷥Σ	Insulins [6]
A61K  38/29  \	4	4	4C084	A61K  38/29	787	þۥ󡤤ʤѥȥþۥϢڥץɡΣ	Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides [2006.01]
A61K  38/30  \	4	4	4C084	A61K  38/30	872	󥷥Ĺҡʤޥȥ᥸㡥ɣǣơݣɣǣơݣΣ	Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2 [2006.01]
A61K  38/31  \	4	4	4C084	A61K  38/31	566	ޥȥΣ	Somatostatins [6]
A61K  38/32  \	4	4	4C084	A61K  38/32	139	ݥΣ	Thymopoietins [6]
A61K  38/33  \	3	3	4C084	A61K  38/33	466	ץԥΥ󡤥ץ󥱥եޤϥץΥե󤫤ͶƳΡΣ	derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin [6]
A61K  38/34  \	4	4	4C084	A61K  38/34	218	ΥȻɷۥΣͣӣȡϡ㡥ݥΥȥԥޤϦ¡ݥΥȥԥΣ	Melanocyte stimulating hormone (MSH), e.g. alpha- or beta-melanotropin [6]
A61K  38/35  \	4	4	4C084	A61K  38/35	329	ȥԥΣãԣȡϡΣ	Corticotropin (ACTH) [6]
A61K  38/36  \	3	3	4C084	A61K  38/36	2673	նŸǤޤϲҡΣ	Blood coagulation or fibrinolysis factors [6]
A61K  38/37  \	4	4	4C084	A61K  38/37	954	֣ɣɣɰҡΣ	Factors VIII [6]
A61K  38/38  \	3	3	4C084	A61K  38/38	898	֥ߥΣ	Albumins [6]
A61K  38/39  \	3	3	4C084	A61K  38/39	1291	ȿڥץɡ㡥顼󡤥饹󡤥ߥ˥󡤥ե֥ͥ󡤥ӥȥͥ󡤴֥ΣãɣǡϡΣ	Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin (CIG) [6]
A61K  38/40  \	3	3	4C084	A61K  38/40	531	ȥ󥹥ե㡥饯ȥե󡤥ܥȥ󥹥եΣ	Transferrins, e.g. lactoferrins, ovotransferrins [6]
A61K  38/41  \	2	2	4C084	A61K  38/41	88	ݥեĴͭڥץɡޤϥĴͭڥץɡΣ	Porphyrin- or corrin-ring-containing peptides [6]
A61K  38/42  \	3	3	4C084	A61K  38/42	354	إ⥰ӥ󡨥ߥӥΣ	Haemoglobins; Myoglobins [6]
A61K  38/43  \	2	2	4C084	A61K  38/43	3308	ǡΡͶƳΡΣ	Enzymes; Proenzymes; Derivatives thereof [6]
A61K  38/44  \	3	3	4C084	A61K  38/44	1085	ԸǡʣˡΣ	Oxidoreductases (1) [6]
A61K  38/45  \	3	3	4C084	A61K  38/45	848	ȥ󥹥ե顼ʣˡΣ	Transferases (2) [6]
A61K  38/46  \	3	3	4C084	A61K  38/46	4418	ÿʬǡʣˡΣ	Hydrolases (3) [6]
A61K  38/47  \	4	4	4C084	A61K  38/47	1402	ꥳ벽ʪ˺ѤΡʣˡ㡥顼饯Σ	acting on glycosyl compounds (3.2), e.g. cellulases, lactases [6]
A61K  38/48  \	4	4	4C084	A61K  38/48	2583	ڥץɷ˺ѤΡʣˡΣ	acting on peptide bonds (3.4) [6]
A61K  38/48 100 \	5	5	4C084	A61K  38/48	1074	ʬǡ㡥ȥץ	serine proteases, e.g. trypsin
A61K  38/48 110 \	6	6	4C084	A61K  38/48	135	ꥯ쥤	Kallikrein
A61K  38/49  \	5	5	4C084	A61K  38/49	563	ʡȿץ饹ߥΡҡΣ	Urokinase; Tissue plasminogen activator [6]
A61K  38/50  \	4	4	4C084	A61K  38/50	378	ڥץɷʳúǡǷ˺ѤΡʣˡ㡥ѥ饮ʡΣ	acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase [6]
A61K  38/51  \	3	3	4C084	A61K  38/51	211	ꥢʣˡΣ	Lyases (4) [6]
A61K  38/52  \	3	3	4C084	A61K  38/52	54	顼ʣˡΣ	Isomerases (5) [6]
A61K  38/53  \	3	3	4C084	A61K  38/53	142	ꥬʣˡΣ	Ligases (6) [6]
A61K  38/54  \	3	3	4C084	A61K  38/54	85	ˣˣޤϣˣˣΡʾΥ롼פʬवǤޤϹΤκʪΣ	Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 to A61K38/46 or A61K38/51 to A61K38/53 [6]
A61K  38/55  \	2	2	4C084	A61K  38/55	3180	ץƥ˳ޡΣ	Protease inhibitors [6]
A61K  38/56  \	3	3	4C084	A61K  38/56	135	ʪͳΣ	from plants [6]
A61K  38/57  \	3	3	4C084	A61K  38/57	700	ưʪͳ表ҥͳΣ	from animals; from humans [6]
A61K  38/58  \	4	4	4C084	A61K  38/58	19	ҥͳ衤㡥ҥ른󡤥Σ	from leeches, e.g. hirudin, eglin [6]
A61K  39/00  \	0	0	4C085	A61K  39/00	901	ޤϹΤͭޡȱʬʪǣΣˡΣ	Medicinal preparations containing antigens or antibodies (materials for immunoassay G01N 33/53) [2]
A61K  39/00  A	0	0	4C085	A61K  39/00	733	˴ؤ붦̵	Common technology related to antigens
A61K  39/00  B	0	1	4C085	A61K  39/00	192		Culture
A61K  39/00  C	0	1	4C085	A61K  39/00	205	ϲ	Insolubilization
A61K  39/00  D	0	1	4C085	A61K  39/00	167	ʬΥ	Separation, refinement
A61K  39/00  E	0	1	4C085	A61K  39/00	142	경	Stabilization
A61K  39/00  F	0	1	4C085	A61K  39/00	69		Equipment
A61K  39/00  G	0	1	4C085	A61K  39/00	1834		Preparation
A61K  39/00  H	0	0	4C085	A61K  39/00	8564	ưʪХƥꥢߥ륹ʳι	Antigens other than protozoa, bacteria, chlamydia, virus
A61K  39/00  J	0	1	4C085	A61K  39/00	219	ޥץ饺޹	Mycoplasma antigens
A61K  39/00  K	0	1	4C085	A61K  39/00	402	ݹ	Mycoantigens
A61K  39/00  Z	0	0	4C085	A61K  39/00	1133	¾Τ	Others
A61K  39/002  \	1	1	4C085	A61K  39/002	653	ưʪΣ	Protozoa antigens [3]
A61K  39/005  \	2	2	4C085	A61K  39/005	49	ȥѥΥ޹Σ	Trypanosoma antigens [3]
A61K  39/008  \	2	2	4C085	A61K  39/008	51	꡼ޥ˥Σ	Leishmania antigens [3]
A61K  39/012  \	2	2	4C085	A61K  39/012	146	๳Σ	Coccidia antigens [3]
A61K  39/015  \	2	2	4C085	A61K  39/015	325	˦㡥ץ饺⥸๳Σ	Hemosporidia antigens, e.g. Plasmodium antigens [3]
A61K  39/018  \	3	3	4C085	A61K  39/018	18	Х٥㡥ꥢΣ	Babesia antigens, e.g. Theileria antigens [3]
A61K  39/02  \	1	1	4C085	A61K  39/02	1981	ХƥꥢιΣ	Bacterial antigens [2]
A61K  39/04  \	2	2	4C085	A61K  39/04	656	ߥХƥꥦ°㡥˶ݡΣ	Mycobacterium, e.g. Mycobacterium tuberculosis [2,3]
A61K  39/05  \	2	2	4C085	A61K  39/05	426	ͥХƥꥦ°ץԥХƥꥦ°Σ	Corynebacterium; Propionibacterium [3]
A61K  39/07  \	2	2	4C085	A61K  39/07	264	ݡΣ	Bacillus [3]
A61K  39/08  \	2	2	4C085	A61K  39/08	656	ȥꥸ°㡥˽ݡΣ	Clostridium, e.g. Clostridium tetani [2]
A61K  39/085  \	2	2	4C085	A61K  39/085	462	֥ɥݡΣ	Staphylococcus [3]
A61K  39/09  \	2	2	4C085	A61K  39/09	988	ϢݡΣ	Streptococcus [3]
A61K  39/095  \	2	2	4C085	A61K  39/095	763	ʥꥢ°Σ	Neisseria [3]
A61K  39/10  \	2	2	4C085	A61K  39/10	546	֥륻°ܥǥƥ°㡥ɴݡΣ	Brucella; Bordetella, e.g. Bordetella pertussis [2,3]
A61K  39/102  \	2	2	4C085	A61K  39/102	470	ѥĥ°إե饹°Σ	Pasteurella; Haemophilus [3]
A61K  39/104  \	2	2	4C085	A61K  39/104	234	塼ɥʥ°Σ	Pseudomonas [3]
A61K  39/106  \	2	2	4C085	A61K  39/106	370	ӥ֥ꥪԥХΣ	Vibrio; Campylobacter [3]
A61K  39/108  \	2	2	4C085	A61K  39/108	463	ҥ°֥°Σ	Escherichia; Klebsiella [3]
A61K  39/112  \	2	2	4C085	A61K  39/112	439	ͥ°°Σ	Salmonella; Shigella [3]
A61K  39/114  \	2	2	4C085	A61K  39/114	16	եХƥꥦ°Σ	Fusobacterium [3]
A61K  39/116  \	2	2	4C085	A61K  39/116	206	¿ХƥꥢΣ	Polyvalent bacterial antigens [3]
A61K  39/118  \	1	1	4C085	A61K  39/118	276	ߥ㡥ȥ饳ޥߥޤϥ¥ߥΣ	Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci [3]
A61K  39/12  \	1	1	4C085	A61K  39/12	3402	륹Σ	Viral antigens [2]
A61K  39/125  \	2	2	4C085	A61K  39/125	231	ԥʥ륹ʡ㡥ꥷ륹Σ	Picornaviridae, e.g. calicivirus [3]
A61K  39/13  \	3	3	4C085	A61K  39/13	326	ݥꥪ륹Σ	Poliovirus [3]
A61K  39/135  \	3	3	4C085	A61K  39/135	104	֥륹Σ	Foot-and-mouth disease virus [3]
A61K  39/145  \	2	2	4C085	A61K  39/145	1907	륽ߥ륹ʡ㡥ե륨󥶥륹Σ	Orthomyxoviridae, e.g. influenza virus [3]
A61K  39/15  \	2	2	4C085	A61K  39/15	304	쥪륹ʡ㡥ҵβΡ륹Σ	Reoviridae, e.g. calf diarrhea virus [3]
A61K  39/155  \	2	2	4C085	A61K  39/155	615	ѥߥ륹ʡ㡥ѥ饤ե륨󥶥륹Σ	Paramyxoviridae, e.g. parainfluenza virus [3]
A61K  39/165  \	3	3	4C085	A61K  39/165	239	ץޤ㿾륹Σ	Mumps or measles virus [3]
A61K  39/17  \	3	3	4C085	A61K  39/17	177	˥塼å¥륹Σ	Newcastle disease virus [3]
A61K  39/175  \	3	3	4C085	A61K  39/175	82	Υƥѡ륹Σ	Canine distemper virus [3]
A61K  39/187  \	2	2	4C085	A61K  39/187	81	ڥ饦륹Σ	Hog cholera virus [3]
A61K  39/193  \	2	2	4C085	A61K  39/193	33	ϤǾԿꥦ륹Σ	Equine encephalomyelitis virus [3]
A61K  39/20  \	2	2	4C085	A61K  39/20	176	륹Σ	Rubella virus [2]
A61K  39/205  \	2	2	4C085	A61K  39/205	335	֥ɥ륹ʡ㡥¥륹Σ	Rhabdoviridae, e.g. rabies virus [3]
A61K  39/21  \	2	2	4C085	A61K  39/21	1219	ȥ륹ʡ㡥Ϸ쥦륹Σ	Retroviridae, e.g. equine infectious anemia virus [3]
A61K  39/215  \	2	2	4C085	A61K  39/215	751	ʥ륹ʡ㡥˥ȥɻٱꥦ륹Σ	Coronaviridae, e.g. avian infectious bronchitis virus [3]
A61K  39/225  \	3	3	4C085	A61K  39/225	47	Ĳꥦ륹Σ	Porcine transmissible gastroenteritis virus[2006.01]
A61K  39/23  \	2	2	4C085	A61K  39/23	272	ѥܥ륹ʡ㡥ǭ帺ɥ륹Σ	Parvoviridae, e.g. feline panleukopenia virus [3]
A61K  39/235  \	2	2	4C085	A61K  39/235	377	ǥΥ륹ʡΣ	Adenoviridae [3]
A61K  39/245  \	2	2	4C085	A61K  39/245	1020	إڥ륹ʡ㡥ñإڥ륹Σ	Herpetoviridae, e.g. herpes simplex virus [3]
A61K  39/25  \	3	3	4C085	A61K  39/25	244	Ӿ׿륹Σ	Varicella-zoster virus [3]
A61K  39/255  \	3	3	4C085	A61K  39/255	123	ޥå¥륹Σ	Marek's disease virus [3]
A61K  39/265  \	3	3	4C085	A61K  39/265	65	ɻٱꥦ륹Σ	Infectious rhinotracheitis virus [3]
A61K  39/27  \	3	3	4C085	A61K  39/27	16	Ϥٱꥦ륹Σ	Equine rhinopneumonitis virus [3]
A61K  39/275  \	2	2	4C085	A61K  39/275	295	ݥå륹ʡ㡥ӥݥå륹Σ	Poxviridae, e.g. avipoxvirus [3]
A61K  39/285  \	3	3	4C085	A61K  39/285	186	륹ޤ쥦륹Σ	Vaccinia virus or variola virus [3]
A61K  39/29  \	2	2	4C085	A61K  39/29	1469	αꥦ륹Σ	Hepatitis virus [3]
A61K  39/295  \	2	2	4C085	A61K  39/295	540	¿륹ʼ륹ޤ쥦륹ˣˡ륹ȥХƥꥢȤ¿Σ	Polyvalent viral antigens (vaccinia virus or variola virus A61K 39/285); Mixtures of viral and bacterial antigens [3]
A61K  39/35  \	1	1	4C085	A61K  39/35	618	륲Σ	Allergens [3]
A61K  39/36  \	2	2	4C085	A61K  39/36	223	ʴΤΡΣ	from pollen [2,3]
A61K  39/38  \	1	1	4C085	A61K  39/38	27	ؤιΣ	Antigens from snakes [2]
A61K  39/385  \	1	1	4C085	A61K  39/385	1047	ôΤ˷礷ϥץƥޤϹΣ	Haptens or antigens, bound to carriers [3]
A61K  39/39  \	1	1	4C085	A61K  39/39	5937	ȱ¥ղʪˤäħŤ줿Ρ㡥ŪХȡΣ	characterised by the immunostimulating additives, e.g. chemical adjuvants [3]
A61K  39/395  \	1	1	4C085	A61K  39/395	1440	ΡʶŽǣˣˡȱ֥֥ȱַ㡥ѵΣ	Antibodies (agglutinins A61K 38/36); Immunoglobulins; Immune serum, e.g. antilymphocytic serum [3]
A61K  39/395  A	1	0	4C085	A61K  39/395	653	Ρ̥Υݥʥ빳Τ	Antibodies (excluding monoclonal)
A61K  39/395  B	1	1	4C085	A61K  39/395	353	ˡ	Manufacturing method
A61K  39/395  C	1	1	4C085	A61K  39/395	2336	ߥ뵻	Missile technology
A61K  39/395  D	1	1	4C085	A61K  39/395	18162	ʪФ	For specific substances
A61K  39/395  E	1	2	4C085	A61K  39/395	5042	Ф	For cancer
A61K  39/395  F	1	2	4C085	A61K  39/395	95	󥿡ݥեФ	For interferon
A61K  39/395  G	1	2	4C085	A61K  39/395	537	ѵФ	For lymphocytes
A61K  39/395  H	1	0	4C085	A61K  39/395	839	Υݥʥ빳	Monoclonals
A61K  39/395  J	1	1	4C085	A61K  39/395	469	ˡܡ˦	Manufacturing method
A61K  39/395  K	1	1	4C085	A61K  39/395	136		Refinement
A61K  39/395  L	1	1	4C085	A61K  39/395	4062	ߥ뵻	Missile technology
A61K  39/395  M	1	1	4C085	A61K  39/395	1576	ޡ경	Medicines, preparations, stabilization
A61K  39/395  N	1	1	4C085	A61K  39/395	26611	ʪФ	For specific substances
A61K  39/395  P	1	2	4C085	A61K  39/395	1034	ǡǥҥӥݤФ	For enzymes, enzyme inhibitors
A61K  39/395  Q	1	2	4C085	A61K  39/395	209	ʪФΡ̸	For microorganisms (protozoa)
A61K  39/395  R	1	3	4C085	A61K  39/395	852	ٶݡӤФ	For bacteria, mold
A61K  39/395  S	1	3	4C085	A61K  39/395	1375	륹Ф	For viruses
A61K  39/395  T	1	2	4C085	A61K  39/395	11175	Ф	For cancer
A61K  39/395  U	1	2	4C085	A61K  39/395	4618	ȱĴҤФ	For immunoregulation factors
A61K  39/395  V	1	0	4C085	A61K  39/395	894	ȱ֥֥	Immunoglobulins
A61K  39/395  W	1	1	4C085	A61K  39/395	450	̮Ϳѡ͡경	Treatment (for intravenous administration), stabilization
A61K  39/395  X	1	1	4C085	A61K  39/395	263	ʬΥ	Separation, refinement
A61K  39/395  Y	1	1	4C085	A61K  39/395	3003	ӡ۹ޡޡ̥ߥ	Medical purpose, compounding agent, preparation (missile)
A61K  39/395  Z	1	0	4C085	A61K  39/395	213	¾Τ	Others
A61K  39/40  \	2	2	4C085	A61K  39/40	167	ХƥꥢΤΡΣ	bacterial [2,3]
A61K  39/42  \	2	2	4C085	A61K  39/42	134	륹ΤΡΣ	viral [2,3]
A61K  39/44  \	2	2	4C085	A61K  39/44	399	ôΤ˷礷ΡΣ	Antibodies bound to carriers [2,3]
A61K  40/00  \	0	0	4C087	A61K  40/00	10	˦ȱˡʹޤϹΤͭޣˣˡΣ	Cellular immunotherapy (medicinal preparations containing antigens or antibodies A61K 39/00)[2025.01]
A61K  40/10  \	1	1	4C087	A61K  40/10	372	Ѥ˦μħΤΡΣ	characterised by the cell type used[2025.01]
A61K  40/11  \	2	2	4C087	A61K  40/11	1646	Ժ˦㡥翻ѵΣԣɣ̡ϤޤԡΣԣϺ˦ۥ顼Σ̣ˡϺ˦Σ	T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells[2025.01]
A61K  40/13  \	2	2	4C087	A61K  40/13	192	º˦Σ	B-cells[2025.01]
A61K  40/15  \	2	2	4C087	A61K  40/15	837	ʥ륭顼ΣΣˡϺ˦ʥ륭顼ԡΣΣˣԡϺ˦Σ	Natural-killer [NK] cells; Natural-killer T [NKT] cells[2025.01]
A61K  40/17  \	2	2	4C087	A61K  40/17	266	ñ塨ޥեΣ	Monocytes; Macrophages[2025.01]
A61K  40/19  \	2	2	4C087	A61K  40/19	252	˦Σ	Dendritic cells[2025.01]
A61K  40/20  \	1	1	4C087	A61K  40/20	11	˦θǽޤϵǽħΤΡΣ	characterised by the effect or the function of the cells[2025.01]
A61K  40/22  \	2	2	4C087	A61K  40/22	114	ȱޤȱִΣ	Immunosuppressive or immunotolerising[2025.01]
A61K  40/24  \	2	2	4C087	A61K  40/24	121	󼨺˦ΣУáϡΣ	Antigen-presenting cells [APC][2025.01]
A61K  40/30  \	1	1	4C087	A61K  40/30	433	ȱַϤκ˦ʬҤȴȯħΤΡΣ	characterised by the recombinant expression of specific molecules in the cells of the immune system[2025.01]
A61K  40/31  \	2	2	4C087	A61K  40/31	1367	鹳ΡΣãҡϡΣ	Chimeric antigen receptors [CAR][2025.01]
A61K  40/32  \	2	2	4C087	A61K  40/32	543	Ժ˦ΡΣԣãҡϡΣ	T-cell receptors [TCR][2025.01]
A61K  40/33  \	2	2	4C087	A61K  40/33	154	ΡԺ˦󥲡㡼Σ	Antibodies; T-cell engagers[2025.01]
A61K  40/34  \	2	2	4C087	A61K  40/34	24	ڥץɡΣ	Antigenic peptides[2025.01]
A61K  40/35  \	2	2	4C087	A61K  40/35	181	ȥΣ	Cytokines[2025.01]
A61K  40/36  \	2	2	4C087	A61K  40/36	40	ȱ֥åݥ˳ޡΣ	Immune checkpoint inhibitors[2025.01]
A61K  40/40  \	1	1	4C087	A61K  40/40	13	ȱַϤκ˦ˤɸŪȤ롤ޤ󼨤빳ħΤΡΣ	characterised by antigens that are targeted or presented by cells of the immune system[2025.01]
A61K  40/41  \	2	2	4C087	A61K  40/41	160	ưʪιΣ	Vertebrate antigens[2025.01]
A61K  40/42  \	3	3	4C087	A61K  40/42	1085	󹳸Σ	Cancer antigens[2025.01]
A61K  40/43  \	2	2	4C087	A61K  40/43	24	ưʪΣ	Protozoan antigens[2025.01]
A61K  40/44  \	2	2	4C087	A61K  40/44	37	ݹΣ	Fungal antigens[2025.01]
A61K  40/45  \	2	2	4C087	A61K  40/45	54	ХƥꥢιΣ	Bacterial antigens[2025.01]
A61K  40/46  \	2	2	4C087	A61K  40/46	165	륹Σ	Viral antigens[2025.01]
A61K  40/48  \	2	2	4C087	A61K  40/48	8	륲Σ	Allergens[2025.01]
A61K  40/50  \	1	1	4C087	A61K  40/50	284	Ʊ۷Ϻ˦λѤħΤΡΣ	characterised by the use of allogeneic cells[2025.01]
A61K  41/00  \	0	0	4C084	A61K  41/00	2163	ưͥ륮ޤγʪ뤳ȤˤäޡΣ	Medicinal preparations obtained by treating materials with wave energy or particle radiation
A61K  41/10  \	1	1	4C084	A61K  41/10	15	ưʪޤϥҥȤؤͿΰޤԳޤϱΣ	Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
A61K  41/13  \	2	2	4C084	A61K  41/13	14	ĶȤˤΡΣ	by ultrasonic waves[2020.01]
A61K  41/17  \	2	2	4C084	A61K  41/17	219	糰Σգ֡ϤޤֳΣɣҡϡޤϥˤΡΣ	by ultraviolet [UV] or infrared [IR] light X-rays or gamma rays
A61K  45/00  \	0	0	4C084	A61K  45/00	67506	ˣˣ°ʤʬͭޡΣ	Medicinal preparations containing active ingredients not provided for in groups A61K 31/00-A61K 41/00 [2,6]
A61K  45/00 101 \	1	1	4C084	A61K  45/00	418	˦Ϥɷ㤹ȱֳŪޡ㡥ФΡʣȣߡ	immunological preparations stimulating endothelial cellular system, e.g. anitcancer (Created in May 1999)
A61K  45/06  \	1	1	4C084	A61K  45/06	8097	Ū⤿ʤʬκʪ㡥ñޤӶޡΣ	Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca [2]
A61K  45/08  \	1	1	4C084	A61K  45/08	812	ʪȲŪħΤʤʪ㡥ҥߥޤɽ̳ʪȤκʪΣ	Mixtures of an active ingredient and an auxiliary substance neither being chemically characterised, e.g. antihistaminicum and surface active substance [2]
A61K  47/00  \	0	0	4C076	A61K  47/00	371	ѤԳʬ㡥ôΤޤԳźúޡħΤޡʬȲط礷ɸŪޤޤϽޡΣ	Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient [2]
A61K  47/02  \	1	1	4C076	A61K  47/02	14091	̵ʪΣ	Inorganic compounds [5]
A61K  47/04  \	2	2	4C076	A61K  47/04	7571	°ǡβʪΣ	Non-metals; Compounds thereof [5]
A61K  47/06  \	1	1	4C076	A61K  47/06	3218	ͭʪ㡥ŷޤϹúǡݥꥪե󡤹ڥȥ饿ޤϥ饤ȡΣ	Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
A61K  47/08  \	2	2	4C076	A61K  47/08	2100	ǤͭΡΣ	containing oxygen [5]
A61K  47/10  \	3	3	4C076	A61K  47/10	21824	륳롨եΡ롨α㡥ꥻ󡨥ݥꥨ󥰥ꥳΣУţǡϡݥޡУţǡУϣť륭륨ƥΣ	Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers [2017.01]
A61K  47/12  \	3	3	4C076	A61K  47/12	14973	ܥαޤ̵ʪΣ	Carboxylic acids; Salts or anhydrides thereof [2006.01]
A61K  47/14  \	3	3	4C076	A61K  47/14	11440	ܥΥƥ롤㡥ûΥꥻɡ溿ȥꥰꥻɡѥ٥ޤϣУţǻûƥΣ	Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters [2017.01]
A61K  47/16  \	2	2	4C076	A61K  47/16	2401	ǤͭΡΣ	containing nitrogen [2006.01]
A61K  47/18  \	3	3	4C076	A61K  47/18	11129	ߥ󡨥ߥɡǢǡ͵饢˥ಽʪߥλĤޤǤΥߥλͭ륪ꥴڥץɡΣ	Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids [2017.01]
A61K  47/20  \	2	2	4C076	A61K  47/20	4935	βͭΡ㡥륹ۥɡΣģͣӣϡϡɥȡ饦βʥȥꥦޤϥߥΥۥΣ	containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids [2006.01]
A61K  47/22  \	2	2	4C076	A61K  47/22	9058	ʣǴļʪ㡥ӥȥեޤϥԥɥΣ	Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones [2006.01]
A61K  47/24  \	2	2	4C076	A61K  47/24	7505	úǡǡǡϥǤޤβʳθҤͭΡ㡥ޤϥΣ	containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids [2006.01]
A61K  47/26  \	2	2	4C076	A61K  47/26	16310	ú岽ʪ㡥륳롤ߥ˻ñޤϥꥴͶƳΡ㡥ݥ꥽١ȡӥûƥޤϥΣ	Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin [2006.01]
A61K  47/28  \	2	2	4C076	A61K  47/28	3741	ƥɡ㡥쥹ƥ롤ޤϥΣ	Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid [2006.01]
A61K  47/30  \	1	1	4C076	A61K  47/30	3033	ʬͭʪޤϹʬ̵ʪ㡥̵ݥΣ	Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates [2006.01]
A61K  47/32  \	2	2	4C076	A61K  47/32	16692	úǡú˰·ΤߤͿȿˤäʬҲʪ㡥ܥޡΣ	Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers [2006.01]
A61K  47/34  \	2	2	4C076	A61K  47/34	18365	úǡú˰·ΤߤͿȿʳȿˤäʬҲʪ㡥ݥꥨƥ롤ݥꥢߥλݥꥷ󡤥ݥۥե󡤥ݥꥢ륭󥰥ꥳζŹΤޤϥݥޡζŹΡʣˣͥˡΣ	Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence) [2017.01]
A61K  47/36  \	2	2	4C076	A61K  47/36	16795	¿ࡨͶƳΡ㡥ࡤǤפ󡤥륮ǥȥ󡤥ҥȥ󡤥̥󡤴ŷޤϥڥΣ	Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin [2006.01]
A61K  47/38  \	3	3	4C076	A61K  47/38	15484	ͶƳΡΣ	Cellulose; Derivatives thereof [2006.01]
A61K  47/40  \	3	3	4C076	A61K  47/40	2870	ǥȥ󡨤ͶƳΡΣ	Cyclodextrins; Derivatives thereof [2006.01]
A61K  47/42  \	2	2	4C076	A61K  47/42	11419	ݥڥץɡʬʪͶƳΡ㡥֥ߥ󡤥ޤϥʣĤޤǤΥߥλͭ륪ꥴڥץɣˣݥꥢߥλˣˡΣ	Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein (oligopeptides having up to five amino acids A61K47/18; polyamino acids A61K47/34) [2017.01]
A61K  47/44  \	1	1	4C076	A61K  47/44	7116	ˣˣΣʾΥ롼פ˳äޤϥåŷޤ줿ŷäޤϥå㡥ҥޥݥꥨȥҥޥ󥿥åꥰʥȡå̪ϹޤϥΥʹꥻɡ㡥溿ȥꥰꥻɣˣˡΣ	Oils, fats or waxes according to two or more groups of A61K47/02 to A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin (synthetic glycerides, e.g. medium-chain triglycerides, A61K47/14) [2017.01]
A61K  47/46  \	1	1	4C076	A61K  47/46	3791	¤ʬޤϤȿʪ㡥桤ݡ̡ͺޤϿʪʪΣ	Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts [2006.01]
A61K  47/50  \	1	1	4C076	A61K  47/50	7196	ʬȲط礷Գʬ㡥ŹΰΡΣ	the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates [2017.01]
A61K  47/51  \	2	2	4C076	A61K  47/51	209	ԳʬޤǤΡΣ	the non-active ingredient being a modifying agent [2017.01]
A61K  47/52  \	3	3	4C076	A61K  47/52	389	ޤ̵ʪǤΡ㡥ʬʣβ줿̵Σ	the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient [2017.01]
A61K  47/54  \	3	3	4C076	A61K  47/54	4287	ޤͭʪǤΡΣ	the modifying agent being an organic compound [2017.01]
A61K  47/55  \	4	4	4C076	A61K  47/55	1344	ޤŪޤϼŪ˳ޤǤ⤢ΡʤΤɥåǤΡΣ	the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug[2017.01]
A61K  47/56  \	3	3	4C076	A61K  47/56	1014	ޤͭʬҲʪǤΡ㡥ꥴޡݥޡޤϥǥɥޡΣ	the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule [2017.01]
A61K  47/58  \	4	4	4C076	A61K  47/58	997	úǡú˰·ΤߤͿȿˤäΡ㡥ݥʥ᥿˥졼ȡݥꥢ륢ߥɡݥꥹ󡤥ݥӥ˥ԥɥ󡤥ݥӥ˥륢륳ޤϥݥꥹ󥹥ۥΣ	obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin [2017.01]
A61K  47/59  \	4	4	4C076	A61K  47/59	1280	úǡú˰·ΤߤͿȿʳȿˤäΡ㡥ݥǢǤޤϥݥꥦ쥿Σ	obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes [2017.01]
A61K  47/60  \	5	5	4C076	A61K  47/60	3548	ͭʬҲʪݥꥪ륭ΥꥴޡݥޡޤϥǥɥޡǤΡ㡥УţǡУУǡУţϤޤϥݥꥰꥻΣ	the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol [2017.01]
A61K  47/61  \	4	4	4C076	A61K  47/61	1774	ͭʬҲʪ¿ΤޤϤͶƳΤǤΡΣ	the organic macromolecular compound being a polysaccharide or a derivative thereof [2017.01]
A61K  47/62  \	3	3	4C076	A61K  47/62	1096	ޤڥץɤޤϥݥꥢߥλǤΡΣ	the modifying agent being a protein, peptide or polyamino acid [2017.01]
A61K  47/64  \	4	4	4C076	A61K  47/64	4808	ȥڥץɤηΡηΤޤϰȥݥꥢߥληΡʤޤŪޤ˶ͭޤʣβڥץɡޤϥݥꥢߥλǤΡʥڥץΥ󥫡ˣˡΣ	Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent  (peptidic linkers A61K47/65) [2017.01]
A61K  47/65  \	4	4	4C076	A61K  47/65	2088	ڥץΥ󥫡Ϣޡڡ㡥Ǥ԰ʥڥץΥ󥫡Σ	Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers [2017.01]
A61K  47/66  \	4	4	4C076	A61K  47/66	453	ޤκ˦ɸŪˤ뤿˥ڥץɤޤͿץ쥿ƥ󥰥ƥǤΡΣ	the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells [2017.01]
A61K  47/68  \	3	3	4C076	A61K  47/68	7946	ޤΡȱ֥֥ޤϤҤǤΡ㡥ƣҡΣ	the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment [2017.01]
A61K  47/69  \	2	2	4C076	A61K  47/69	2640	ΤʪŪ֤ޤϥ̥֤ħͭΤǤΡ㡥ޥ른γҡʣΡƥȤޤϥåȡΣ	the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit [2017.01]
A61K  48/00  \	0	0	4C084	A61K  48/00	31953	Ҽ¤Ť뤿Τκ˦ʪͭޡҼšΣ	Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy [5]
A61K  49/00  \	0	0	4C085	A61K  49/00	6543	ΤޡΣ	Preparations for testing <u>in vivo</u> [3]
A61K  49/04  \	1	1	4C085	A61K  49/04	1928	¤ƺޡΣ	X-ray contrast preparations [3]
A61K  49/04 100 \	2	2	4C085	A61K  49/04	187	βХꥦޤ	including barium sulfates
A61K  49/04 200 \	2	2	4C085	A61K  49/04	85	ϥͭʪ	halogen-containing compound
A61K  49/04 210 \	3	3	4C085	A61K  49/04	665	襦Ǵͭʪ	iodine-containing compound
A61K  49/06  \	1	1	4C085	A61K  49/06	2402	˼ġΣΣͣҡ¤ƺޡıˡΣͣңɡ¤ƺޡΣ	Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations [2006.01]
A61K  49/08  \	2	2	4C085	A61K  49/08	2263	ôΤħΡΣ	characterised by the carrier [7]
A61K  49/10  \	3	3	4C085	A61K  49/10	800	ͭʪΣ	Organic compounds [7]
A61K  49/12  \	4	4	4C085	A61K  49/12	878	ʬҲʪΣ	Macromolecular compounds [7]
A61K  49/14  \	4	4	4C085	A61K  49/14	748	ڥץɡ㡥Σ	Peptides, e.g. proteins [7]
A61K  49/16  \	5	5	4C085	A61K  49/16	478	Ρȱ֥֥󡨤ҡΣ	Antibodies; Immunoglobulins; Fragments thereof [7]
A61K  49/18  \	2	2	4C085	A61K  49/18	2449	̤ʪŪ֤ħΡ㡥ޥ른󡤥ޥץ롤ݥΣ	characterised by a special physical form, e.g. emulsions, microcapsules, liposomes [7]
A61K  49/20  \	2	2	4C085	A61K  49/20	94	ե꡼饸ޤΡΣ	containing free radicals [7]
A61K  49/22  \	1	1	4C085	A61K  49/22	706	ޡĶȱޡΣ	Echographic preparations; Ultrasonic imaging preparations[2006.01]
A61K  50/00  \	0	0	4C085	A61K  50/00	3	ǤμŤޤϸǻѤƳźޡ㡥ŷסΣţãǡϤޤϷͿΤŶˤȶ˻ѤƳޤޤϥΣ	Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography [ECG] or for transcutaneous drug administration [2006.01]
A61K  50/00 100 \	1	1	4C084	A61K  50/00	272	ӡŸΤʤˣͿػߡ	for therapy [prohibit classfying A61K 50/00 without expansion symbol]
A61K  50/00 200 \	1	1	4C085	A61K  50/00	244	ӡŸΤʤˣͿػߡ	for testing [prohibit classfying A61K 50/00 without expansion symbol]
A61K  51/00  \	0	0	4C085	A61K  51/00	28	ǤμŤޤϸѤʪͭޡΣ	Preparations containing radioactive substances for use in therapy or testing in vivo
A61K  51/00 100 \	1	1	4C084	A61K  51/00	1980	ŤѤΡŸΤʤˣͿػߡ	for therapy [prohibit classfying A61K 51/00 without expansion symbol]
A61K  51/00 200 \	1	1	4C085	A61K  51/00	4824	ѤΡŸΤʤˣͿػߡ	for testing [prohibit classfying A61K 51/00 without expansion symbol]
A61K  51/02  \	1	1	4C085	A61K  51/02	9	ôΤħΤΡΣ	characterised by the carrier
A61K  51/02 100 \	2	2	4C084	A61K  51/02	254	ŤѤΡŸΤʤˣͿػߡ	for therapy [prohibit classfying A61K 51/02 without expansion symbol]
A61K  51/02 200 \	2	2	4C085	A61K  51/02	4582	ѤΡŸΤʤˣͿػߡ	for testing [prohibit classfying A61K 51/02 without expansion symbol]
A61K  51/04  \	2	2	4C085	A61K  51/04	51	ͭʪΣ	Organic compounds
A61K  51/04 100 \	3	3	4C084	A61K  51/04	294	ŤѤΡŸΤʤˣͿػߡ	for therapy [prohibit classfying A61K 51/04 without expansion symbol]
A61K  51/04 200 \	3	3	4C085	A61K  51/04	1519	ѤΡŸΤʤˣͿػߡ	for testing [prohibit classfying A61K 51/04 without expansion symbol]
A61K  51/04 300 \	3	3	4C085	A61K  51/04	31	̥쥪ɡ̥쥪ɡꥴ̥쥪ɡ˻ŸΤʤˣͿػߡ	Sugar, nucleoside, nucleotide, oligonucleotide, nucleic acid [prohibit classfying A61K 51/04 without expansion symbol]
A61K  51/04 310 \	4	4	4C084	A61K  51/04	142	ŤѤΡŸΤʤˣͿػߡ	for therapy [prohibit classfying A61K 51/04 without expansion symbol]
A61K  51/04 320 \	4	4	4C085	A61K  51/04	554	ѤΡŸΤʤˣͿػߡ	for testing [prohibit classfying A61K 51/04 without expansion symbol]
A61K  51/06  \	3	3	4C085	A61K  51/06	3	ʬҲʪΣ	Macromolecular compounds
A61K  51/06 100 \	4	4	4C084	A61K  51/06	159	ŤѤΡŸΤʤˣͿػߡ	for therapy [prohibit classfying A61K 51/06 without expansion symbol]
A61K  51/06 200 \	4	4	4C085	A61K  51/06	360	ѤΡŸΤʤˣͿػߡ	for testing [prohibit classfying A61K 51/06 without expansion symbol]
A61K  51/08  \	3	3	4C085	A61K  51/08	42	ڥץɡ㡥Σ	Peptides, e.g. proteins
A61K  51/08 100 \	4	4	4C084	A61K  51/08	363	ŤѤΡŸΤʤˣͿػߡ	for therapy[prohibit classfying A61K 51/08 without expansion symbol]
A61K  51/08 200 \	4	4	4C085	A61K  51/08	1835	ѤΡŸΤʤˣͿػߡ	for testing [prohibit classfying A61K 51/08 without expansion symbol]
A61K  51/10  \	4	4	4C085	A61K  51/10	82	Τޤȱ֥֥󡨤Υե饰ȡΣ	Antibodies or immunoglobulins; Fragments thereof
A61K  51/10 100 \	5	5	4C084	A61K  51/10	597	ŤѤΡŸΤʤˣͿػߡ	for therapy [prohibit classfying A61K 51/10 without expansion symbol]
A61K  51/10 200 \	5	5	4C085	A61K  51/10	1703	ѤΡŸΤʤˣͿػߡ	for testing [prohibit classfying A61K 51/10 without expansion symbol]
A61K  51/12  \	1	1	4C085	A61K  51/12	11	̤ʪŪ֤ħΤΡ㡥աޥץ롤ݥΣ	characterised by a special physical form, e.g. emulsion, microcapsules, liposomes
A61K  51/12 100 \	2	2	4C084	A61K  51/12	83	ŤѤΡŸΤʤˣͿػߡ	for therapy [prohibit classfying A61K 51/12 without expansion symbol]
A61K  51/12 200 \	2	2	4C085	A61K  51/12	1983	ѤΡŸΤʤˣͿػߡ	for testing [prohibit classfying A61K 51/12 without expansion symbol]
A61K 101:00  \	0	0		A61K 101/00	34	°Σ	Indexing scheme associated with group A61K 51/00, relating to the nature of the radioactive substance.
A61K 101:02  \	1	1		A61K 101/02	105	ϥΣ	Halogens [6]
A61K 103:00  \	0	0		A61K 103/00	87	°Σ	Radioactive metals [6]
A61K 103:10  \	1	1		A61K 103/10	41	ƥͥࡨ˥Σ	Technetium; Rhenium [6]
A61K 103:20  \	1	1		A61K 103/20	29	󥸥Σ	Indium [6]
A61K 103:30  \	1	1		A61K 103/30	37	ีǡΣ	Rare earths [6]
A61K 103:32  \	2	2		A61K 103/32	39	åȥꥦΣ	Yttrium [6]
A61K 103:34  \	2	2		A61K 103/34	20	ɥ˥Σ	Gadolinium [6]
A61K 103:36  \	2	2		A61K 103/36	6	åƥӥΣ	Ytterbium [6]
A61K 103:40  \	1	1		A61K 103/40	38	˥ɡΣ	Actinides [6]
A61K 125:00  \	0	0		A61K 125/00	2143	庬ԡԤޤϲԤͭΤޤϤ餫ΡΣ	Containing or obtained from roots, bulbs, tubers, corms or rhizomes [8]
A61K 127:00  \	0	0		A61K 127/00	2990	դͭΤޤϤ줫ΡΣ	Containing or obtained from leaves [8]
A61K 129:00  \	0	0		A61K 129/00	803	ͭΤޤϤ줫ΡΣ	Containing or obtained from bark [8]
A61K 131:00  \	0	0		A61K 131/00	4073	ҡڤμ¡̼¤ޤϹʪͭΤޤϤ줫ΡΣ	Containing or obtained from seeds, nuts, fruits or grains [8]
A61K 133:00  \	0	0		A61K 133/00	916	֤ͭΤޤϤ餫ΡΣ	Containing or obtained from flowers or blossoms [8]
A61K 135:00  \	0	0		A61K 135/00	1234	ԡޡޤޤϿͭΤޤϤ餫ΡΣ	Containing or obtained from stems, stalks, branches, twigs or shoots [8]
